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ABSTRACT 
 
Iron plays a potential role in oxidative stress-mediated injuries and pathologies e.g. 
rheumatoid arthritis (RA). Four decades ago it was suggested that iron may have a 
crucial role in the progression of inflammation in RA.  Indeed, free radicals generated 
by iron can cause damage to lipids, proteins, carbohydrates, and DNA.  It is this 
destructive process that is believed to occur in rheumatoid joints. However, none had 
differentiated between the role of iron in both acute and chronic phases of the disease 
and the origin of this 'labile' iron.  Since RA cells are chronically exposed to oxidative 
stress, we have therefore chosen Jurkat cells to be our cell model. We used the 
parental (J16) cell line was used to mimic the acute phase of oxidative stress and the 
H2O2-resistant (HJ16) cells to mimic the chronic phase. By using hydrogen peroxide 
(H2O2) as the oxidising agent, we aim to study the role of iron in acute and chronic 
phase of oxidative stress and to know its origin. In the present study, we found that 
both antioxidants and H2O2-induced labile iron are modulated when cells are 
chronically exposed to H2O2. HJ16 cells contain higher total intracellular glutathione 
levels and glutathione peroxidase activity than J16 cells while the superoxide 
dismutase and catalase activity are similar. Haem oxygenase-1 (HO-1) was not 
detectable nor was it induced in these cell lines; HO-2 on the other hand was 
expressed but not induced. Although they had the same ‘basal’ LIP and L-Ft levels, 
J16 cells contain more than 7-fold higher H-Ft levels than in HJ16 cells. It was also 
found that H2O2-induced labile iron is directly correlated with necrotic cell death. 
These results are consistent with the conclusion that both antioxidant defence 
mechanism and labile iron status are modulated in cells chronically exposed to H2O2. 
We have also shown that the ‘basal’ and ‘H2O2-induced’ NFκB activation was higher 
in the HJ16 cells. We have also provided a link between labile iron release, lysosomal 
membrane damage and the ensuing necrotic cell death following H2O2 treatment.  
 
 VIII
 
ABBREVIATIONS 
 
 
AA   Adjuvant Arthritis 
ADP   Adenosine 5’-diphosphate  
AI   Anaemia of inflammation 
ARD   Ankyrin repeat domain 
ATP   Adenosine 5’-triphosphate 
BSO   Buthionine-[S,R]sulfoximine  
CA   Calcein 
CA-AM  Calcein-acetoxymethyl ester 
CIA   Collagen induced arthritis 
CM   Condition media 
CO    Carbon Monoxide 
DFO   Desferrioxamine 
DMEM   Dulbecco's Modified Eagle's Medium  
DMSO  Dimethyl Sulphoxide 
DMT1   Divalent metal transporter 1 
DNA   Deoxyribonucleic acid 
DTT   Dithiothreitol 
EDTA   Ethylenediaminetetraacetic acid 
EGTA   Ethylene gycol-bis[β-aminoethylether]-N,N,N’N’tetraacetic acid 
EMEM                       Earle’s modified minimum essential medium 
EMSA   Electrophorectic mobility shift assay 
FAD   Flavin adenine dinucleotide 
Fe2+                     Ferrous iron 
Fe3+                     Ferric iron 
Ft   Ferritin 
GPx      Glutathione peroxidase 
GR                      Glutathione disulphide reductase  
GSH                    Glutathione (reduced) 
GSSG      Glutathione disulphide (oxidised) 
 IX
GSH/GSSG  Total intracellular glutathione 
H   Hour / Hours 
H-Ft   H-chain of Ferritin 
H2O2                           Hydrogen peroxide 
HCP-1  Haem carrier protein-1 
HEPES  N-[2-hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid] 
HO-1   Haem oxygenase 1 
HO-2   Haem oxygenase 2 
IL-1β   Interleukin-1β 
IRE   Iron-responsive element 
IRP   Iron regulatory protein 
RNS   Reactive nitrogen species 
ROS   Reactive oxygen species  
RT    Room temperature 
L•   Fatty acid radical 
LDL   Low density lipoprotein 
L-Ft   L-chain of Ferritin 
LIP   Labile iron pool 
LI   Labile iron 
LOO •                         Fatty acid peroxyl radical 
LOOH  Lipid hydroperoxide 
LPI    Labile plasma iron 
MnSOD  Manganese superoxide dismutase 
Mt-Ft   Mitochondrial ferritin 
NADP   Nicotinamide adenine dinucleotide phosphate 
NADPH  Nicotinamide adenine dinucleotide phosphate (reduced) 
NBTI   Non-transferrin bound iron 
NF-κB   Nuclear Factor kappa B  
NLS   Nuclear localization sequence  
NO   Nitric oxide 
NO2   Nitrogen dioxide 
NP-40   Nonidet P-40 
NR   Neutral red 
 X
OA    Osteoarthritis 
O2              Oxygen 
1O2                              Singlet oxygen 
O2•-                      Superoxide anion 
OH•                             Hydroxyl radical 
PBS                             Phosphate buffered saline 
Pi   Inorganic Phosphate 
PI   Propidium Iodide 
PL   Picoliter 
PMSF   Phenylmethanesulfonyl fluoride 
PUFA   Polyunsaturated fatty acids 
RA                              Rheumatoid Arthritis 
RHD   Rel-homology domain  
ROS   Reactive oxygen species 
RT   Room temperature 
SDS    Sodium dodecyl sulphate 
SF   Synovial fluid 
SFM                           Serum free media 
SIH    Salicylaldehyde isonicotinoyl hydrazone  
SOD   Superoxide dismutase 
TCA   Trichloroacetic acid 
Tf   Transferrin 
TfR   Transferrin receptor 
TNF   Tumor necrosis factor 
TRx    Thioredoxin 
UTR   Untranslated region 
UV              Ultraviolet  
V   Volts 
Chapter one – Introduction  
     
Page | 1 
 
CHAPTER ONE 
 
INTRODUCTION 
 
 
1.1 Inflammation  
Inflammation has long been recognised both in clinical practice and in 
research laboratories (McCarty, 1989).  The Roman physician Celsus (30 BC - 38 
AD) described the classical signs of inflammation as 'redness' and 'swelling' with 
'heat' and 'pain' (rubor et tumor cum calore et dolore).  A century later, Galen (130-
200 AD) added 'loss of function' (function laesa) to be the fifth sign of inflammation 
(Bonta et al, 1985 and Junqueira et al, 1986).  Many of the classical features of 
inflammation were described as early as 1600 BC in Egyptian papyrus writings 
(Goldsby et al, 2003). 
 
1.1.1 General overview 
Inflammation is a term used to illustrate the body's complex physiological 
response, whether acute or chronic, to tissue injury (Underwood, 1996).  It is a 
vascular and cellular defence reaction against foreign bodies; mainly pathogenic 
bacteria or chemical substances (Junqueira et al, 1986). This response is not a single 
event but rather a sequence of events to that particular injury (Bonta et al, 1985).   
Injuries can be classified into three types: (i) physical injury, (ii) chemical 
injury, and (iii) pathogenic organisms.  Physical injuries are those injuries that are 
related to trauma, radiation, heat, or cold.  Chemical injuries are due to acid, alkalis, 
phenols etc, and pathogenic organisms such as bacteria, viruses or fungi can also 
cause injury to the exposed tissue (Mulvihill et al, 2001).  In 1940, it was postulated 
that the endogenous release of substances was responsible for the characteristic 
changes seen in inflammation (Menken, 1940). Many years later, in a study 
performed by Spector and Willoughby (1957), it was shown that the first substance to 
be released was histamine in acute inflammation.  After this discovery, other 
mediators have been postulated to be responsible for the initiation of inflammation, 
e.g. 5-hydroxytryptamine, bradykinin, and prostaglandins (Di rosa et al, 1971).    
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Depending on the duration of inflammation, it may be subdivided into acute 
and chronic inflammation.  The transition from the acute to the chronic phase may be 
the result of three different factors (Bonta et al, 1985 and Goldsby et al, 2003) : (a) 
the persistence of the initiating inflammatory irritant (e.g. poorly degradable 
substance i.e. microoganisms possessing cell wall components that enable them to 
resist phagocytosis), (b) the presence of an endogenous antigen (e.g. modified protein 
is important in the development of adjuvant arthritis), or (c) various endogenous 
factors which alter the cell type and their function (e.g. mitogenic factors).  
 
1.1.2 Acute inflammation  
Acute inflammation is evident when the response of the microcirculation to 
tissue injury is a brief vasoconstriction of the arteriolar vessels which is then followed 
by vasodilatation (Bonta et al, 1985). Due to the release of histamine from mast cells, 
during acute inflammation, increased blood flow and capillary permeability occur 
along with the accumulation of fluid, leukocytes, and inflammatory mediators such as 
cytokines (Feghali and Wright, 1997). This produces oedema and in turn causes 
pressure on the nerves resulting in pain and loss of function. The role of this acute 
response is to clear dead cells from the site of the injury, to protect the site against any 
pathogens, and to permit the immune system to gain access to the site of 
inflammation (Junqueira et al, 1986).   
Neutrophils predominate during this initial or acute phase, since they were 
principally present in acute inflammatory lesions (Stevens and Lowe, 1995). Acute 
inflammation usually begins within two hours of the injury and lasts for a couple of 
days.  IL-1, IL-6, and TNF-α are cytokines which play a crucial role in the 
development of local and systemic features of the acute response (Goldsby et al, 
2003).   
Reactions to the skin from a burn or an insect bite, acute epiglottitis, acute 
meningitis, and acute hepatitis are various examples of acute inflammation.  
 
1.1.3 Chronic inflammation 
It is crucial that inflammatory reactions are self-limited upon e.g. elimination 
of the triggering factors, if not, they do perpetuate to chronic inflammation (Schett, 
2008).  The transition between the acute phase and the chronic phase is largely 
dependent on the persistence of the inflammatory cause.  When the cause persists, 
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chronic inflammation follows, which may last for a prolonged duration of time - 
weeks, months, or even indefinitely, and subsequently the cell population changes 
(Feghali and Wright, 1997).  Chronic inflammation can occur in three different 
scenarios: (1) when phagocytes are unable to degrade the microoganisms, (2) in an 
autoimmune disease in which self-antigens continually activate T cells, or (3) in 
cancer where the inflammation contributes to tissue damage (Goldsby et al, 2003). 
Lymphocytes and macrophages are the predominant cells in chronic 
inflammation (Junqueira et al, 1986; Underwood, 1996; and Stevens and Lowe, 
1999).  In the inflamed area, these cells engulf the remains of cells and fibres and 
participate in the production of antibodies against invading microoganisms (Junqueira 
et al, 1986).  Lymphocytes are the key components in the onset and exacerbation of 
autoimmune diseases and the cytokines produced by them have a great impact on 
disease progression (Horwood, 2008).  Large numbers of activated macrophages 
release hydrolytic enzymes and reactive oxygen and nitrogen species which are 
responsible for the tissue damage observed in chronic inflammation (Goldsby et al, 
2003). Cytokines released by activated macrophages are known to stimulate fibroblast 
proliferation and collagen production.  IFN-γ and TNF-α, are the two central 
cytokines which play a central role in the initiation of this chronic response; IFN-γ is 
produced primarily by T cells whereas TNF-α is mainly produced by macrophages.   
Examples of chronic inflammation would be: implanted foreign body in a 
wound, tuberculosis, inflammatory bowel disease (Crohn's disease and ulcerative 
colitis), and rheumatoid arthritis. 
 
1.1.3.1 Rheumatoid arthritis 
 Rheumatoid arthritis (RA) is a chronic inflammatory and a systemic 
autoimmune disease of unknown aetiology, affecting 1-1.5 % of the world's 
population and involves all racial and ethnic groups (McCarty, 1989 and Khurana and 
Berney, 2005). It is an illness with significant mortality and morbidity rates due to 
organ damage and failure. The ratio of female to male patients is approximately 2-4:1, 
the basis of this difference is unknown (Khurana and Berney, 2005). Symmetric 
inflammation of synovial joints leading to progressive erosion of both articular 
cartilage and periarticular bone is its main characteristic (Doan and Massarotti, 2005 
and Lipsky, 2007).  Symptoms such as weight loss, fatigue, and malaise also occur in 
rheumatoid arthritic patients in addition to the articular manifestations (Khurana and 
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Berney, 2005). Rheumatoid arthritis is therefore a disease which combines chronic 
inflammation and bone loss; growing evidence shows that inflammation per se is a 
major precipitator for skeletal destruction (Schett, 2006).  
Although the aetiology of RA is not known, it is believed to be related to a 
complex of genetic, endogenous (e.g. hormonal, endocrine, or metabolic factors), and 
exogenous factors (e.g. geographic, infectious agents, or occupational factors) 
(McCarty, 1989 and Doan and Massarotti, 2005). All have been shown to be 
implicated in the progress of RA but none is shown to be its primarily cause.  
Evidence coming from different experimental approaches (Panayi et al, 2001) 
strongly supports the hypothesis that RA is a disease initiated and driven by T cells 
irrespective of its cause.  Macrophages, fibroblasts, and T lymphocytes are three cell 
populations which are found abundantly in the rheumatoid arthritic synovium (Tran et 
al, 2005); T-cells represent 40% of the synovial cellular infiltrate (Ling and Miossec, 
2007). These cells are shown to play a substantial role in the development and the 
progression of RA (Cope, 2002). Stimulation of monocytes, macrophages, and 
synovial fibroblasts, by T-cells, leads to the secretion of a number of mediators 
including enzymes which are involved in the erosion and degradation of bone and 
cartilage. Along with this, these cells produce antibodies and proinflammatory 
cytokines (notably IL-1, IL-6 and TNF-α) that drive the chronic inflammation in RA 
(Doan and Massarotti, 2005 and Lipsky, 2007).  
 
1.1.3.2 Osteoarthritis 
Osteoarthritis (Weiland et al, 2005) is one of the most common musculo-
skeletal diseases and as in RA, the aetiology is largely unknown. It is characterised by 
the gradual development of pain, stiffness, and limitation of motion and these 
symptoms are localized in the joints (McCarty, 1989). It is therefore a painful and 
disabling disease that affects millions of patients around the globe i.e. every 1.5 
minutes, a joint is replaced due to osteoarthritis (OA) in Europe.  It mostly affects 
people above the age of 65, and inflammation can occur in OA but is more like a wear 
process, where the cartilage in the joint can’t tolerate the load which has been placed 
on it.  In RA by comparison, this process is a complication that only occurs later. 
Figure 1.1 shows an illustration of the cross section of a normal, RA, and OA knee 
joint. 
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Figure 1.1 : 
Cross section of a normal, RA, and OA knee joint. 
The topmost illustration shows the cross section of a normal knee joint: a crescent-
shaped disk held in place by ligaments (the meniscus) reduces friction during joint 
movement, while the membrane surrounding movable joints (the synovium) secretes 
a lubricating fluid. 
Below that, the two illustrations on the left show the effect of rheumatoid arthritis, 
and the two illustrations on the right show the effects of osteoarthritis. 
FDA Consumer Health Information; used with permission. 
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1.2 Iron 
The chemical symbol for iron, Fe, comes from the Latin word for iron – 
ferrum.  Iron, with an atomic number of 26, is the second most abundant metal in the 
Earth's crust (aluminium is the most abundant metal).   
 
1.2.1 General aspects 
Iron is an essential element for nearly all living organisms by participating in a 
wide variety of important metabolic processes, such as oxygen transport (binding and 
release of haemoglobin), DNA synthesis, electron transport, lipid metabolism, 
photosynthesis and gene regulation (Lieu et al, 2001 and Cairo et al, 2006).  
Therefore, iron is indispensable for the living species. Under aerobic conditions, 
ferrous iron (Fe2+) is readily oxidised in solution to give ferric iron (Fe3+) which is 
insoluble at neutral physiological pH. As a result of this, iron has limited 
bioavailability (Papanikolaou and Pantopoulus, 2005) since environmental iron is in 
the ferric state (Syed et al, 2006).  
Iron, in mammals, is a component of an iron storage protein (e.g. myoglobin 
and ferritin) and iron transport protein (e.g. haemoglobin and transferrin) (reviewed in 
Ganz and Nemeth, 2006) and the majority is present in the haemoglobin in 
erythrocytes (reviewed in Dunn et al, 2007). In humans, iron represents around 50 
mg/kg in an adult man and because of increased blood loss during menstruation and 
child birth, around 40 mg/kg of total body weight in an adult woman (Worwood, 
2005).  Figure 1.2 shows a diagrammatic representation of iron distribution in the 
body (75kg man).  Iron in circulating haemoglobin accounts for the largest 
component (nearly 80%).  The remainder is mostly contained in ferritin and 
haemosiderin.  Haemosiderin is the insoluble product of ferritin proteolysis in 
lysosomes (Halliwell and Gutteridge, 1999).  Iron in myoglobin represents around 
10%, with 1.3% in cytochromes and iron-sulphur proteins, and 0.1% in transferrin. 
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Figure 1.2: 
 
Diagrammatic representation of iron distribution in the body 
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1.2.2     Iron Absorption 
Due to epithelial shedding in the gastrointestinal tract and the skin and 
because of blood loss in women, around 1-2 mg of iron is lost on a daily basis.  This 
loss is usually compensated by the absorption of iron through the diet which contains 
approximately 10-20 mg of iron of which 1-2 mg is absorbed under normal 
circumstances.  This absorption is increased several fold when iron levels are low 
(e.g. in anaemia and hypoxia) and decreased when the iron stores are replete (e.g. in 
iron overload conditions and inflammation) (Andrews, 2005 and Ganz, 2007). 
Dietary iron is absorbed in the duodenum by the duodenal enterocytes 
absorptive lining close to the gastro-duodenal junction (Andrews, 2000 and Miret et 
al, 2003).  It consists of two components, haem and non-haem iron.  Haem iron is 
exclusively present in animal tissues (e.g. in red meat), and is highly bioavailable and 
readily absorbed.  Haem is a molecule that consists of protoporphyrin ring that binds 
ferrous iron. It results from the breakdown of haemoglobin and myoglobin found in 
meat products. Non-haem iron which is present in e.g. cereals and vegetables (and 
also in meat) is either in the reduced ferrous (Fe2+) or mostly, in the oxidised ferric 
state (Fe3+). Low pH in the gastric efflux facilitates iron absorption as it releases iron 
from ligands in food.   
Haem enters the cell (see figure 1.3) via the haem carrier protein 1 (HCP-1) 
(Shayeghi et al, 2005) which is expressed in the apical membrane of duodenal 
epithelial cells, and inside the cell haem is degraded by haem oxygenase to yield 
ferrous iron (see section 1.4.2.4).  The enterocytes of the luminal brush border contain 
an enzymatic ferric reductase activity, called Dcytb (the cytochrome b-like protein) 
(McKie et al, 2002), to ensure that non-haem iron is in the ferrous (Fe2+) state since 
the bioavailability of iron is reduced when it is in the ferric state (Fe3+).  Along with 
the Dcytb, the presence of dietary reducing agents, such as ascorbate and small 
peptides containing cysteinyl and histidyl residues aid this reduction (Sharp, 2005).  
Divalent metal transporter 1 (DMT1, also known as Nramp2 and DCT1) is the apical 
major ferrous transporter, which is responsible for transporting iron into the cell. 
Other divalent metals such as Mn2+, Cu2+ and Zn2+ are also transported by DMT1 
(reviewed in Donovan and Andrews, 2004).   
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          (Apical)                                                                                 (Basolateral) 
 
 
 
Figure 1.3:  
 
The absorption of dietary iron by duodenal enterocytes.  
 
Molecular pathways of haem and non haem iron absorption in the duodenum 
(Modified from Sharp, 2005 and Syed et al, 2006)  
 
Haem enters the cell via the HCP-1 which is expressed in the apical membrane of 
duodenal epithelial cells, and it is degraded by haem oxygenase to yield ferrous iron 
inside the cell.  Iron enters the LIP where it may be then stored in Ft or transferred to 
the plasma and tissues by FP aided by HP, which exhibits a ferroxidase activity. The 
enterocytes of the luminal brush border contain an enzymatic ferric reductase activity, 
apparently the cytochrome b-like protein Dcytb, to ensure that non-haem iron is in the 
ferrous state since the bioavailability of iron is reduced when it's in the ferric state. 
DMT1 is the apical major ferrous transporter, which is responsible for transporting 
iron into the cell. 
 
Abbreviation used: Dcytb, cytochrome b-like protein; DMT1, Divalent metal 
transporter 1;  FP, ferroportin; Ft, ferritin; HCP1, haem carrier protein 1; HP, 
hephaestin; HO, Haem oxygenase; LIP; Labile iron pool. 
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Identified in 2000 by three groups (Abboud and Haile, 2000; Donovan et al, 2000; 
McKie et al, 2000), ferroportin (also known as IREG1 and MTP1) is a distinct 
transporter which is an excellent candidate for the basolateral transfer of iron to the 
plasma and tissues, although little is known how it transports iron (Ganz, 2007).  Iron 
exports from intestinal cells appear to be aided by hephaestin, which exhibits a 
ferroxidase activity (i.e. converts Fe2+ to Fe3+) required for such export (reviewed in 
Ganz and Nemeth, 2006) and ceruloplasmin is involved in iron export from non-
intestinal cells. This notion is supported by the fact that hephaestin deficiency results 
in severe iron-deficiency anaemia (Anderson et al, 2002) and the deficiency of 
ceruloplasmin leads to iron accumulation in macrophages, hepatocytes, and cells of 
the central nervous system (Xu et al, 2004). 
 
1.2.3 Iron homeostasis and metabolism 
Although iron is indispensable for living organisms from bacteria to mammals 
(see 1.2.1), the tight control of this abundant transition metal metabolism is critical 
since disease is associated with both iron overload and deficiency (Andrews, 2000).  
Firm control of iron uptake, storage, and export is essential for cellular iron 
homeostasis (Hentze et al, 2004).  It is normally controlled by the coordinate 
regulation of the expression of two proteins i.e. Ferritin (Ft) and transferrin receptor 
(TfR) (Harford and Klausner, 1990).  
The presence of non-transferrin bound iron (NBTI) in the plasma of patients 
with iron overload disorders (e.g. thalassemia and haemochromatosis) and also in 
patients undergoing chemotherapy was first reported in 1975 (Hershko, 1975). 
However, still very little is known about its chemical nature. Following its receptor 
mediated uptake, NTBI causes organ dysfunction (Syed et al, 2006).  Nevertheless, 
the majority of iron in the blood plasma of normal individuals and in the intestinal 
fluid is bound and transported by transferrin (Tf) (Klausner et al, 1993), that is an 80 
kDa serum glycoprotein capable of binding a maximum of two atoms of ferric iron 
(Aisen and Listowsky, 1980).  Plasma diferric Tf binds to the cell surface TfR, which 
is located on the surface of plasma membrane.  The latter is a homodimer of 95 kDa 
that is capable of binding to two molecules of Tf.  The Tf-TfR complex is then 
internalised by endocytosis.  The endosome is then acidified and iron is exported to 
the cytosol via DMT1 (reviewed in Muckentahler et al, 2008), this results in the 
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release of ferric iron from the Tf and its subsequent reduction to ferrous iron.  Iron is 
then utilised for the synthesis of iron-containing proteins and the excess is stored in 
the 440 kDa iron storage protein, ferritin.  Cytosolic iron is stored in Ft in the ferric 
state but the mechanism of delivery is unknown.  Recently, Shi et al, (2008) proposed 
that human poly (rC)-binding protein (PCBP1) can act as cytosolic iron chaperone in 
the delivery of iron to Ft.  The remaining fraction of cytosolic iron usually stays in the 
cytosol weakly bound to low molecular weight ‘chelates’ such as citrate, ATP, 
pyrophosphates, and ascorbate. This fraction is accessible to iron chelators and 
therefore it is referred to as ‘chelatable iron’.  The chelatable iron, which is in both 
ionic forms (Fe2+ and Fe3+), is also known as the "labile iron pool" (LIP) (Jacobs, 
1977 and Kakhlon and Cabantchik, 2002).  The LIP, at normal levels, represents less 
than 5 % of the total cellular iron (Kakhlon and Cabantchik, 2002 and Andrews, 
2004), but this portion changes with the iron status of the cell (reviewed in Arredondo 
and Nunez, 2005).  The LIP reflects the iron status of the cell since it contains the 
cells' metabolically and catalytically reactive iron, therefore it is a marker of total iron 
content in the cells.  The balanced movement of iron from extracellular and 
intracellular sources maintains the LIP.  The Calcein (CA) assay is a simple and non-
invasive fluorescent technique that is capable of measuring LIP in living cells 
(Epsztejn et al, 1997). 
Transferrin has three major functions: (1) It allows ferric iron to remain 
soluble i.e. in aqueous and pH neutral plasma environment, (2) It allows iron to 
circulate in the safe form, and (3) It facilitates the cellular import of iron (Heeney and 
Andrews, 2004).   
Ferritin (see section 1.4.1.3) is the principal site for iron storage and 
detoxification in microbial, plants, and animal species (Kuhn, 1994 and Aisen et al, 
1999). In addition to its storage capacity, it serves as an iron source for haem 
synthesis and iron containing proteins, and it replenishes the LIP (Meyron-Holtz et al, 
1999).  The mammalian Ft is a heteropolymer of a combination of heavy (H) and light 
(L) chains of around 21 kDa and 19 kDa, respectively (Theil, 1987) which co-
assemble to form a protein shell of 24 subunits.  It can hold up to 4,500 iron atoms in 
its iron core that it surrounded by the shell, but usually has fewer.   To store iron in Ft, 
several steps are required: (1) Fe2+ binding and migration to the ferroxidase site, (2) 
Fe2+ oxidation, (3) Fe3+ hydrolysis, and finally (4) nucleation and the core formation 
(reviewed in Harrison and Arosio, 1996 and Yang et al, 1998).  The H-chain has a 
Chapter one – Introduction  
     
Page | 12 
 
ferroxidase capacity which is responsible for the rapid oxidation of ferrous iron to 
ferric iron and its incorporation.  Therefore, the H-Ft has been proposed to be a 
regulator of the intracellular labile iron pool and a possible attenuator of oxidative 
stress in cells (Epsztejn et al, 1999). The L-chain contributes to the overall protein 
stability and is responsible for iron hydrolysis, nucleation, and the core formation 
(Lawson et al, 1989; Levi et al, 1992; Santambrogio et al, 1993; reviewed in Harrison 
and Arosio, 1996; Yang et al, 1998).  Unlike H-Ft, L-Ft does not seem to have a 
major role in iron metabolism since subjects with genetic hyperferritinaemia-cataract 
syndrome have nearly 10-fold higher L-Ft than normal with no obvious abnormalities 
in iron metabolism (Beaumont et al, 1995 and Girelli et al, 1995). 
Several studies have shown that the levels of iron co-ordinately control the 
levels of TfR and Ft.  For example, during iron deficiency; the synthesis of Ft (L and 
H chain) will be brought to an end while the TfR expression is increased in 
mammalian cells therefore a higher number of TfRs will be present on their cell 
surface for internalisation. The opposite is true when iron is raised in culture medium; 
TfR is down regulated, whereas Ft synthesis is increased to remove excess iron 
(Kuhn, 1994 and reviewed in Cairo and Pietrangelo, 2000). 
Levels of Ft and TfR are controlled by two mammalian iron regulatory 
proteins (IRP1 and IRP2), which are also the sensors of cytoplasmic labile iron 
(reviewed in Cairo and Pietrangelo, 2000).  To ensure that the cells always contain 
sufficient iron for essential metabolic needs without exceeding the threshold of 
toxicity, intensive regulation of these proteins is essential (reviewed in Cairo et al, 
2002).  Adjustment of the intracellular iron concentration to normal and standard 
levels is mainly achieved by the use of these proteins at post-transcriptional levels, 
IRP-2 being the major sensor and modulator of iron metabolism (Recalcati et al, 
2006).  Iron-responsive elements (IRE) are stem loop structures with special base 
sequence in the mRNA of the Ft and TfR proteins (Theil 1990 and Eisenstein, 2000).  
In both H and L subunit of Ft, there is one IRE situated in the 5'- untranslated region 
(UTR), whereas TfR has five IRE motifs in its 3' UTR (Thomson et al, 1999). In iron-
deficient cells, IRP-1 is activated by the removal of an attached iron-sulphur cluster 
and IRP-2's half life is prolonged which causes them to bind to the Ft's and TfR's IRE 
(Samaniego et al, 1994).  The consequences of this binding complex are (1) inhibition 
of Ft mRNA translation and (2) the increase of the stability of TfR mRNA from 
nucleolytic degradation, therefore more protein is made.  This will also increase the 
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translation of DMT1 and decrease ferroportin (reviewed in Muckentahler et al, 2008).   
Conversely, in iron replete cells, IRP-1 will be inactivated by its conversion to 
cytosolic aconitase (its physiological importance remains to be defined) and IRP-2 
will be degraded subsequent to oxidation and ubiquitination (Iwai et al, 1998). This 
will cause (1) translation of mRNA encoding H and L Fts and (2) degradation of TfR 
mRNA.    The lack of IRP binding activity will also decrease the translation of DMT1 
and increase ferroportin (reviewed in Muckentahler et al, 2008).   Thus, the IRP/IRE 
system (see figure 1.4) plays an important role for the regulation of Ft and TfR 
proteins (Eisenstein, 2000) and it has been suggested that this regulation is via the 
cytosolic LIP (Meyron-Holtz et al, 1999). 
 
 
1.2.4 Iron and inflammation 
During inflammation, T cells and macrophages produce a number of cytokines 
which influence the metabolism of iron; affecting its cellular uptake, transport, 
storage, as well as its absorption (Weiss, 2005).   The induction of iron sequestration 
in macrophages and the decrease in iron absorption in the small intestine was shown 
in infections and inflammatory diseases.  This results in the development of anaemia, 
termed ‘anaemia of inflammation’ (AI), formerly known as ‘anaemia of chronic 
disease’ (ACD).    
The AI is a most common condition that is noticeable in patients suffering 
from inflammatory disorders (e.g. rheumatic diseases) (Konijn, 1994).  It is 
characterised by low to normal serum iron levels (i.e. hypoferremia), low serum iron 
binding capacity, and normal to elevated ferritin concentrations.  Several 
proinflammatory cytokines, such as IL-1β and TNF-α, have been shown to contribute 
to the development of AI by the induction of hypoferremia.  These cytokines cause a 
significant decrease in the low serum iron via the induction of Ft biosynthesis in 
macrophages (Alvarez-Hernandez et al, 1989 and Brock and Alvarez-Hernandez, 
1989). They were also found to down-regulate TfR expression (Weiss, 2002) and to 
decrease Tf levels in patients with active RA and AI (Jongen-Lavernic et al, 1995).  
The up-regulation of DMT1 expression and the increase of iron influx into activated 
macrophages were shown by IFN-γ, LPS, and TNF- α. (Ludwiczek et al, 2003).   
 
 
Chapter one – Introduction  
     
Page | 14 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 : 
 
Illustration of the Iron regulatory proteins / Iron responsive elements system.  
 
On the right, is a ribbon diagram of aconitase and on the left is a ribbon diagram of 
IRP bound to IRE. The pink circles on the right and the left represent the aconitase 
and IRP, respectively.  The small white vertical lines on the 5’ or the 3’ region 
represent the IRE.   
 
In iron deficiency, IRP binds to the IRE motifs of H- and L-Ft and TfR and therefore 
represses the translation of H- and L-Ft and stabilises TfR mRNA; leading to 
increased protein expression.  Under iron excess conditions, IRP has low affinity for 
the IRE and instead has aconitase activity. This in turn leads to the translation of Ft 
and the destabilisation of TfR mRNA.  
 
Reproduced and modified from Dr. James Dowden (University of Nottingham, UK); 
used with permission. 
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Rheumatoid arthritic patients with anaemia had significantly higher serum levels of 
TNF- α, IL-1 and IL-6, when compared to non-anaemic RA patients (Voulgari et al, 
1999).  When macrophages were stimulated by IFN-γ and lipopolysaccharide (LPS), 
this induced nitric oxide (NO) synthesis and activated the IRP/IRE binding system 
(Weiss et al, 1993).  Lipopolysaccharide, an endotoxin, is a component of the outer 
membrane of gram negative bacteria.  Low intracellular iron is correlated with the 
production of NO which in turn decreases Ft synthesis and subsequently produces an 
increase in free iron (Weiss et al, 1994).  It was recently demonstrated that T cells 
from RA patients produce ˃ 2.5 times more NO than healthy donor T cells (Nagy et 
al, 2008). Since TNF-α increases NO production in vitro (e.g. in Jurkat cells), this 
indicates that the TNF-α induced NO production may contribute to RA disease 
progression. 
Nemeth et al, (2004a) showed that hypoferremia of inflammation is mediated 
by IL-6 inducing the synthesis of hepcidin, an iron-regulatory hormone.  Hepcidin is a 
25 amino acid polypeptide, with an antimicrobial action, produced mainly by 
hepatocytes, distributed in plasma and first isolated from the urine (reviewed in Ganz, 
2003).  During inflammation and infections, hepcidin is markedly induced causing the 
sequestration of iron in macrophages, hepatocytes and enterocytes (Ganz, 2005).  It 
acts by inhibiting iron release from macrophages and from hepatic stores, and by 
inhibiting intestinal iron absorption. Hepcidin exerts its action by directly binding to 
ferroportin (FP) ; this binding causes the internalisation of FP and its and degradation 
in the lysosomes (Nemeth et al, 2004b). The loss of ferroportin from the cell 
membrane prevents cellular iron export.  Acute and chronic inflammation and iron 
overload were shown to induce hepcidin synthesis, whereas anaemia and hypoxia 
suppress it (Pigeon et al, 2001 and Nicolas et al, 2002). 
 
1.2.5 Rheumatoid arthritis and Iron 
The potential role of iron in rheumatoid arthritis is well documented for the 
past four decades.  In vitro studies revealed that ferrous ions in trace amounts were 
very active in the depolymerisation of purified hyaluronic acid and this is correlated 
with the low viscosity of synovial fluid (SF) of patients with RA.  Spectrographic 
studies showed that SF from patients with RA contained elevated concentration of 
iron (Niedermeier et al, 1962). By emission spectrometric analysis, the mean 
concentration of iron was higher in the SF of RA patients than normal subjects 
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(Niedermeier and Griggs, 1971).   Muirden and Senator (1968) were one of the first to 
suggest the critical role that iron could play in the pathogenesis of RA.  In this study, 
their intention was to demonstrate the distribution of iron, using Prussian blue 
staining, in both normal and joint disease synovia.  The staining occurred in all but 
one of the 23 rheumatoid arthritic synovia. On the other hand, all of the normal 
synovia showed a negative reaction with Prussian blue staining.   
Proinflammatory cytokines such as TNF-α, IL-1, IL-6, and INF-γ, were shown 
to increase Tf and non-Tf bound iron uptake into human monocytes and increase Tf-
bound iron uptake by synovial fibroblasts isolated from rheumatoid arthritic 
synovium (Telfer and Brock, 2004). This suggests that cytokines present in the 
rheumatoid arthritic synovium may lead to the accumulation of iron which contributes 
to the pathogenesis of the disease.  Interestingly, TNF-α, IL-1, and IL-6 were also 
responsible for the induction of Ft synthesis in a hepatic cell line (reviewed in Torti 
and Torti, 2002). 
Iron, mainly bound to Ft, is present in both the rheumatoid synovial membrane 
and fluid (Blake et al, 1981).  In rheumatoid arthritic and osteoarthritic patients, iron 
concentration in the synovial tissue was significantly elevated (Ogilvie–Harris and 
Fornaiser, 1980).  In RA, anaemia is the most frequent extra-articular manifestation of 
the disease.  Its frequency in patients ranges from 15% to 80%, depending on the 
inflammatory condition.  Nine of the eleven rheumatoid arthritic patients receiving 
iron dextran for the treatment of anaemia showed an exacerbation of synovitis (Blake 
et al, 1985).  In vitro, iron dextran stimulates lipid peroxidation.  As a result of this 
lipid peroxidation, it was suggested that iron dextran worsens synovial inflammation. 
Administration of desferrioxamine (DFO) to a chronic inflammatory animal model 
significantly decreased the chronic inflammatory phase (Blake et al, 1983).  
Desferrioxamine (DFO) is a chelating agent that has a high binding affinity for iron, it 
complexes one molecule of Fe3+ per molecule of DFO. Its advantage is in its capacity 
to chelate the 'free iron' inside the cell.  It was therefore suggested that effective iron 
chelation and its removal may modify the inflammatory process in man.  
Desferrioxamine is also a weak scavenger of superoxide anion but a powerful one of 
hydroxyl radical and therefore it efficiently inhibits lipid peroxidation and protects 
cells against oxidative damage (Halliwell and Gutteridge, 1986). Also, when adjuvant 
arthritic rats were treated with DFO, the incidence and severity of joint inflammation 
was reduced (Andrews et al, 1987a). It was also reported that mild iron deficiency 
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significantly reduces the severity of adjuvant induced joint chronic inflammation 
(Andrews et al, 1987b). Taken together, these results suggest a potential role for iron 
in inflammatory joint disease notably rheumatoid arthritis. 
 
 
1.3 Oxidative Stress 
Oxygen is an element that exists in the atmosphere at the percentage of 21%, 
existing as a diatomic molecule, O2, which is referred to as dioxygen.  Oxygen has a 
pivotal role in all animals, plants, and bacteria, since it is essential for the production 
of energy by the use of the O2 dependent electron transport.  Experiments have shown 
that the O2 will cause toxicity if given at a concentration higher than normal 
(Martinez-Cayueta, 1995). 
 
1.3.1   General overview 
 “Oxidative stress” is a term introduced to illustrate the imbalance within the 
cells between the production of prooxidants and antioxidant defences in favour of the 
former.  It occurs either from the increased production of reactive oxygen species 
(ROS) or reactive nitrogen species (RNS), or a deficiency in the antioxidant defence 
systems (Halliwell and Gutteridge, 1999 and Morel and Barouki, 1999). 
 
1.3.2 Free Radicals   
Any atom, molecule, or complex possessing an unpaired electron(s) and 
capable of independent existence is defined as a “free radical” (Cadogan, 1973).  
They can exist in either the gaseous or the liquid phase.    
Free radicals can be formed by three independent methods: 
(a)  Addition of a single electron:              A +  e -                A • - 
(b)  Loss of a single electron:                       A                       A • +  +   e -           
(c) Homolytic fission of a covalent bond where each pair possesses one of the 
unpaired electron:                                     A : B                    A •  +  B • 
The primary source of the production of free radicals within the cells is the 
leakage of electrons, in the mitochondria and the endoplasmic reticulum, from the 
electron transport chain.  Additionally free radicals are also produced by activated 
phagocytes (i.e. macrophages, monocytes, and lymphocytes) during inflammation 
(Cheeseman and Slater, 1993).  In addition to these intracellular sources, there are 
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also exogenous sources such as ionizing radiation, tobacco smoking, and pollutants 
(Martinez-Cayueta, 1995). 
 
1.3.3 Reactive oxygen species (ROS) 
Reactive oxygen species (ROS) is a term used to include oxygen radicals and 
non-radical derivatives of oxygen.  Superoxide anion radical (O2•-) and hydroxyl 
radical (OH•) are examples of oxygen radicals, whereas hydrogen peroxide (H2O2) 
and singlet oxygen (1O2) are examples of non-radicals. 
Superoxide anion (O2•-) is formed by the addition of a single electron to a 
dioxygen molecule, from about 1-3 % of the oxygen we breath in (Halliwell, 1994).  
The protonated form of the reduction of molecular dioxygen by two electrons is H2O2.  
Both O2•- and H2O2 are produced by the NADPH oxidase which is located in the cell 
membrane.  Singlet Oxygen (1O2) is produced by a process which involves the input 
of energy to turn the two parallel spinning electrons into antiparallel spinning.  The 
major source of the OH• is formed via the metal catalyzed Haber-Weiss or the Fenton 
reaction: Superoxide anion radical (O2•-) converts ferric iron to ferrous ions and then 
ferrous ions react with H2O2 to produce OH•: 
          O2•- + Fe3+                           O2 + Fe2+ 
          Fe2+ + H2O2                        Fe3+ + OH- + OH•     (Fenton reaction) 
Net :  O2•-  + H2O2     metal catalyst   O2 +  OH- + OH•    (Haber-Weiss reaction)   
The most potent catalysts of OH• formation under normal physiological 
conditions are iron and copper ions (Halliwell and Gutteridge, 1999).  The hydroxyl 
radical is more reactive than O2•- and H2O2, possessing a short half life, while O2•- and 
H2O2 have longer half lives but are less reactive (Martinez-Cayueta, 1995).   
All major cellular components may be injured by ROS.  The cell membrane 
and the membrane of cell organelles (e.g. mitochondria, lysosomes, and peroxisomes) 
are rich in polyunsaturated fatty acids (PUFAs).  Polyunsaturated fatty acids contain 
two or more carbon-carbon double bonds.  The oxidative damage of PUFAs will 
result in lipid peroxidation; a free radical chain reaction that will generate fatty acid 
radical (L•) and consequently fatty acid peroxyl radical (LOO•), and aldehydes 
(Cheeseman and Slater, 1993).  In addition to rupturing the membrane and causing 
cell death, lipid peroxidation products can inhibit protein synthesis and block 
macrophage action (Winrow et al, 1993).  Furthermore ROS can cause disturbances 
in proteins since they could react with amino acids such as histidine and cysteine.  
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Reactive oxygen species can also cause a cellular ion imbalance by attacking the 
proteins responsible for the maintenance of such balance (Halliwell and Gutteridge, 
1999).  In addition, DNA strand breakage has been demonstrated when cells were 
exposed to ROS, since OH• can damage sugars, purines, and pyrimidines.  
Carbohydrate damage has also been noticed in view of the fact that OH• in the 
presence of iron is responsible for the depolymerization of hyaluronic acid in vitro 
studies (Wong et al, 1981).  The viscosity of synovial fluid within the joints is 
maintained by hyaluronic acid since it has lubricating properties. 
 
1.3.4   Reactive nitrogen species (RNS) 
Oxides of nitrogen such as nitric oxide (NO•) and nitrogen dioxide (NO2•) are 
also free radicals which have the term 'reactive nitrogen species'.  Nitric oxide (NO•) 
is formed in vivo from the amino acid L-arginine by three different NO-synthases 
(NOS) while NO2• is made when NO• reacts with oxygen.  They are both found in 
polluted air and smoke from the burning of organic material e.g. cigarette smoking.  
Peroxynitrite (ONOO-) is often regarded as both a ROS and RNS, it is the reaction 
product of O2•- and NO• (Halliwell and Gutteridge, 1999) which are both produced 
from cells of the immune system during inflammation (Valko et al, 2007).  
Peroxynitrite (ONOO-) is considered to be a potent oxidant and a major cytotoxic 
agent that can cause DNA fragmentation and lipid oxidation (Mladenka et al, 2006).  
In addition to ONOO-, nitrous acid (HNO2) and dinitrogen trioxide (N2O3) are 
examples of non-radical RNS. 
 
1.3.5   Oxidative stress in Rheumatoid arthritis 
Oxidative stress has been implicated in several physiological and pathological 
conditions (Vendemiale et al, 1999), such as atherosclerosis, diabetes, aging, 
rheumatoid arthritis, osteoarthritis, cancer, inflammatory bowel disease, and many 
more (Halliwell and Gutteridge, 1999 and Martinez-Cayueta, 1995).   It is important 
to mention that the oxidative stress in many human diseases is a consequence and not 
a cause. In principle, disease-associated oxidative stress could result from either (or 
both): (1) decreased amount of enzymatic and non-enzymatic antioxidants (see 
section 1.4) and (2) increased production of ROS/RNS (see sections 1.3.3 and 1.3.4). 
For example during inflammatory processes, oxidative burst occurs (Halliwell et al, 
1992) that is characterised by the massive production of ROS/RNS in that 
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environment which play a key role in defending cells against pathogens.  The 
consequent increase in ROS/RNS leads to changes in signal transduction and gene 
expression; a common phenomenon seen in disease.  Signal transduction (also called, 
cell signalling) is a process enabling information to be transmitted from outside the 
cell to various functional elements inside the cell and it is also the mechanism by 
which cells communicate with each other.  Tissues often respond to mild oxidative 
stress by producing extra antioxidants, but severe oxidative stress can cause tissue 
injury and consequently cell death (Halliwell, 1994).   
 Several lines of evidence are in agreement with the concept that an 'oxidative 
stress' contributes to the pathogenesis of RA.  Several studies have been suggesting 
that the rheumatoid synovium is relatively ischemic and that ischemia-reperfusion has 
been implicated to be major factor in the injury occurring in RA (Han et al, 2003). As 
ischemia-reperfusion occurs in the inflamed joint upon rest and movement, the 
authors suggest that it could be a potential target for the treatment of RA.  During the 
isolation and stimulation of cells which are present in the inflamed joint (e.g. 
macrophages, neutrophils, and lymphocytes), the ability to produce ROS was noticed 
(Merry et al, 1989). T cell stimulation leads to the production of ROS and cytokines 
(reviewed in MacKenzie, 2006).  Interestingly, also cytokines such as TNF-α and IL-
1 lead to oxidant production (Finkel, 2003).  In rheumatoid arthritic synovial 
lymphocytes, Remans et al, (2005) found intracellular ROS production.  Hydrogen 
peroxide appears to be one of the ROS involved, since the addition of catalase (see 
1.4.2.3) suppressed the intracellular ROS production. It was concluded that chronic 
oxidative stress observed in synovial T lymphocytes originates from intracellular 
ROS production.  In other studies, Malondialdehyde (MDA) was measured as a 
marker of lipid peroxidation in rheumatoid arthritic patients and control subjects.  The 
levels of plasma (Kamanli et al, 2004) and serum (Ozkan et al, 2007) MDA were 
significantly higher in patients with RA compared to the control.  Recently Altindag 
et al, (2007) also demonstrated that DNA damage and total oxidative status was 
higher in patients with RA than in healthy controls and that total antioxidant status 
was lower in the same patients.  It was therefore concluded in this study that the 
increase in lymphocyte DNA damage increase in patients with RA may be related to 
the increased oxidative stress and decreased antioxidant capacity. 
 
 
Chapter one – Introduction  
     
Page | 21 
 
1.3.6   Oxidative stress and the regulation of iron 
Iron is an important element believed to generate oxidative stress i.e. an 
increase in the steady state concentration of prooxidants (e.g. by the formation of 
OH•) that damage membranes and DNA (Meneghini, 1997).  The higher the LIP in 
the cells, the higher levels of ROS are noticed.  Therefore, the LIP is not only a 
marker of the total Fe content in the cells but also determines the redox state of it. 
Oxidative stress in the form of ultraviolet (UV) light has been shown to 
accumulate iron.  Ultraviolet (UV) B radiation was shown to increase the skin level of 
non-haem iron (Bissett et al, 1991) and UVA radiation caused an immediate increase 
in 'free' iron in fibroblasts (Pourzand et al, 1999).  When rat livers were exposed to 
oxidative stress in the form of phorone (a glutathione depleting drug), data suggests 
that there was an early increase in the levels of free iron pool (Cairo et al, 1995).  
Breuer et al, (1997) also showed that H2O2 induced a significant increase in LIP levels 
in cultured K562 cells.  Iron deficiency is compensated by increased IRP activity 
which consequently results in the induction of TfR levels and reduced Ft synthesis, 
and therefore increases LIP levels (reviewed in Hentze and Kuhn, 1996).  Stimulation 
of IRP activity by exposure of cells to H2O2 was shown in a number of studies 
(Pantopoulos and Hentze, 1995; Martins et al, 1995; Pantopoulos et al, 1996; 
Pantopoulos et al, 1997; Mueller et al, 2001).    On the contrary, incubation of rat 
liver lysates with xanthine oxidase (which generates both superoxide anions and 
H2O2) revealed that a combined action of both H2O2 and O2•- were responsible to 
induce a reversible inactivation of IRP (Cairo et al, 1996 and Cairo et al, 1998). IRP 
inactivation by H2O2 and O2•- combination may serve as a protective mechanism 
against oxidative damage since it diminishes LIP before it converts H2O2 and O2•- into 
a potent oxidant. It has been demonstrated that H2O2 and O2•- can release iron from Ft 
(Rudeck et al, 2000 and Agrawal et al, 2001). Menadione-induced oxidative stress in 
B6 fibroblasts caused a post-translational inactivation of IRP (Gehring et al, 1999).  
IRP inactivity was also observed in rat subjected to ischemia-reperfusion, a process 
accompanied by a burst of ROS (Tacchini et al, 1997).  There is therefore substantial 
evidence to conclude that the IRP proteins are targeted under conditions of oxidative 
stress in the cells (reviewed in Cairo et al, 2002).  In a recent study, Andriopoulos et 
al, (2007) showed that sustained low levels of H2O2 up-regulated TfR1, leading to 
increased transferrin-mediated iron uptake and iron accumulation in the cells.  Since 
IRP-1 was only partially and temporarily activated (likely because of H2O2 signalling) 
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the authors suggested that this effect is independent of IRP/IRE system. The lower 
biological reactivity of H2O2 (compared to many ROS) with its capacity to cross 
membranes makes H2O2 an ideal signaling molecule (Hampton and Orrenius, 1997).  
Indeed, it has been proposed that extracellular H2O2 seem to act through a membrane-
transduced signaling process (reviewed in Cairo and Pietrangelo, 2000).  Activation 
of IRP by H2O2 has been seen in intact cells but not in lysates (Mueller, 2005).  Taken 
together, it seems that IRP responds in a different way to a variety of oxidative stress 
stimuli (Gehring et al, 1999). 
 
 
1.4     Antioxidant defence systems 
As previously mentioned, free radicals have been implicated in several 
physiological and pathological conditions.  In addition they can cause protein 
oxidation, lipid peroxidation, carbohydrate damage, and DNA damage.  Fortunately, 
our bodies acquire several defence mechanisms intended to prevent the damage or at 
least to minimize it.  
Antioxidants are one of the major defence systems the body has acquired.  An 
antioxidant is defined as “a substance that when present at low concentration 
compared to those of an oxidisable substrate significantly delays or prevents 
oxidation of that substrate” (Sies, 1997).  There are considerable data to show their 
beneficial effects in animal models and clinical trials in the treatment of RA (Kunsch 
et al, 2005).  Antioxidants can be divided into two categories; enzymatic and non-
enzymatic antioxidants which can be found in both aqueous and membrane 
compartments within the cells.  
 
1.4.1  Non-enzymatic antioxidants 
 
1.4.1.1   Glutathione  
 Glutathione (L-γ-glutamyl-L-cysteinyl-glycine) is a tripeptide molecule that is 
found in animals, plants, and many aerobic bacteria.  In mammalian cells it is present 
in a millimolar range (Meister and Anderson, 1983) and it is the major cellular 
antioxidant. It is highly abundant in the cytosol (1-11 mM), nucleus (3-15 mM), and 
mitochondria (5-11 mM).   It is synthesised by two steps (Halliwell and Gutteridge, 
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1999) as detailed below: First, the dipeptide formation is catalysed by γ-
glutamylcysteine synthetase: 
        L-glutamate + L-cysteine + ATP Æ L-γ-glutamyl-L-cysteine + ADP + Pi 
Then GSH is produced by glutathione synthetase: 
       L-γ-glutamyl-L-cysteine + glycine + ATP Æ  GSH + ADP + Pi 
  Glutathione is present in two forms, the reduced form (GSH) and the oxidised 
form (GSSG) where it redox-cycles between them, but the vast majority (95-99%) is 
in the reduced form (Dethmers and Meister, 1981 and Meister and Anderson, 1983).  
In the cytosol and mitochondrial matrix, mammalian cells contain approximately 10 
mM GSH and 0.5 mM GSSG (Droge et al, 1994).  GSSG is synthesised by the 
addition of two GSH molecules with the oxidation of the –SH groups in cysteine to 
form a disulphide bridge (-S-S-) (Halliwell and Gutteridge, 1999).   
  The glutathione system within the cells acts as a major homeostatic redox 
buffer and represents a primary antioxidant defence considering that it depends on the 
relative amounts of GSH/GSSG.  Intracellular glutathione acts as an antioxidant in 
several ways.  It can reduce peroxides to form H2O (Martinez-Cayueta, 1995) or 
scavenge directly ROS (Cuzzocrea et al, 2004).  It can also act as a chelator of Cu2+ 
and reduces its activity to generate ROS (Halliwell and Gutteridge, 1999).  
Glutathione, in yeasts, was found to play a major role in the maturation of cytosolic 
iron-sulphur proteins (Sipos et al, 2002).     
  Oxidative stress in the form of UVA radiation (oxidising component of 
sunlight, 320 - 380 nm) or H2O2 has been found to deplete intracellular glutathione 
(Lautier et al, 1992 ; Brunk et al, 1995a ; Hempel et al, 1996).  Treatments of Wistar 
rats with phorone, a glutathione depleting drug that amplifies the effects of ROS, 
induced Ft synthesis 6-fold in liver slices as a late response (Cairo et al, 1995).  
Recently, it was found that homocysteic acid, a glutathione depleting drug, increased 
the levels of H- and L-Ft mRNA (by nearly 2-fold) in HT22 murine hippocampal 
cells (Morozova et al, 2007). Exposure of mouse nerve cell line to glutamate blocks 
cysteine uptake and therefore depletes GSH, this leads to the accumulation of ROS 
and ultimately apoptotic cell death (Sagara et al, 1998).  Several studies have shown 
that the depletion of intracellular glutathione sensitises cell populations to several 
circumstances such as aerobic ionising radiation, cytotoxic drugs, and H2O2.  Indeed, 
glutathione depletion (by buthionine-[S,R]sulfoximine, BSO) sensitises cultured 
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human lymphoid cells against γ radiation (Dethmers and Meister, 1981), therefore it 
is regarded as a major protective agent.   
 
1.4.1.2   Thioredoxin (TRx) 
  Thioredoxin is a thiol-polypeptide molecule that is present in mammalian 
cells.  It is generally concentrated in the endoplasmic reticulum and also can be found 
on the cell surface. In addition to glutathione, TRx is also a major carrier of redox 
potential within cells (Kontou et al, 2004).  They both maintain signalling 
components in a reduced state and are counterbalanced in signalling by oxidative 
stress, typically ROS (Jones et al, 2004).  The term redox signalling is used to 
describe a regulatory process in which a signal is delivered through redox reactions 
(Valko et al, 2007).  TRx has two –SH groups (reduced form) that is converted to an 
oxidised TRx with a disulphide (-S-S-).  It undergoes redox reactions in the presence 
of proteins (Halliwell and Gutteridge, 1999). 
          TRx—(SH)2 + protein—S2        TRx—S2 + protein—(SH)2 
  Thioredoxin exerts its antioxidant activity by different pathways.  It has been 
shown to possess a radical-scavenging activity (Schenk et al, 1994).  It has been also 
involved in DNA repair, since it acts as a hydrogen donor for ribonucleotide 
reductase, which is an enzyme that is involved in the production of 
deoxyribonucleosides.  It is also implicated in protein repair since it supplies 
methionine sulphoxide reductase with electrons.  Methionine sulphoxide reductase 
repairs oxidative damage to methionine residues (Halliwell and Gutteridge, 1999).  
Thioredoxin levels in the synovial fluid and the synovial tissue of rheumatoid arthritic 
patients were elevated when compared with other joint diseases (Maurice et al, 1999).  
This observation suggests that synovial TRx may be a potential biomarker for RA 
(Kunsch et al, 2005).   
 
1.4.1.3    Ferritin (Ft) 
The ferritin molecule is a hollow protein shell (outside diameter around 13 
nm, inside diameter around 8 nm), composed as mentioned in section 1.2.3, of heavy 
(H) and light (L) chains which co-assemble to form a protein shell of 24 subunits.  
Ratios of H-and L-Fts broadly differ from H24L0 to H0L24, these change in various 
diseases and under certain conditions (Halliwell and Gutteridge, 1999 and Theil, 
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2003).  H-Ft is ubiquitous and contains a ferroxidase site, whereas L-Ft is catalytically 
inactive and unique to animals.  Most intracellular iron is stored in Ft; it can store up 
to 4500 ion of iron (Halliwell and Gutteridge, 1999).  In addition to iron, traces of 
other metals can be found in Ft including copper (Halliwell and Gutteridge, 1999).  
Cairo et al (1995) have suggested that liver Ft can act as a pro- or an anti-
oxidant in a time dependent manner.  An early decrease in Ft has been shown after 
Wistar rats were treated with phorone, a glutathione depleting drug that amplifies the 
effects of ROS. Interestingly, 6-fold induction of Ft synthesis was shown as a late 
response. Treatment of skin fibroblasts with UVA lead to a total degradation of Ft 
(Pourzand et al, 1999).  Six hours following UVA treatment, Ft levels returned to 
normal and increased up to 3-fold 24-48 hours following UVA treatment (Vile and 
Tyrrell, 1993).  In endothelial cells, iron loading for 1 h significantly increased the 
cytotoxicity of H2O2 or oxidants from activated inflammatory cells (Balla et al, 1992 
and Balla et al, 1993).  Interestingly, at 16 h the cells became highly resistant to 
oxidative-mediated injury.  This was correlated with 50-fold and 10-fold increase in 
haem oxygenase (HO) and Ft, respectively.  The same phenomenon has also been 
seen in murine L1210 lymphocytic leukaemia cells using various types of oxidative 
insults (Lin and Girotti, 1997).  Long exposure (i.e. 20-24 h) to hemin increased 
significantly the resistance of cells against H2O2- and 1O2-mediated toxicity. This 
resistance was correlated with 12- to 15-fold increase in H-Ft; L-Ft, on the other hand, 
was not modified.  Iron loading of J774 macrophages increased the lysosomal iron 
content and their sensitivity to H2O2-induced (0.25 mM for 30 minutes) oxidative 
damage (Garner et al, 1998).  However, after 24-72 hours, the cells were desensitised 
to the cytotoxic effects of H2O2.  The resistance observed was linked to the lysosomal 
iron exocytosis and Ft synthesis.  Therefore, it seems from the above studies that: in 
the early stages of oxidative challenge, Ft might act as a pro-oxidant molecule since 
its degradation could be a potential source of iron involved in the exacerbating the 
oxidative damage occurred in cells as a result of oxidative insult. 
The evidence for Ft acting as an antioxidant molecule is also overwhelming 
(reviewed in Arosio and Levi, 2002).  Various studies have reported that different 
forms of oxidative challenge have demonstrated an increase in Ft levels, conferring 
resistance to the subsequent insult.  It was demonstrated that the ferroxidase sites in 
H-Ft significantly reduces the production of OH• from the Fenton reaction (Zhao et al, 
2006). Induction of HO-1 by UVA radiation increases the Ft levels up to 3-fold 24-48 
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hours post-UVA radiation in human skin fibroblasts (Vile and Tyrrell 1993 and Vile 
et al, 1994).  UV radiation has been shown to increase the Ft levels in both the 
epidermal and dermal tissue allowing increased protection against oxidative stress 
(Applegate et al, 1998). Hela cells, exposed to H2O2 treatment, increased the synthesis 
of H- and L-Ft and this overexpression in turn reduced the accumulation of ROS 
(Orino et al, 2001).   It was suggested that Ft has an active role in regulating LIP 
levels and attenuating ROS generation in human erythroleukemia cells (Kakhlon et al, 
2001).  In vivo and in vitro studies, acute UVA exposure increased the expression Ft 
levels in basal epidermal cells (Siete et al, 2004).  When human HL-60 leukaemia 
cells were pre-treated with hemin, they became more resistant to H2O2 and 1O2 
toxicity (Lin and Girotti, 1998).  This was correlated with 4 to 12-fold increase in Ft 
protein levels over a period of 24 hours. Bovine artery endothelial cells became 
sensitive to photodynamic therapy after 1 h treatment with hemin, but after 23 h they 
became more resistant (Lin et al, 1998).  The hyperresistance to photodynamic 
therapy was correlated with the induction of H-Ft by hemin in these cells.  The 
authors suggested that the enhanced oxidant resistance observed is due to the ability 
of Ft to rapidly sequester redox-active iron.  Doxorubicin is an anticancer drug that 
generates ROS in H9c2 cardiomyocytes (embryonic rat heart-derived cell line) and 
promotes iron-catalysed oxidative damage (Corna et al, 2004).  Through the action of 
ROS, it has also been shown that it increased H-Ft levels in these cells, and this has 
been correlated with the resistance to iron-mediated damage.  Oxidised low density 
lipoprotein (LDL), an oxidant, dramatically stimulated L-Ft in the THP-1 macrophage 
line but failed to induce either H- or L-Ft in other studies (reviewed in Torti and Torti, 
2002).  L-Ft has been suggested to have an important role in the protection against 
oxidative damage due to the presence of antioxidant-responsive element (ARE) in the 
human L-Ft gene, which was positively regulated by hemin (Hintze and Theil, 2005).  
The ARE increases the expression of a diverse set of proteins involved in redox 
homeostasis such as TRx, HO and glutathione. 
Levi et al, (2001) have described a gene that encodes a mitochondrial ferritin 
(MtF) located inside the matrix of the human mitochondria. Unlike other mammalian 
Fts, human MtF is a homodimer of 24 subunits that has a ferroxidase activity 
significantly lower than the H-chain cytosolic Ft (Bou-Abdallah et al, 2005).  Iron is 
transported to the mitochondria for several metabolic processes, specifically haem 
and [Fe-S] cluster synthesis.  Mitochondrial ferritin can efficiently store large 
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amounts of iron (1) to prevent its participation in Fenton reaction and (2) to protect 
the cell from iron being escaped during haem and [Fe-S] cluster synthesis. Since 
mitochondrial chelatable iron has been linked to several human diseases (e.g. 
Friedreich ataxia, Parkinson’s and Alzheimer’s disease), a new fluorescent indicator 
to determine this iron pool was synthesised (Petrat et al, 2002). During sideroblastic 
anaemia, large quantities of iron (due to the blockage of haem synthesis) and high 
levels of this new ferritin (MtF) appear to be present in the mitochondria. This 
suggests that MtF is responsible for the detoxification and the trafficking of iron in 
the mitochondria (reviewed in Arosio and Levi, 2002). 
 
1.4.1.4    Vitamins 
  Antioxidant protection can also be achieved by vitamins that are available in 
our diet.  Vitamin C (ascorbic acid) exerts its antioxidant levels by scavenging ROS 
i.e. O2•- and OH•.  On the contrary, in vitro studies have shown that it has prooxidant 
properties as it acts as an iron reductant to produce OH•, but it has no major 
physiological relevance as any excess is simply excreted from the body (Halliwell and 
Gutteridge, 1999). The levels of vitamin C in human plasma were found to be around 
10-100 µM (Halliwell and Gutteridge, 1999). Good sources of vitamin C in our diet 
are vegetables and fresh fruits, especially tomatoes.  It has very important roles in the 
body, in addition of functioning as an antioxidant, it regenerates vitamin E.  In lipid 
peroxidation, vitamin E (a fat soluble vitamin) acts as an inhibitor of the free-radical 
reaction. Vitamin E has 8 members in its family, the best characterised is α-
tocopherol.  α-tocopherol, as well as inhibiting lipid peroxidation, it also acts as a 
scavenger of lipid peroxyl radicals (Cheeseman and Slater, 1993).  Vitamin E may 
also act as a hydrogen donor to ROS, resulting in a less reactive species (Martinez-
Cayueta, 1995). Green vegetables and cereal grains are excellent sources of vitamin 
E.  α-tocopherol succinate pre-treatment protected cardiac myocytes against H2O2- 
and O2•--induced lysosomal damage (Roberg and Öllinger, 1998).  α-tocopherol 
acetate was also involved in preventing UVA-mediated activation of NF-κB that 
appeared to cause membrane damage to human skin fibroblasts (Vile et al, 1995 and 
Reelfs et al, 2004). 
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1.4.2 Enzymatic antioxidants 
 
1.4.2.1   Glutathione peroxidase (GPx) / Glutathione reductase (GR) 
  Glutathione peroxidase (GPx) and Glutathione reductase (GR) are present at 
high concentration in some parts of the human body i.e. liver, kidney, and whole 
blood.  Glutathione peroxidase, first discovered in 1957, can be found in the 
cytoplasm and the mitochondria.  It has four selenium atoms (Se), on its four protein 
subunits, which are responsible for its activity. Glutathione peroxidase catalyses the 
reduction of H2O2 yielding oxidised glutathione (GSSG):  
                                       H2O2 + 2GSH     GPx         GSSG + 2H2O  
It also catalyses the reduction of lipid hydroperoxides (Martinez-Cayueta, 1995): 
                               LOOH + 2GSH         GPx         GSSG + H2O + LOH     
  On the other hand GR contains flavin adenine dinucleotide (FAD), as its 
active site, on its two protein subunits. It is a cytosolic protein.  Whilst the conversion 
of GSH to GSSG is high in normal cells (Halliwell and Gutteridge, 1999), GR acts by 
reducing oxidised glutathione to GSH. 
                      GSSG + NADPH + H+        GR            2GSH + NADP+  
 
1.4.2.2    Superoxide dismutase (SOD) 
  SOD exerts its activity to produce H2O2 and O2 from the dismutation of O2•-
(Martinez-Cayueta, 1995).    
                 O2•-  +  O2•-  + 2H+       SOD           H2O2 + O2 
In mammalian cells three SODs are present: SOD1, SOD2 and SOD3 (Raha and 
Robinson, 2000). SOD1 is the cytosolic copper-zinc (CuZn) containing superoxide 
dismutase (or alternatively CuZnSOD), SOD2 is the intramitochondrial manganese 
(Mn) superoxide dismutase (or alternatively MnSOD), and SOD3 is the extracellular 
CuZn superoxide dismutase.  Whereas SOD2 (MnSOD) is mostly present in the 
mitochondria, it is also present in the cytosol at a very low concentration (Halliwell 
and Gutteridge, 1999). 
 
1.4.2.3    Catalase 
  Catalase is composed of four protein subunits, each of which have a ferric 
(Fe3+) haem group bound to its active site (Halliwell and Gutteridge, 1999).  It is 
present in all major body organs and at high concentrations in the liver.  Catalase is 
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mainly located in the peroxisome, a cellular organelle found in the cytoplasm bound 
by a single membrane.  As mentioned in the previous section, H2O2 is the product of 
the dismutation of O2•-.  Catalase removes the harmful effects of H2O2 (see section 
1.3.3) by the following reaction (Martinez-Cayueta, 1995) : 
                                   2 H2O2          catalase              2 H2O + O2  
  
 
1.4.2.4    Haem Oxygenase (HO) 
  Haem oxygenase (HO) is the rate limiting enzyme, found in the endoplasmic 
reticulum, that catalyses the degradation of haem (a pro-oxidant) and the formation of 
biliverdin and carbon monoxide (CO), and the release of ferrous iron ions (Halliwell 
and Gutteridge, 1999): 
Heam          HO               Biliverdin + CO + Fe2+ 
Biliverdin is then reduced, by biliverdin reductase, to produce bilirubin (an 
antioxidant).  With a decrease in the pH, the potency of bilirubin as a free radical 
scavenger is increased (Winrow et al, 1993).  All three discrete products (i.e. Fe2+, 
CO, and biliverdin-bilirubin) have vital physiological roles which may be 
complementary (Snyder and Baranano, 2001).  Depending on the cellular redox 
potential and the metabolic fate of haem iron, HO may have both pro- and antioxidant 
properties (Ryter and Tyrrell, 2000). 
  To date, three haem oxygenase isozymes have been identified: HO-1, HO-2 
and finally HO-3.  HO-1 (the inducible form) and HO-2 (in general; the constitutive 
form) isozymes are both known to be haem catalyst (Maines et al, 1986), HO-3 has a 
poor haem catalyst activity (Wunder and Potter, 2003).  Out of the three, HO-3 is less 
understood; it is thought to serve primarily as a haem-binding protein (McCoubrey et 
al, 1997 and Weng et al, 2003).    
 While HO-2 is believed to be the constitutive form of HO, HO-1 is a stress-
induced enzyme (Keyse and Tyrrell, 1989) which is activated by a number of stimuli 
such as UV radiation and H2O2 in human skin fibroblasts.  Since HO-1 mRNA is 
strongly induced by ROS, this makes it a potential marker for cellular oxidative stress 
at the mRNA level.  It has been proposed that H2O2 formation during mitochondrial 
respiratory chain deficiency (a pro-oxidant state) leads to the overexpression of 
antioxidant enzymes; GPx activity, GPx and HO-1 mRNAs (Brambilla et al, 1997).   
Glutathione depletion by BSO treatment of human skin fibroblasts lead to a 
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significant increase in the level of HO mRNA (Lautier et al, 1992).  It was also 10-
fold higher 24 h after either UVA or H2O2 treatment.  Synthesis of HO-1 but not HO-
2 was shown to be induced by glutathione depletion in Chinese hamster ovary cells 
(Saunders et al, 1991).  Glutathione depletion also induced HO-1 protein and mRNA 
in rat brain (Ewing and Maines, 1993). Interestingly, HO-1 was most expressed in the 
lesions of synovial tissue of patients with RA than in those from the other patient 
groups (osteoarthritis, and patients with noninflammatory joint disease). Both hemin 
and auranofin (a disease-modifying antirheumatic drug) induced HO-1 and reduced 
expression of TNF-α mRNA, LPS-induced secretion of IL-6 and IL-8, and expression 
of cyclooxygenase 2 in the synovial cell lines (Kobayashi et al, 2006).    
   As mentioned earlier (see section 1.4.1.3), induction of HO-1 by UVA 
radiation increases the Ft levels up to 3-fold 24-48 hours post-UVA treatment in 
human skin fibroblasts (Vile and Tyrrell 1993 and Vile et al, 1994).   The 
photoimmunoprotective activity of UVA radiation seen in mice has been attributed to 
the HO induction (Reeve and Tyrrell, 1999).  A strong relationship between HO 
induction and photoimmunoprotection by UVA has been established (Reeve and 
Domanski, 2002). Cells overexpressing HO have shown hypersensitivity to UVA 
shortly after hemin treatment (Kvam et al, 2000).  These cells were no longer 
hypersensitive to UVA, 24 hours post-hemin treatment.    It has also been found that 
HO-1 is linked to the efflux of iron from the cells, therefore it was suggested that its 
induction prevents cell damage and death by regulating cellular iron (Ferris et al, 
1999).  Therefore, the HO system has been implicated in antioxidant, anti-
inflammatory, and cytoprotective events (Taramelli et al, 2000; Ryter and Tyrrell, 
2000; Tranter and Jones, 2008).  
 
 
1.5    Lysosome 
  Lysosomes were first isolated by Christian de Duve and colleagues in rat liver, 
later they were found to exist in a variety of cells and tissue (De Duve and Wattiaux, 
1966) including animal and plant cells.  They are membrane bound organelles filled 
with around 40 types of hydrolytic enzymes, including cathepsins, proteases, 
nucleases, lipases, and phospholipases.  These enzymes are active under acidic 
condition (pH around 5.0) and this is maintained by an ATP driven H+ pump located 
in the lysosomal membrane (Alberts et al, 2002).  Lysosomes mainly serve as sites for 
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degradation in the cell and a centre for normal turnover of organelles; it is also the 
major site of intracellular catabolic processes (Sriram et al, 2006). 
 
1.5.1 The role of  lysosomal iron in oxidative stress 
In animal cells, Ft is consistently found in the cytosol and lysosomes 
(reviewed in Harrison and Arosio, 1996).  The lysosomal degradation of 
metalloproteins (e.g. cytochromes) and ferruginous material (e.g. Ft) ensures the 
intralysosomal availability of redox-active low-molecular-weight chelatable iron i.e. 
LIP (Ciechanover, 2005).  By laser scanning microscopic study, chelatable iron was 
found to be 2-3 fold higher in the endosomal/lysosomal apparatus than in the cytosol 
of isolated rat hepatocytes and rat liver endothelial cells (Petrat et al, 2001).  
Therefore a major part of the LIP might be present in the lysosomes (Kakhlon and 
Cabantchik, 2002).  This, along with the OH• produced by Fenton reaction, accounts 
for the sensitivity of lysosomes to oxidative stress.  Also, since the lysosomal 
environment is acidic it facilitates the release of iron from proteins and it enhances its 
reduction to ferrous iron, therefore the oxidative damage is enhanced.   
Treatment of macrophage–like J-774 cells with a bolus dose of 0.5 mM H2O2 
caused lysosomal damage and plasma membrane blebbing as an early sign of damage 
(Brunk et al, 1995b).  These effects were prevented by pre-treatment with DFO, which 
is taken up by endocytosis and stored intralysosomally.  DFO, being a hydrophilic 
compound, has limited cellular penetration (Rice-Evans et al, 1989 and Link et al, 
2003) therefore it enters the cells by endocytosis and finally accumulates in the 
lysosomes (Lloyd et al, 1991 and Cable and Lloyd, 1999).   When the cells are not 
exposed to the drug anymore, DFO can then slowly leave the lysosomal compartment, 
reaching the cytosol and subsequently the extracellular fluid.  The protective effects 
of DFO were prevented by the inhibition of its endocytosis.   Lipid peroxidation, 
destabilisation of lysosomes, and eventually cell death were seen when rat 
hepatocytes were treated with naphthazarin, a redox-cycling drug which mainly exerts 
its toxicity through oxidative stress (Öllinger and Brunk, 1995).  Pre-treatment with 
DFO protected the cells from lysosomal destabilisation and cell death.  Exposure to a 
low steady state of H2O2 (25 µM) in Jurkat T cells induces apoptosis, which is 
consequence of lysosomal rupture (Antunes et al, 2001).  Pre-exposure to DFO 
preserved lysosomal stability and consequently protected the cells from apoptosis.  
Ogawa et al, (2004) have shown that ROS formation was augmented in the 
Chapter one – Introduction  
     
Page | 32 
 
mitochondria and the lysosomes of irradiated T cells in the presence of a low 
concentration of H2O2 (0.1 mM) when compared with those treated only with 
irradiation.  Both lysosomal and cellular damage were prevented when cells were pre-
treated with the lipophilic chelator salicylaldehyde isonicotinoyl hydrazone (SIH) 
and/or DFO prior to their exposure to H2O2, since LIP was efficiently decreased 
(Kurz et al, 2006).    
When human fibroblasts were irradiated with a moderate dose of blue light, 
this (moderate) stress of photo-oxidation resulted in apoptosis (Brunk et al, 1997). 
The blue light-mediated damage appears to be accompanied by leakage of lysosomal 
contents including hydrolytic enzymes, such as cathepsin D (CATH D) (Roberg and 
Öllinger, 1998).  Severe photo-oxidation, on the other hand, results in severe 
lysosomal damage and consequently cellular necrosis, therefore the cascade of events 
is dependent on the magnitude of the insult.  Treatment of macrophages with oxidised 
LDL induced lysosomal destabilisation, relocation of CATH D to the cytosol, and 
increased cathepsin L (CATH L) cytosolic activity (Li et al, 1998). During lysosomal 
membrane permeabilisation, cathepsin B (CATH B) and CATH D have been 
documented to be released from the lysosomes (Erdal et al, 2005).  Treatment of 
human skin fibroblasts with UVA radiation (320 – 380 nm) lead to an immediate 
release of iron via the proteolysis of Ft (Pourzand et al, 1999).  This study provided 
the first evidence that UVA-mediated Ft degradation originates from the 
destabilization of lysosomal membranes and the subsequent leakage of proteolytic 
enzymes.  Chymotrypsin, a lysosomal protease that is responsible for the degradation 
of Ft molecules in lysosomes, was around 3-fold higher in the cytosolic fraction of 
UVA-treated cells when compared with unirradiated controls.  The degradation of Ft 
was prevented when cells were pretreated with Chymotrypsin-specific lysosomal 
protease inhibitors (i.e. Chymostatin and Leupeptin).  Delocalisation of CATH B 
from the lysosomal compartment to the cytosol was observed after UVA radiation in 
human skin fibroblasts (Basu-Modak et al, 2006).   When human skin fibroblasts 
were pre-treated with catechins (flavonoid constituents with protective properties 
predominantly against oxidative stress) prior to UVA-radiation; iron release was 
prevented (Basu-Modak et al, 2006).  Based on measurements of lysosomal integrity 
(Lysosensor assay and CATH B immunocytochemistry), the data strongly indicate 
that catechins protect against lysosomal damage induced by UVA.  40 Gy radiation of 
radio-resistant lymphoma (J774) cells increased the ‘loose’ iron by nearly 5-fold 
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(Persson et al, 2005).  This increase was correlated with lysosomal rupture and 
consequent cell death following a second dose of 20 Gy.  Addition of DFO before the 
first or second radiation stabilised the lysosomal membrane and largely prevented cell 
death. Cytochemical analysis from this study revealed that the most redox-active iron 
lies within the lysosomes.  Unless catalytically active iron is present, neither 
superoxide radicals nor H2O2 induced any lysosomal damage by themselves in 
lysosome-enriched mitochondrial fraction of a rat liver homogenate (Zdolsek and 
Svensson, 1993).  Overall, these results support the idea that oxidative stress per se is 
not injurious but it requires the presence of intralysosomal redox active iron 
(reviewed in Terman et al, 2006).  
 
1.5.2 The role of lysosomal iron in rheumatoid arthritis 
Lysosomes are abundant in the lining cells of the synovial membrane.  There 
is a considerable amount of evidence to support that lysosomal membrane damage is 
linked to acute and chronic inflammation in joints.  The lysosomal membrane 
contains large amount of PUFAs (see section 1.3.3) that are susceptible to lipid 
peroxidation. When lipid peroxidation occurs the membrane is disrupted and this 
releases hydrolytic enzymes which will potentiate inflammation (Blake et al, 1981).  
Increased lysosomal enzyme activity has been found in the synovial fluid and 
membrane in RA.  It is evident that materials in lysosomes can provoke inflammation, 
tissue injury and breakdown of connective tissue (Weissmann, 1972).   
It was concluded that the extensive tissue breakdown in adjuvant arthritis is 
due to the release and degradative action of lysosomal enzymes on connective tissue 
components (Anderson, 1970). Administration of two non-steroidal anti-
inflammatory was found to increase the lysosomal stability in adjuvant arthritic rats 
(Reddy and Dhar, 1987).  Oral administration of several anti-inflammatory drugs such 
as phenlybutazone and hydrocortisone decreased both the enzymatic activity and 
oedema. The study concluded that these drugs may act by inhibiting lysosomal 
enzyme, stabilising cell or lysosomal membrane, or decreasing influx of leucocytes.   
In patients with RA, high enzyme levels were found and this was correlated with 
damage to the joints (Muirden, 1972).  In all patients with RA, elevated cysteine 
protease CATH B, dipeptidyl peptidases I, asparate protease CATH D and two 
glycosidases were found (Sohar et al, 2002).  The magnitude of the increased activity 
was correlated with duration of the disease.   
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Recently, Cleome gynandra was found to markedly decrease lysosomal 
enzymes in both the plasma and the liver of adjuvant-induced arthritic rats 
(Narendhirakannan et al, 2007).  Cleome gynandra, a common weed which grows in 
tropical countries, is commonly used to treat rheumatism.  It was proposed that 
Cleome gynandra might exert its anti-inflammatory actions by stabilizing the 
lysosomal membrane and thereby preventing the release of lysosomal enzymes.  The 
above findings support the concept that lysosomal enzymes are involved in 
connective tissue damage and that lysosomes play a crucial role in the pathogenesis of 
RA. 
 
 
1.6 The NF-κB transcription factor  
Nuclear Factor κB (NF-κB) is a transcription factor that was first discovered 
in 1986, as a nuclear factor that binds to a site in the immunoglobulin κ light chain 
enhancer in B cells only, hence its name (Sen and Baltimore, 1986).  Within a few 
years, it was found that NF-κB is present virtually in all cell types.  The NF-κB 
regulates the transcription of many genes involved in immune and inflammatory 
responses, and apoptosis (Ghosh and Karin, 2002).  The activation of NF-κB has been 
implicated in various diseases (Baldwin, 2001) e.g. rheumatoid arthritis, cancer, 
AIDS, inflammatory bowel disease etc.  The NF-κB is a dimer of proteins that 
belongs to the NF-κB/Rel family. 
 
1.6.1    The NF-κB/Rel family 
 In mammalian cells the NF-κB/Rel family consists of 5 members; RelA (p65), 
RelB, c-Rel, p50 (NF-κB 1), and p52 (NF-κB 2). The first three are produced within 
the cells as transcriptionally active proteins, whereas p50 and p52 are generated from 
p105 and p100, respectively, by proteolytical degradation (Mercurio and Manning, 
1999).  They can form homo- and hetero-dimers with each other but certain dimers do 
not exist i.e. RelB can only hetero-dimerise with p50 or p52 (Ryseck et al, 1995).   
The “classical” NF-κB dimer is RelA/p50 given that it is the most abundant and 
biologically active within the cells, and it was also the first form to be identified 
(Huxford et al, 1998 and Karin and Ben-Neriah, 2000).   
This family possesses an N terminal region of around 300 amino acids called 
the Rel-homology domain (RHD), hence the family’s name.  The RHD is responsible 
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for dimerisation with other member of the same family, nuclear translocation since it 
has a nuclear localization sequence (NLS), DNA binding, and the interactive domains 
of the inhibitory IκB proteins (Siebenlist et al, 1994).  
 
1.6.2 The IκB family 
Members of this family include IκBα, IκBβ, IκBγ, IκBε, p100, p105, and Bcl-
3.  They contain six to eight ankyrin repeat domains (ARD) which are 33 amino acids 
in length (Siebenlist et al, 1994).  These ARDs regulate the binding to RHD and 
shield the NLS of NF-κB (Karin and Ben-Neriah, 2000).  The protein that is best 
characterised and the first cloned is IκBα.  In spite of the fact that the main function 
of IκBα is to bind to NF-κB proteins to maintain them in the cytoplasm, it is also 
involved in the removal of NF-κB from the nucleus (reviewed by Yamamoto and 
Gaynor, 2004).  Free IκBα has a very short half-life ranging from 70 seconds to less 
that 1 hour depending on the cell line (Ginn-Pease and Whisler, 1998).  
 
1.6.3 The IκB kinase (IKK) complex 
The IKK complex is a very high molecular weight protein complex composed 
of several polypeptides (DiDonato et al, 1997).  It consists of three IKK polypeptides; 
IKKα (IKK1), IKKβ (IKK2), and IKKγ.  IKKα and IKKβ are catalytic subunits 
whereas IKKγ is regulatory (reviewed by Karin, 1999). It was revealed that IKK 
activity is dependent on its phosphorylation and this is achieved by NF-κB inducing 
kinase (NIK) (Malinin et al, 1997).  NIK is a member of the mitogen-activating 
protein kinase kinase kinase (MAPK3) family which phosphorylates IKKα 
specifically at Ser-176 (Ling et al, 1998). 
 
1.6.3   NF-κB activation pathways 
In most cells NF-κB is present in a latent state retained in the cytoplasm, 
sequestered to IκBα.  IκBα degradation has been observed with all NF-κB inducers 
tested (Thanos and Maniatis, 1995).  Activation of NF-κB has been shown with a 
variety of stimuli including inflammatory cytokines, bacterial products, bacteria, 
viruses, and oxidative stress (Pahl, 1999).  Its activation can be divided into two 
pathways, the ‘classical’ and the ‘alternative’ pathway (Senftleben et al, 2001). 
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1.6.3.1       The ‘classical’ pathway 
After cell stimulation, the IKK complex is activated by the phosphorylation of 
particular serine residues within the activation loop of IKKα and IKKβ (reviewed by 
Yamamoto and Gaynor, 2004).  Then the IκB protein gets phosphorylated, at Ser 32 
and Ser 36 in IκBα and Ser 19 and Ser 23 in IκBβ (Chen et al, 1995 and DiDonato et 
al, 1996), by the IKK complex. This phosphorylation marks the protein for 
polyubiquitination (Maniatis, 1999 and Sun and Chen, 2004) by an ubiquitin 
containing complex at two lysines, Lys-21 and Lys-22 (Scherer et al, 1995).  Roff et 
al, (1996) emphasised the importance of the degradation of IκB in the activation of 
NF-κB, IκB is then selectively degraded by 26S proteasome.  Next the NLS will be 
exposed and this causes nuclear translocation of NF-κB to the nucleus.  The NF-κB 
would then bind to the cis-acting κB sites (5’-GGGPuNNPyPyCC-3’) in the DNA to 
initiate transcription (Pahl, 1999) of the target genes.  This pathway is suggested to be 
involved in the innate immunity whereas the ‘alternative’ pathway is involved in the 
adaptive immunity (Bonizzi and Karin, 2004).   
The involvement of IKK complex in NF-κB activation does not occur in two 
cases.  One of these is the activation of NF-κB by short-wavelength ultraviolet C 
(UVC) light accompanying the degradation of IκBα.  In UVC treated cells, neither 
IKK activation nor IκBα phosphorylation was observed (Li and Karin, 1998). The 
second exception was tyrosine (Tyr-42) phosphorylation of  IκBα (Imbert et al, 1996)  
which was observed during the treatment of cells with tyrosine phosphatase inhibitor 
(pervanadate), hypoxia (Koong et al, 1994), upon reoxygenation of  hypoxic cells, or 
after H2O2 treatment (Schoonbroodt et al, 2000).   This led to the dissociation of IκBα 
from NF-κB.  The degradation of IκB by different pathways is dependent on the cell-
type and the kind of stimulus.  
Under specific circumstances, such as nutrient deprivation, other proteolytic 
systems have been implicated such as lysosomal degradation.  In Chinese hamster 
ovary cells, the increase in IκB degradation has been completely inhibited by 
lysosomal inhibitors (Cuervo et al, 1998) and the half-life of IκBα pool in the 
lysosomes has been significantly increased by the presence of antioxidants, 
suggesting that intracellular ROS mediates IκBα degradation in the lysosomes.  This 
results in an increase in the NF-κB activity. 
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1.6.3.2    The ‘alternative’ pathway 
Several years ago an ‘alternative’ pathway leading to NF-κB activation was 
reported that occurs specifically in B cells (Senftleben et al, 2001 and reviewed in 
Simmonds and Foxwell, 2008).  Unlike the classical pathway, this pathway is 
dependent only on IKKα, and not IKKβ nor IKKγ.   RelB/p100 is the target molecule 
of the IKKα homodimers in this pathway.  Following cell stimulation, the IKKα 
homodimers get phosphorylated at two C-terminal sites.  This generates the 
polyubiquitination and proteasomal degradation of only the inhibitory C-terminal half 
of p100, and not the whole protein.  This would cause the processing of p52 from 
p100 (see section 1.6.1). Subsequently this would result in the nuclear translocation of 
RelB/p52 dimer to induce gene expression (reviewed in Yamamoto and Gaynor, 
2004). 
 
 
1.6.4        Redox regulation of NF-κB 
Reduction-oxidation or “Redox” is a term introduced to classify the oxidation 
and reduction reactions that have occurred.  Oxidation is the loss of electrons while 
reduction is the gain of electrons (Langrehr, 1971).  The intracellular redox within the 
cells is pivotal for various biological events to occur i.e. enzyme activation, DNA 
synthesis, cell cycle regulation, and transcriptional activation of several genes 
(Arrigo, 1999).  Recently, much interest has been seen with regard to the redox 
regulation of transcription factors, including NF-κB. 
Glutathione acts as a homeostatic redox buffer (see section 1.4.1.1).  It was 
reported that partial depletion of intracellular glutathione in human T cell line inhibits 
activation and nuclear translocation of NF-κB whereas the administration of 
extracellular cysteine inhibits the DNA-binding activity of the NF-κB complex. This 
inhibition is suggested to be caused by the elevation of GSSG levels (Mihm et al, 
1995). Therefore, it was proposed that GSSG was necessary for NF-κB activation in 
the cytoplasm, while GSH was required for the NF-κB DNA binding (Droge et al, 
1994).  Treatment of human promonocytic (U937) cells with BSO significantly 
decreased GSH, increased ROS production and activated NF-κB as a survival cell 
response against oxidative stress (Filomeni et al, 2005).    
In addition to these observations, TRx overexpression in the cytoplasm 
suppresses the degradation of IκBα (Hirota et al, 1999).  Therefore an oxidizing 
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environment is required in the cytoplasm for the activation of NF-κB (Ginn-Pease and 
Whisler, 1998). On the other hand a reducing environment was shown to be necessary 
in the nucleus.  The reduction of the cysteine residue at position 62 (Cys-62) in the 
NF-κB is essential for its DNA binding.  This is thought to be achieved by TRx which 
regulates the NF-κB binding by reducing Cys-62 (Matthews et al, 1992).  It was also 
demonstrated that TRx translocates from the cytoplasm to the nucleus in response to 
UVB radiation and TNF-α (Hirota et al, 1999), which are both stimuli of NF-κB 
activation.  It is important to mention that the oxidation of Cys-62 resulted in the 
inhibition of DNA binding (Arrigo, 1999).   
 
1.6.5  Oxidative stress and NF-κB activation 
NF-κB was the first transcription factor shown to be regulated by oxidative 
stress.  Several lines of evidence support this hypothesis.  The majority of the agents 
that induce NF-κB activity may be involved in ROS synthesis (Schreck et al, 1991).  
Furthermore, NF-κB activation has been shown to be induced directly by ROS i.e. 
H2O2 and by SOD overexpression, and interestingly was prevented by catalase 
overexpression (Schmidt et al, 1995).  Finally, antioxidants were shown to be effective 
in the blockage of NF-κB activation (reviewed in Schreck et al, 1992).  
The IκBα phosphorylation and degradation was shown to be responsive to 
oxidative stress and blocked by antioxidants (Li and Karin, 1999).  It was proposed 
that ROS generated would induce NF-κB activation by activating IKK which 
consequently leads to the dissociation of IκBα (Sen et al, 2004). In several cell lines 
NF-κB activation was induced by ROS in the form of H2O2 (Byun et al, 2002 and Li 
and Karin, 1999).  UVC (200 – 290 nm), UVB (290 – 320 nm), and for the first time 
UVA (320 – 380 nm) via oxidative stress was able to active NF-κB in human skin 
fibroblasts (Vile et al, 1995).  Labile-iron release by UVA was found to be a key 
regulator of UVA-induced NF-κB activation (Reelfs et al, 2004).  Specific membrane 
antioxidants (butylated hydroxytoluene and α-tocopherol) that inhibit lipid 
peroxidation, have inhibited UVA radiation-dependent activation of NF-κB.  
Antioxidants may act to prevent IκBα phosphorylation and degradation by (i) 
scavenging radicals, (ii) chelating metal ions to prevent Fenton reaction (see section 
1.3.3), (iii) maintaining the activity of other antioxidative enzymes, or (iv) inhibiting 
the activity of oxidising enzymes (Schreck and Baeuerle, 1992).  However it was 
proven that a number of other cell lines were not sensitive to H2O2 treatment, 
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including monocytic cells, astrocytoma, standard Jurkats except at high concentration, 
J. Jhan lymphoblastoid T cells, and some other cell lines (Bowie and O’Neill, 2000).  
Interestingly Lahdenpohja et al (1998) have reported that the ROS-forming capacity 
is weaker after chronic oxidative stress to Jurkat cell lines, and subsequently this has 
lead to the decreased NF-κB transcription since IκBα is not effectively 
phosphorylated and degraded.  
 
1.6.6 NF-κB and rheumatoid arthritis 
NF-κB has been proposed to have a central role in inflammation (Tak and 
Firestein, 2001).  Several studies have shown the link between the activation of NF-
κB and a number of inflammatory diseases.  Indeed, the NF-κB complex was found to 
be highly activated in patients with chronic inflammatory conditions such as 
rheumatoid arthritis (Handel et al, 1995; Asahara et al, 1995; Marok et al, 1996; 
Gilston et al, 1997 and Han et al, 1998).  It was also markedly increased in murine 
collagen-induced arthritis (CIA) (Han et al, 1998), and in adjuvant arthritis in rats and 
in carrageenan rat air pouch model of inflammation (Ellis et al, 2000).   It is not 
surprising to know that target genes for NF-κB include many genes that are involved 
in the inflammatory response, such as IL-1, TNF-α, IL-6, and inducible nitric oxide 
synthase (Baeuerle and Henkel, 1994). 
The activation of NF-κB protected animal models of RA against apoptosis and 
provided a potential link between inflammation and hyperplasia (Miagkov et al, 
1998).   Inhibition of NF-κB in T cells resulted in reducing the NF-κB regulated gene 
expression (Gerlag et al, 2000) and decreasing CIA (Seethraman et al, 1999 and 
Gerlag et al, 2000).  IMD-0506, an inhibitor of IKK, suppressed the nuclear 
translocation of NF-κB and the phosphorylation of IκBα induced by TNF-α in 
fibroblast-like synoviocytes (Okazaki et al, 2005).  This also suppressed the 
production of inflammatory cytokines.  Spontaneous production of TNF-α and other 
pro-inflammatory cytokines is NF-κB dependent in rheumatoid synovial tissue 
(Bondeson et al, 1999).   Treatment with dexamethasone resulted in reducing the 
number of cells stained for activated NF-κB in carrageenan rat air pouch model of 
inflammation (Ellis et al, 2000). 
Several drugs that are used for treating RA are either inhibitors of NF-κB 
activation (e.g. sulfasalazine and gold compounds), or they block IκB kinase (e.g. 
aspirin and sodium salicylate), or they increase IκBα (e.g. glucocorticoids) (Jue et al, 
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1999).  Therefore several papers have proposed that the blockage of NF-κB activation 
would be a good therapeutic target for both acute and chronic inflammation (Lee et 
al, 1998; Epinat and Gilmore, 1999; Feldmann et al, 2002; Wang et al, 2006; 
Tergaonkar, 2006).  However, because of its central role in many normal biological 
processes, global inhibition may not be therapeutically viable (Aya et al, 2005).  
Indeed, inhibition of the NF-κB activation can result in exacerbation of inflammation 
if TNF-α production by macrophages is not controlled (reviewed in Simmonds and 
Foxwell, 2008). 
 
1.6.7    The role of iron in NF-κB activation 
In synovial cells, the NF-κB is activated and this activation was correlated 
with increased IRP activity (Guillén et al, 1998).  The addition of iron in the lungs of 
rat demonstrated Ft induction, oxidative stress, elevated IL-1 levels, as well as NF-κB 
activation (Zhou et al, 2003).   Immediate labile-iron release by UVA is a key 
regulator of UVA-induced NF-κB activation in human skin fibroblasts (Reelfs et al, 
2004).  Studies using liver macrophages and rat brain microglia in cell culture have 
provided evidence to support the direct participation of chelatable iron in NF-κB 
activation and its prevention with iron chelators such as DFO (Youdim et al, 1999).   
Increase in the intracellular labile iron leads to IKK and NF-κB activation in response 
to LPS or TNF-α in macrophages, and iron chelators abrogated this response (Xiong 
et al, 2003).  It was therefore proposed that iron is responsible for the NF-κB 
activation in hepatic macrophages (Xiong et al, 2004).  Ferritin (heavy chain) was 
shown to be rapidly induced by NF-κB activation, which had an antiapoptotic 
activity, in response to TNF-α treatment (Pham et al, 2004). This induction 
suppressed the accumulation of ROS which is achieved through iron sequestration.   
This study suggests that H-Ft to be an essential mediator of antioxidant and protective 
activities of NF-κB. Recently, Tacchini et al, (2008) have demonstrated that the 
upregulation of NF-κB by inflammatory signals induces a rapid activation of the 
transcription factor hypoxia-inducible factor 1 (HIF-1)-dependent TfR1 expression 
and iron uptake in macrophages. 
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1.7 Aims and objectives of the project 
The synovial fluid and tissue of patients suffering from RA contain high levels 
of free ‘labile’ iron but its origin has not been properly investigated.  Furthermore 
because of the phenomenon of ischemia-reperfusion, synovial cells’ components are 
chronically exposed to ROS. We therefore sought to investigate the mechanism 
underlying the adaptation of synovial T cells to H2O2 by evaluating changes in 
antioxidant molecules and enzymes, intracellular labile iron, and NF-κB activation. 
Several studies have also shown a role for iron in the progression of inflammatory 
diseases such as RA (see section 1.2.4 and 1.2.5); but none, to our knowledge, had 
differentiated between the role of iron in both acute and chronic phases of the disease.  
Therefore, to investigate the role of iron in both acute and chronic oxidative 
conditions was necessary.   
To achieve our aims, we have extensively studied two cell lines which were 
Jurkat cells, human T-cell leukaemia cell line.  One of them was the parental cell line 
(J16 cell line) and the other was derived from the parental cell line and gradually 
adapted to be resistant to H2O2 (HJ16 cell line).  In established RA, T cells represent 
the most abundant inflammatory cells in the joint (Aya et al, 2005 and Deng and 
Lenardo, 2006).  Experimental and clinical evidence for T cell involvement in the 
pathology of RA is compelling.  Indeed, activated synovial T cells are key initiators 
and orchestrators of inflammation in RA, and therefore they represent key cellular 
targets for therapy (Cope et al, 2007).  Jurkat cells are widely used in the study of T-
cell activation processes (Schreck et al, 1991) and they are considered as critical 
determinants of the extent and chronicity of an inflammatory response.  The Jurkat T 
cell lines composed of ‘parental J16’ and ‘H2O2 resistant HJ16’ provide a good model 
to study the differential response of cells to both acute and chronic exposure. We have 
used the parental cell line to mimic the acute condition after relevant treatments of 
H2O2 and the resistant cell line to mimic the chronic condition.  The HJ16 cell line 
that was established following the gradual adaptation of the J16 cell line to increasing 
concentrations of oxidising agent H2O2, provides us with a useful model to mimic the 
chronic exposure of T cells in synovium to ROS that is almost certainly involved in 
the pathology of RA.   
We used H2O2 as an oxidising agent, since this is commonly used to study the 
effect of ROS in biochemical pathways.  Furthermore it is likely that H2O2 is 
produced in the synovial membrane during the ischemia-reperfusion cycles. Tissues, 
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in different pathological conditions, are confronted with elevated H2O2 concentrations 
derived either extra- or intracellularly.  Hydrogen peroxide is generated during normal 
metabolism and produced in large amounts by phagocytic cells during inflammation 
(Hampton and Orrenius, 1997).  Because it is uncharged and soluble in both aqueous 
and lipid phases, H2O2 would be expected to distribute rapidly between cellular 
compartments (Hyslop et al, 1995).  
  In addition to UVA (Morliere et al, 1997 and Pourzand et al, 1999) and visible 
light irradiation (Ohishi et al, 2005), it has already been shown that the exposure of 
cells to H2O2 (see section 1.3.6) provokes an increase in the LIP that correlates with 
cell damage and necrotic cell death, although the mechanisms involved has not yet 
been fully understood.  To understand this phenomenon, we have investigated the role 
of LIP, Ft, and HO (i.e. HO-1 and HO-2) in our cell model.  The lysosomal 
compartment seems to contain the major important cellular pool of labile iron (Petrat 
et al, 2001 and Persson et al, 2003) since the degradation of many macromolecules 
that are rich in iron (e.g. ferritin and mitochondrial electron-transport complexes) 
occurs in the lysosomes (Radisky and Kaplan, 1998 and Kurz et al, 2007) making 
these organelles vulnerable to oxidative stress (Persson et al, 2005). Therefore, 
understanding the link between lysosomal membrane damage and the above 
parameters may define pathological mechanisms associated with oxidative stress and 
lysosomal activity.  
            The potentially harmful free ‘labile’ iron is recognised as an important 
promoter of oxidative stress through aiding the production of ROS and thus a 
potential mediator of the inflammatory process in RA. Previous studies carried out by 
A. Yiakouvaki in this laboratory (PhD Thesis, 2003 – University of Bath)  have 
provided us with a link between the amount of H2O2-induced labile iron release and 
the extent of oxidative damage and cell death in Jurkat T cells. Furthermore, the study 
has shown that adaptation of Jurkat T cells to H2O2 can influence the basal level of 
antioxidant enzymes that is likely to contribute to the resistance of the HJ16 cells to 
H2O2 insult. This thesis has continued the study of Yiakouvaki (2003) by further 
characterising the differential response of parental J16 and H2O2-adapted/resistant 
HJ16 Jurkat T cells to H2O2 insult with special focus on (1) The role of antioxidant 
systems (e.g. GSH/GSSG, HO, and Ft); (2) The role of NF-κB activation; (3) The role 
of iron; and (4) The role of lysosomes.                                                                             
           In addition to the Jurkat cells, we have performed preliminary studies on a 
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series of primary human and rat fibroblasts.  The human fibroblasts were developed 
and cultured in our laboratory from human synovial tissues; normal (HN-1), 
rheumatoid arthritic (HRA-1) and osteoarthritic patients (HOA-1). In addition to the 
human cells, two primary rat synoviocytes were kindly provided by Dr. Vivienne 
Winrow (School for Health, University of Bath, UK) for the purpose of our study.  
The latter were isolated from normal Wistar rats (VW-1) and Wistar rats with 
adjuvant arthritis (AAVW-1).  To gain insight into levels of synovial intracellular iron 
levels, the labile plasma iron was also measured on a series of normal, RA and OA 
synovial fluid.                                                                                                                    
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CHAPTER TWO 
 
MATERIALS AND METHODS 
 
  
  
2.1 Chemicals and Reagents 
Cell culture materials were obtained from Gibco (Germany) except for fetal 
bovine serum (PAA Laboratories, Austria) and RPMI-1640 medium (Promocell, 
Germany).  All chemicals were from Sigma-Aldrich Chemical (Poole, UK) unless 
otherwise indicated.  Protease inhibitors cocktail tablets, Annexin-V-FLUOS, 
Klenow enzyme, and Bovine Serum Albumin (BSA) were supplied from Roche 
(Mannheim, Germany).  Glutathione reductase, Hydrogen peroxide solution, and 
Mowiol® 4-88 were obtained from Calbiochem (CN Biosciences LTD, Nottingham).  
Dimethyl sulphoxide and Nonident P-40 was purchased from VWR International Ltd 
(Leicestershire, England).  Antibodies for immunocytochemistry (p65, Cathepsin-B 
and Oct-1) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, 
California).  CA-AM (Calcein-acetoxymethyl ester) and LysoSensorTM Green DND-
153 were purchased from Molecular Probes (Leiden, Netherlands).  Desferrioxamine 
mesylate Ph. Eur. (DFO) was purchased from Ciba-Geigy laboratories (Basel, 
Switzerland).   [α32P]-dATP was obtained from Amersham Biosciences UK Limited 
(Buckinghamshire, England).  Stock solutions (100 mM) of deoxynucleotide 
triphosphates (dNTPs) such as dCTP, dGTP, and dTTP were purchased from 
Promega (Madison, USA). 
 
  
2.2   Cell Culture 
The Jurkat J16 cells are a human T-cell leukaemia cell line.  The HJ16 cells 
are a polyclonal H2O2 resistant cell line which were derived from the J16 cell line 
after gradual adaptation to 3mM H2O2.  In this process, HJ16 cells were treated with 
increasing concentration of H2O2 (i.e. from 0.1 mM to 3 mM) at weekly to 
fortnightly intervals.  After each treatment the surviving cells were allowed to recover 
normal growth characteristics before further exposure to a higher concentration of 
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H2O2. Following this adaptation, stocks of HJ16 cells were stored in Liquid Nitrogen 
to ensure their resistance to H2O2.  The J16 and HJ16 cell lines were kindly provided 
by Dr. N.D Hall (Pharmacy and Pharmacology, University of Bath, UK). Since in an 
independent study from our laboratory (i.e. Yiakouvaki, 2003) it was found that 
HJ16 cells had 3.4-fold higher cell volume than J16 cells (i.e. J16 cells: 0.47 ± 0.08 
pl and HJ16: 1.6 ± 0.19 pl), where applicable, normalisation of the data in this thesis 
was always performed to protein concentration and not to the cell number/cell 
volume.  
Both cell lines were cultured routinely in RPMI-1640 medium supplemented 
with 10% v/v heat inactivated fetal bovine serum (FBS), L-Glutamine (2 mM), 
Penicillin/Streptomycin (50 IU/ml each) and 2.7% v/v sodium bicarbonate. They 
were incubated at 37°C in a humidified atmosphere with 5% CO2.      
 
 
2.3     Treatments 
2.3.1 Hydrogen peroxide (H2O2) treatment  
Stock solution: 176mM in phosphate buffered saline (PBS)  
 
Hydrogen peroxide (H2O2) solutions were freshly prepared from a 30% stock 
solution.  Treatments were performed in serum free media (SFM) to prevent the 
degradation of H2O2 by the catalase present in the serum.  Cells were incubated with 
the relevant concentration of H2O2 for 30 minutes. After centrifugation, they were 
resuspended and incubated in the conditioned media for the times indicated in the 
Results section (see Chapter Three). The J16 and HJ16 cell lines were both tested 
routinely during the experimental work to demonstrate their differential sensitivity to 
H2O2 treatment. 
 
2.3.2 Buthionine-[S,R]sulfoximine (BSO) treatment  
Stock solution: 50mM in phosphate buffered saline (PBS)  
Unless otherwise stated, cells were incubated with 25 µM BSO for 18 h at 37°C in 
the conditioned media prior to experimentation. 
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2.3.3 DFO treatment 
Stock solution: 150 mM in H2O 
Unless otherwise stated, cells were treated with 100 µM of DFO for 18 h at 37°C 
prior to experimentation. 
 
2.3.4 Hemin treatment 
Stock solution: 20 mM in dimethyl sulphoxide. 
Unless otherwise stated, cells were treated with 20 µM of hemin for 18 h at 37°C 
prior to experimentation. 
 
 
2.4     MTT Assay 
 
The MTT assay is widely used in cell proliferation and cytotoxicity assays 
(Berridge et al, 1996).  It is a sensitive colorimetric assay (Mosmann, 1983 and 
Doyle and Griffiths, 1998) that was performed to determine the viability of cells after 
relevant treatments.  Cellular and mitochondrial dehydrogenase enzyme converts 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide], a yellow 
water-soluble substrate, into a dark blue formazan product that is insoluble in water.  
The amount of formazan produced is directly proportional to the viable cell number. 
The MTT stock solution of 5mg/ml in PBS was filtered through a 0.2 μm 
filter (Ministart®, Germany) for sterilisation and stored at –20ºC.  On the day of the 
experiment and after the relevant treatments, the pellets were resuspended in SFM 
containing MTT stock solution at a final concentration of 0.5mg/ml.  From this 
solution, 100-200 μl were placed, in triplicate, into a 96 well microplate.  The 96-
well microplate was then incubated for 3h at 37ºC.  Then the MTT / SFM solution 
was aspirated and 50-200 μl of dimethyl sulphoxide (DMSO) was added to each 
well.  Finally, the plate was swirled for 3 minutes by a 3D rocking platform (Stuart 
Scientific, UK) and the absorbance was read by VERSAmaxTM (Molecular devices, 
California) at 550 nm. 
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2.5    Flow Cytometric Analysis  
Quantification of apoptotic, necrotic, and live cells were evaluated by flow 
cytometry.  Apoptotic lymphocytes were shown to express phosphatidylserine (PS) 
on the outer layer of the plasma membrane (Fadok et al, 1992).  In the early stages of 
apoptosis, PS translocates from the inner part of the plasma membrane to the outer 
layer.  Annexin-V-FLUOS is a phospholipid binding protein with a high affinity for 
PS.  Therefore it is suitable for the detection of apoptotic cells.  On the other hand, 
necrotic cells that lose cell membrane integrity are stained with both Annexin-V-
FLUOS and Propidium Iodide (PI). Therefore, Annexin-V-FLUOS and PI double-
staining can differentiate between necrotic and apoptotic cells.  
After relevant treatments and incubation periods, cells were collected and 
washed with PBS.  Cells were then resuspended in 100 μl of  incubation buffer (10 
mM Hepes/NaOH pH 7.4, 140 mM NaCl, 5 mM CaCl2) containing Annexin-V-
FLUOS (20μl/ml) and PI (20μl/ml). Samples were then transferred to a 5ml 
polystyrene round-bottom tube and incubated for 10-15 minutes at room temperature 
(RT) in a dark place.  Data analysis was performed using CellQuest software 
(Becton-Dickinson, Erembodegem, Belgium). 
 
 
2.6    Protein Measurements 
Protein concentrations were measured according to the method of Bradford 
(1976) with slight modification. This modification was performed to enable the 
measurements of the protein content to be carried out in the 96-well plate to decrease 
the amount of protein extract used.  To calibrate the standard curve, bovine serum 
albumin (BSA, 2 mg/ml) was first diluted (1:1) with MilliQ water (i.e. to 1 mg/ml) 
and used at final concentrations of 0, 1, 2, 4, 6, 10, 15, and 20 mg/ml.  The total 
volume of cellular extract (1-5 μl) or BSA (0-20 μl) with MilliQ water used in the 
each well was 160 µl, done in duplicates.  40 µl of Bio-rad Protein Reagent (Bio-rad, 
500-0006) was finally added, and the solution was thoroughly mixed with a pipette 
(preferably, a multichannel pipette).  The absorbance was read by VERSAmaxTM 
(Molecular devices, California) at 595 nm filter.   
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2.7    Glutathione Measurements  
Total intracellular glutathione was measured according to the 
spectrophotometric method developed by Tietze (1969).  It is an enzymatic recycling 
procedure which offers a high sensitivity rate.  Glutathione is assayed by a system in 
which it is readily oxidised by 5,5’-dithiobis(2-nitrobenzoic acid) DTNB and reduced 
by NADPH in the presence of glutathione reductase (GR).  The rate of 2-nitro-5-
thiobenzoic acid formation is monitored and the glutathione is determined by the 
comparison of the result with a standard curve with the known amounts of 
glutathione (Griffith, 1980 and Pourzand et al, 2000).  
The standard curve consists of GSSG stock solution diluted in [5% TCA in 2 
mM EDTA] in a range of 0.01 – 2 μM.  Cells (1.0 x 106) were incubated with BSO 
for 18 h (see section 2.3.2).  After the incubation period, the pellets were 
resuspended in cold PBS and then extracted in a freshly prepared mixture of [5% 
TCA in 2 mM EDTA] in order to give 500µL per 1.0 x 106 of cells.   
100 μl samples from either the stock solution (0.01 – 2 μM) or the treated 
cells were transferred to an eppendorf  tube containing 1ml of phosphate buffer, 50 
μl of NADPH (5 mM in 0.5% NaHCO3), and 20 μl of freshly prepared DTNB (1.5 
mg/ml in 0.5% NaHCO3).  The eppendorf tube was then placed in a 25°C water bath 
for 10 minutes.  Next, 100μl of GR (18 u/ml in phosphate buffer) was added to the 
mixture and change in absorbance was monitored by a Uvikon 922 
spectrophotometer (Kontron instruments, Italy) for 6 minutes at 412 nm (25°C). 
The total intracellular glutathione was then normalised by two 
determinations, cell count and total cellular protein. For this purpose, either the 
viability of cells were assessed using a haemocytometer and the cells were stained by 
Trypan blue (Doyle and Griffiths, 1998), or the cells were lysed and the total cellular 
protein was then measured via the Bradford assay (see section 2.6).   
 
 
2.8    Electrophoretic Mobility Shift Assay (EMSA) 
An adaptation of the protocol described by Schreiber et al, (1989) was used 
for the analysis of the activation of NF-κB by EMSA.  Typically, 0.5 x 106 cells from 
four 6 cm plates of specified treatments were used.  Cells were then washed with 2ml 
ice-cold PBS and pelleted by centrifugation at 1500 rpm (400 xg, Falcon 6/300 -
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MSE) at 4ºC.  The pellet was resuspended with 80 μl of Buffer A [10 mM HEPES 
(pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA] with a fresh supplementation 
of DTT (1 mM) and Protease inhibitors cocktail tablets (20x), and allowed to swell 
for 15 minutes on ice.  0.5% of 10% w/v NP-40 was added and the eppendorf was 
vigorously vortexed for 10 seconds. The lysates were then centrifuged for 30 seconds 
at 13,000 rpm (9000 xg, Micro Centaur – MSE).  The supernatant which contained 
the cytoplasmic proteins was collected and flash-frozen on dry-ice.  It was stored at -
80ºC.  The nuclear pellet was then resuspended in buffer C [20 mM HEPES (pH 7.9), 
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA] with a fresh supplementation of DTT (1 
mM) and Protease inhibitors cocktail tablets (20x).  The Eppendorf was vigorously 
rocked for 15 minutes at 4ºC on a shaking platform.  The nuclear extract was then 
centrifuged for 5 minutes at 13,000 rpm (9000 xg) in a Biofuge 13 centrifuge 
(Heraeus Instruments) in a cold room (4ºC).  The supernatant (nuclear proteins) was 
collected and flash-frozen on dry-ice.  It was stored at -80ºC.  Protein concentration 
was measured (see section 2.6) in duplicates on 3 μl aliquots of the extracts and the 
mean was taken. 
 
2.8.1 Annealing and purification of the oligonucleotides  
The annealing and purification of the oligonucleotides were kindly developed 
and performed by Dr. Olivier Reelfs through the following protocol:  
The oligonucleotides possess HindIII and SalI linker sites on their 5’ and 3’ 
end, respectively (Zabel et al, 1991).  The sequence of the “κB” oligonucleotides 
used as a radioactive DNA was as follows:  
5’-  AGCTTCAGAGGGGACTTTCCGAGAGG - 3’ 
3’ – AGTCTCCCCTGAAAGGCTCTCCAGCT – 5’ 
Equal amounts of each oligonucleotide and its complementary strand were 
mixed in a buffer containing 100 mM Tris (pH 7.6), 100 mM MgCl2, boiled for 3 
minutes and the mixture was left to be cooled at RT. Proper annealing was first 
verified on a 20% polyacrylamide gel, and then purified on a 20% polyacrylamide 
preparative gel in a 0.5x TBE buffer [44.4 mM Tris, 44.4 mM borate, 1 mM EDTA 
(pH 8.0)].  Elution of the band from the gel was performed by electroelution 
(Biotrap; Schleicher & Schuell, Switzerland), the oligonucleotides were ethanol 
precipitated, resuspended in TE buffer [10 mM Tris (pH 7.6), 1 mM EDTA (pH 8.0)] 
and aliquoted at -20ºC.    
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2.8.2 Preparation of the probe 
100 ng of the annealed oligonucleotide was labelled by end-filling using the 
Klenow enzyme in the presence of 50μCi [α32P]-dATP, 0.033 mM of cold dCTP, 
dGTP, dTTP, and 3μl of 10x polymerase buffer [ 0.5 M Tris (pH 7.5), 0.1 M MgCl2, 
10mM DTT, 0.5 mg/ml BSA].  
 
2.8.3 Binding reactions 
For detecting NF-κB binding activity after relevant treatments of both J16 
and HJ16 cell lines: First, 6 μg of the nuclear extract was incubated for 10 minutes at 
RT in a freshly prepared buffer composed of 20 mM HEPES (pH 7.9), 12% glycerol, 
0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT, 5 mM MgCl2, 3mM ATP, and 100 μg 
poly [(dI)-(dC)]. Salt concentration was adjusted to 100 mM in each sample.  After 
the 10 minutes incubation period, 0.3 ng of the labelled oligonucleotide was added to 
the mixture and incubated for 30 minutes at RT. 
 
2.8.4 Running and processing the gel 
The reaction mixtures were loaded on a 5 % polyacrylamide gel and 
electrophoresed at 140V in 0.4x TBE buffer at RT for 2-3 h.  Next the gel was fixed 
in a mixture of methanol: acetic acid: water (at propositions of 10: 10: 80) for 20-30 
minutes and then it was vacuum-dried for 1.5 h (in high mode).  Results were shown 
as autoradiograms using high performance chemiluminescence films (Amersham 
Biosciences UK Limited, England) developed by Fuji X-ray Film Processor (Fuji 
Photo Film Co, Japan).  The bands were scanned and the quantification was assessed 
using LabImage software - Version 2.7.2 (Kapelan Bio-Imaging Solutions, 
Germany). 
 
 
2.9    Western blot analysis 
Whole cell extracts were prepared by the lysis of the cells with 0.1% Triton 
X-100 lysis buffer [20mM TrisHCl (pH 8), 0.1% Triton X-100, 10% glycerol, 2mM 
EDTA, 137mM NaCl, 100mM PMSF, Protease inhibitors cocktail (20x)].  Protein 
measurements were then determined by Bradford's assay (see section 2.6).  Equal 
amounts of protein (40 µg) were diluted with 4x loading buffer [180 mM Tris (pH 
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6.8),  3% SDS, 150 mM DTT, 30% glycerol, 0.0015% bromophenol blue, 0.53 ml 
Milli Q water] and then boiled for 5 minutes at 95°C.  They were then resolved by 
Polyacrylamide (10% acrylamide) gel electrophoresis (SDS-PAGE) for ~ 1.75 h at 
150 volts (V) in running buffer (1.5 % w/v Tris, 7.2 % w/v glycine, 0.5 % SDS) and 
transferred to nitrocellulose membranes (Amersham Biosciences, UK) at 4°C or 1.5 
h at 100 V in a transfer buffer (3% w/v Tris, 14.4 % w/v glycine, 20 % v/v 
methanol).   The transfer was verified by the colouration of the membrane with 
Ponceau S solution for 1-2 minutes and then rinsed several times with a small 
amount of Milli Q water to reveal the bands.   The membrane was then thoroughly 
washed with 0.5% Tween-20 (Acros Organics, Belgium) PBS (PBST) and blocked 
for 1 h in 5% w/v milk powder in 0.05% PBST, placed on a rocking platform (Stuart 
Scientific, UK).  Next, the membrane was washed once with 0.5% PBST and 
incubated with one of the following primary antibodies in 5% w/v milk in 0.05% 
PBST overnight at 4ºC with; 1:50 anti-HO-1 mouse monoclonal antibody (OSA-110, 
Stressgen Bioreagents), 1:200 anti-HO-2 rabbit polyclonal antibody (kindly provided 
by Prof. Rex Tyrrell, University of Bath), or 1:500 anti-actin mouse monoclonal 
antibody (Sigma, A4700).  The membrane was then washed extensively with 0.5% 
PBST and incubated with (1:500 for HO-1 and 1:2000 for Actin) goat anti-mouse 
IgG peroxidase conjugated (Sigma, A4416) or (1:1500 for HO-2) anti-rabbit IgG 
(whole molecule)-Peroxidase (Sigma, A6154) in 5% w/v milk in 0.05% PBST for 1 
h at RT on a rocking platform (Stuart Scientific, UK). The membrane was then 
washed extensively with 0.5% PBST, and the protein bands were finally detected 
using enhanced chemiluminescence (ECL) plus detection system according to 
manufacturer's instructions (Amersham Biosciences).  Re-blot Plus (Strong Antibody 
Stripping Solution) was used in order to re-blot, according to manufacturer's 
instructions (Chemicon, 2504). 
 
 
2.10     Ferritin ELISA   
Enzyme-Linked ImmunoSorbent Assay (ELISA) is a biochemical technique 
used mainly in immunology to quantify the presence of an antibody or an antigen in 
a sample.  Reagents for ferritin ELISA were kindly provided by Dr. Santambrogio 
(Milan, Italy), and the assay performed as described in Santambrogio et al, 2000 and 
2007.  Cytosolic ferritin concentrations were determined in cell lysates by 
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monoclonal antibodies specific for human H- and L- ferritin subunits (rH02, LF03), 
and mitochondrial ferritin concentrations in mitochondria enriched fractions by 
mouse polyclonal antibody specific for mitochondrial ferritin (MoαHuFtMt) by the 
means of ELISA, then normalised to protein concentration (see section 2.6).   
For cell lysates: After relevant treatments, cells (10 x 106 cells / condition) 
were washed with ice cold PBS and the lysates were prepared as described in 2.9.  
The supernatant was then flash frozen on dry ice with ethanol and kept at -80°C until 
use.  Microtiter plates were coated with 0.1 ml of 10µg/ml of rH02 or LF03 
antibodies diluted in 50 mM Na carbonate buffer pH 9.5.  Standard ferritins and 
samples were diluted in PBST with 1% BSA (0.05% Tween-20 in PBS-BSA) and 0.1 
ml was added to the plates, incubated for 1 h at 37°C, washed three times with PBST 
(0.05% Tween-20 in PBS), and further incubated for 1 h at 37°C with the same HRP-
labelled antibodies (LF03-HRP 1:3000 and rH02-HRP 1:15,000, in PBST + 1% 
BSA) to reveal the bound ferritin.  The peroxidase activity was developed with o-
phenylenediamine dihydrochloride (Sigma, P1526). 
For mitochondria preparation (Smith, 1967 and Atorino et al, 2003) : After 
relevant treatments, cells (10 x 106 cells / condition) were washed with ice cold PBS 
and resuspended in ice cold-isotonic buffer (250 mM Sucrose, 5 mM tris-HCl pH 
7.5, 0.1 mM PMSF) and homogenised using PowerGen 125 Homogenizer (Fisher 
Scientific, UK) for 30 seconds. This was then centrifuged at 600 xg for 15 minutes at 
4°C in a Biofuge 13 centrifuge (Heraeus Instruments) to remove the nuclei and cell 
debris.  Next, the supernatant was collected and centrifuged at 13,000 rpm (9000 xg) 
in a Biofuge 13 centrifuge (Heraeus Instruments) for 25 minutes at 4°C.  The pellet 
was finally dissolved in the same buffer containing 1mM EDTA and centrifuged at 
13,000 rpm (9000 xg) for 25 minutes at 4°C in a Biofuge 13 centrifuge (Heraeus 
Instruments).  The mitochondrial pellet was flash frozen on dry ice with ethanol, and 
kept at -80°C until use.  On the day of the assay, the pellet was resuspended in the ice 
cold-isotonic buffer.  As above, microtiter plates were coated with 0.1 ml of 10µg/ml 
of MoαHuFtMt antibodies diluted in 50 mM Na carbonate buffer pH 9.5. Standard 
ferritins and samples were diluted in PBST with 1% BSA (0.05% Tween-20 in PBS-
BSA) and 0.1 ml was added to the plates, incubated for 1 h at 37°C, washed three 
times with PBST (0.05% Tween-20 in PBS), and further incubated for 1 h at 37°C 
with the same HRP-labelled antibody (MoαHuFtMt-HRP 1:6000, in PBST + 1% 
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BSA) to reveal the bound ferritin.  The peroxidase activity was developed with o-
phenylenediamine dihydrochloride (Sigma, P1526). 
 
 
2.11   Neutral red uptake assay 
The neutral red (NR) uptake assay is a cell survival/viability assay, based on 
the ability of the viable cells to incorporate and bind NR.  Neutral red is a relatively 
non-toxic, weakly cationic dye which was introduced as a vital stain in 1894 (Dietz 
et al, 1979).  This dye enters the cells and accumulates in the lysosomes (since it has 
a low pH) and binds to its matrix by non-ionic diffusion, a mechanism by which 
weak acids and bases pass through lipid membranes in a non-ionised form (Anderson 
and Orci, 1988). 
 The neutral red stock solution was made by thoroughly dissolving 0.02g of 
NR powder in 5ml of Milli Q water.  500 µL of the stock solution was added to 39.5 
ml of 10 % FCS-RPMI, this solution was stored overnight at 37°C to remove fine 
precipitates and dye crystals which form when NR is mixed with the medium 
(Borenfreund and Puerner, 1985).  On the day of the assay, this solution was 
centrifuged for 10 minutes at 1200 rpm (120 xg) in a Jouan B 3.11 centrifuge and 
filtered through a 0.2 µm filter (Ministart®, Germany).  The cells were centrifuged 
and washed once with PBS, resuspended in 2-3 ml of the filtered dye/media mixture, 
and then incubated at 37°C for 1.5 h.  Next, they were centrifuged at 1500 rpm (300 
xg) in a Falcon 6/300 MSE centrifuge and fixed with 500 µL of the fixing solution 
(40% formaldehyde + 10% CaCl2) for a maximum of 1 minute since formaldehyde 
will result in the extraction of the dye. The cells were centrifuged again and lysed 
with 500 µL of lysis buffer (1% acetic acid + 50% ethanol).  150 µL of each sample 
was placed in duplicate in a 96-well plate and the absorbance was measured at 540 
nm by VERSAmaxTM (Molecular devices, California). 
 
 
2.12    Lysosensor immunofluorescence 
The LysoSensorTM Green DND-153 was used to monitor the integrity of the 
lysosomal membrane after relevant treatments.  This probe is a fluorescent pH 
indicator that partitions into acidic organelles at the result of protonation.  
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Treatments were performed when cells were placed on sterilised glass 
coverslips laid on the bottom of 3cm3 plates, done in duplicate.  After relevant 
treatments, 500 µL of methanol (stored in -20°C) was placed on the plates for 5 
minutes, to fix the cells on the coverslips.  The methanol was then aspirated and the 
plates were kept at –20°C till use.  On that day, 1 ml of PBS was added to the plates 
for 10 minutes to rehydrate the cells.  The PBS was then aspirated and 500 µL of the 
1 µM probe (stock) solution (freshly prepared in 10% FCS-RPMI) was placed on the 
cells and they were then incubated for 2 h at 37°C.  Meanwhile, microscope slides 
were prepared and cleaned by soaking them in ethanol for 5 minutes, then with Milli 
Q water for 2 minutes and finally in acetone for 5 minutes. After the 2 h, the 
coverslips were drained, washed gently with PBS, and mounted overnight on the 
slides containing 20 µL of Mowiol® 4-88 mounting medium.  Finally, the cells were 
analysed by LSM 510 Confocal Microscope (Carl Zeiss system, Germany) and the 
objective used was described as Plan-Apochromat 63 x / 1.40 oil DIC.  The line of 
excitation used from the Argon laser was 488 nm and the emission was passed 
through a Long Pass 505 nm (LP 505) filter.  Pictures were scanned at a resolution of 
1024x1024 pixels; this is equivalent to an approximate resolution of 1.05 mega 
pixels.  
 
 
2.13   Immunocytochemistry 
Treatments were performed when cells were placed on sterilised glass 
coverslips laid on the bottom of 3cm3 plates, done in duplicate.  After relevant 
treatments, cells were fixed by methanol (stored in -20°C) for 5 minutes.   The 
methanol was then aspirated and the plates were stored in –20°C till use.  On that 
day, 1 ml of PBS was added in the plates for 10-15 minutes to rehydrate the cells.  
The PBS was aspirated and the non-specific sites were blocked by the addition of 
150 µL of Buffer X (0.1 % TritonX100 + 2% BSA in PBS) at room temperature 
(RT) for 10 minutes.  The primary antibodies used were Cathepsin B, NF-κB (p-65), 
and Oct-1 (C-21).  The dilution was 1:100 in Buffer X and they were incubated for 1 
h at RT placing parafilm on the top.  After the 1 h passed, the cells were gently 
washed twice with PBS and were then incubated with the secondary antibody 
(dilution 1:100, in Buffer X) for another 1 h at RT.  The secondary antibody used 
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was a FITC conjugated goat anti-rabbit IgG (Sigma, F9887).  Meanwhile, 
microscope slides were prepared and cleaned by soaking them in ethanol for 5 
minutes, then with Milli Q water for 2 minutes and finally in acetone for 5 minutes. 
After the 1 h incubation time, the coverslips were then drained, gently washed twice 
with PBS, and mounted overnight on the slides containing 20 µL of Mowiol® 4-88 
mounting medium.  Finally, the cells were analysed by LSM 510 Confocal 
Microscope (Carl Zeiss system, Germany) and the objective used was described as 
Plan-Apochromat 63 x / 1.40 oil DIC.  The line of excitation used from the Argon 
laser was 488nm and the emission was passed through a Long Pass 505nm (LP 505) 
filter.  Pictures were scanned at a resolution of 1024x1024 pixels; this is equivalent 
to an approximate resolution of 1.05 mega pixels.  
 
 
2.14     Preliminary Clinical data 
In collaboration with Dr. James Murray orthopaedic consultant (Frenchay and 
the Avon Orthopaedic Centre in Southmead, Bristol) and according to the South 
West Local Research Ethics committee approval BA 574 (2003/4), we have received 
synovial fluid and synovial tissue biopsies from normal, rheumatoid arthritic, and 
osteoarthritic patients (see table 2.1 for the statistics).  The synovial fluid was 
centrifuged at 3000 rpm (1000 xg) in a Falcon 6/300 MSE centrifuge for 15 minutes 
to remove debris and any other unwanted particles.  The supernatant was collected 
and stored at -80ºC.  Before culturing fibroblasts from the biopsies, they were 
washed with 1ml Penicillin/Streptomycin (50 IU/ml each), they were then placed in 6 
cm plates, sliced and sheared into small pieces.  The biopsy was maintained in 15% 
v/v FBS-EMEM supplemented with an antibiotic mix [Penicillin G - 107 units 
(Sigma); Streptomycin sulphate – 10g (Sigma); Fungizone – 100 ml (Gibco)] 
prepared in our laboratory.  The fibroblasts were then cultured and grown in 15% v/v 
FBS-EMEM supplemented with), L-Glutamine (2 mM), Penicillin/Streptomycin (50 
IU/ml each) and 2.7% v/v sodium bicarbonate. They were incubated at 37°C in a 
humidified atmosphere with 5% CO2.      
In addition to the above, Dr Vivienne Winrow (School for Health, University 
of Bath) kindly supplied us with primary rat synoviocytes (fibroblasts), labelled VW-
1 and adjuvant arthritic (AA) rat fibroblasts, labelled AAVW-l.   
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Table 2.1 : 
  
 
Table listing the synovial fluid (top) and the synovial knee biopsies (bottom) 
received and analysed for either labile plasma iron (LPI) or labile iron pool (LIP), 
respectively. 
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Adjuvant arthritis is a chronic model and a standard procedure which has been used 
for many years (Pearson, 1956 ; Currey and Ziff, 1968 ; Andrews et al, 1987). It  is a 
useful model for screening putative therapeutics for diseases such as human RA; it 
induces both soft inflammation and bone destruction (Ragno et al, 1996).  Rats with 
AA share many characteristics with human RA such as genetic linkage, synovial 
CD4+, and T cell dependence (Goodson et al, 2003).  They were grown in 10% v/v 
FBS DMEM (1000 mg/L glucose; Pyruvate) supplemented with L-Glutamine (2 
mM), Penicillin/Streptomycin (50 IU/ml each) and 2.7% v/v sodium bicarbonate 
(0.27%). They were incubated at 37°C in a humidified atmosphere with 5% CO2. 
Since the human and the rat fibroblasts are not cell line (ie not immortalised), they 
will not passage indefinitely. Therefore, as Dr. Vivienne Winrow advised, functional 
studies were not performed beyond passage 12 (maximum).  
 
 
2.15   LIP determination in 96 well-plates 
The level of LIP was determined by an adaptation of the method developed 
by Epsztejn et al, 1997 and Petrat et al, 1999.  The cytochemical calcein-
acetoxymethyl ester (CA-AM) assay is well established as a technique for the assay 
of cellular LIP.   The principle of this assay is that non-fluorescent lipophilic CA-AM 
that easily penetrates cellular membranes produces fluorescent CA when rapidly 
cleaved by unspecific cytosolic esterases. The fluorescent CA is a fluorochromic 
alcohol that chelates labile iron (Tenopoulou et al, 2007).  The level of intracellular 
CA-Fe complexes was determined by the increase in fluorescence produced by the 
addition of the fast membrane permeable iron chelator, salicylaldehyde isonicotinoyl 
hydrazone (SIH). Salicylaldehyde isonicotinoyl hydrazone (kindly provided by 
Professor Ponka, Lady Davis Institute - Canada) is a lipophilic strong chelator that 
restores the fluorescence by removing the complexed iron (Glickstein et al, 2005). 
 Cells were grown for 48 h in dark 96-well plates (Costar, 3603) at a density 
of 6 x 10 4 cells / well (final density needed ~ 8 x 10 4 cells / well).  After the 48 h, 
the conditioned media was aspirated and the cells were washed once with DPBS 
(Dulbecco’s phosphate buffered saline with Ca and Mg – Cambrex, Belgium).  After 
H2O2 treatments, cells were washed once with DPBS and loaded with 0.25 μM CA-
AM in Earle’s minimum essential media [containing 20 mM HEPES (pH 7.3) and 
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BSA 1 mg/ml] for 15 min at 37°C. The cells were then washed with DPBS, and the 
fixing solution [10 mM HEPES buffer containing 150mM NaCl and 2 mM 
diethyltriamine-pentaacetic acid (DTPA)] was added.  The fluorescence (F1) was 
then measured (Excitation 485 – Emission 535) by a Fluoroskan Ascents microplate 
reader (Labsystems, OY).   200 µM of SIH was then added, and the plate was placed 
on a rocking platform (Stuart Scientific, UK) for 15 minutes to allow chelation.  
After the 15 minutes, the fluorescence (F2) was measured (Excitation 485nm – 
Emission 535nm).  The fractional increase of fluorescence (ΔF = (F2-F1) / F2) was 
first determined by the calibration curve and then normalised to total cellular protein.  
This correlates with the LIP (µM/µg) within the cells (Duarte and Jones, 2007).   
The calibration curve was prepared with ferrous ammonium sulphate (Petrat et 
al, 2000).  It was initially diluted with DPBS to 1 mM and then to 1µM (final) and 
from it 1:1 serial dilutions were prepared, till 2.44 x 10-4 µM (total = 12 
concentrations were used).  0.25 µM of CA (Sigma, C0875) was added to the 12 
serial dilutions and the fluorescence (F1) was measured (Excitation 485 – Emission 
535) by a Fluoroskan Ascents microplate reader (Labsystems, OY).  200 µM of SIH 
was then added to the serial dilutions, and the plate was placed on a rocking platform 
(Stuart Scientific, UK) for 15 minutes to allow chelation.  After the 15 minutes, the 
fluorescence (F2) was measured (Excitation 485 – Emission 535).  For the calibration 
curve (Darbari et al, 2003), the fractional increase of fluorescence (ΔF = (F2-F1) / F2) 
was plotted against the iron concentration used (y = 9.981x + 0.088, is the linear 
equation of the trendline). 
 
 
2.16     Labile plasma iron (LPI) measurements 
Labile plasma iron (LPI) represents the redox-active and chelatable 
component of non-transferrin-bound iron (NTBI) (Le Lan et al, 2005).  It is capable 
of permeating into organs and inducing tissue iron overload (Cabantchick et al, 
2005).  The method of measuring LPI is based on its capacity to generate reactive 
oxygen radicals when prompted with ascorbate in a manner blockable by specific 
iron chelators such as DFO.  Non fluorescent dihydrorhodamine (DHR) is converted 
by various oxidants, such as reactive oxygen radicals, to the fluorescent form.  
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As described by Esposito et al, (2003): Quadruplicates of 20 µL synovial 
fluid (SF) were placed in a clear-bottom 96 well plate.  To two of the four wells, 180 
µL iron-free HEPES buffered saline (HBS; HEPES 20mM, 60nM DFO, NaCl 150 
mM, pH 7.4 – treated with 1g of 100ml-1 Chelex-100) containing 40 µM ascorbate 
and 50 µM DHR (= Test mix) was placed.  180 µL iron-free HBS containing 40 µM 
ascorbate, 50 µM DHR, and 50 µM DFO was added to the other two wells (= 
Reference mix).  The kinetics of the fluorescence was measured with the excitation 
at 485 nm and the emission at 538 nm by a Fluoroskan Ascents microplate reader 
(Labsystems, OY).  This was measured for 40 minutes, with readings every 2 
minutes, immediately after the addition of the test and reference mix.  The slopes (r) 
of DHR fluorescence intensity with time were calculated from measurements taken 
15 and 40 minutes. The duplicate values of r in the presence and absence of DFO, 
rDFO and r, respectively, were averaged, and the LPI concentration (µM) was 
determined from calibration curves relating the difference in slopes with and without 
DFO against Fe concentration: LPI = Δr/rst = (r - rDFO)/rst.   
Calibration curves were obtained by spiking plasmalike medium (PLM) with 
Fe:NTA, 1:7 (mol/mol), followed by serial dilution in PLM and incubation for 30 
minutes at 37°C to allow binding of the Fe.  Plasmalike medium (PLM) contained 20 
mM HEPES, 150 mM NaCl, 120 µM sodium citrate, 40 µM sodium ascorbate, 1.2 
mM sodium phosphate dibasic, 10 mM sodium bicarbonate, and 40 mg/mL human 
serum albumin (pH 7.4). Fe3+/NTA complexes were formed by mixing 70 mM 
nitrilotriacetic acid (NTA), titrated to pH 7.0 with NaOH, with 20 mM ferrous 
ammonium sulphate to produce a Fe/NTA molar ratio of 1:7 and allowing the Fe2+ to 
oxidise to Fe3+ in ambient air for 30 minutes. Quadruplicates of 20 µL of these 
samples were assayed for LPI as described in the previous paragraph.  
 
  
2.17     Statistical analysis of data  
Results were expressed as the mean ± standard deviation.  Data were 
analysed using paired or unpaired Student’s one-tailed t-test, as appropriate.  The p 
value of < 0.05 was considered to indicate a significant difference between groups of 
data.   
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CHAPTER THREE 
 
RESULTS 
 
 
Background: 
 
The response of cells to either an acute (single high dose) or chronic (repeated low 
doses) exposure to oxidising agents is quite different. Depending on the degree of the 
oxidising insult, acute exposure could trigger a series of intracellular antioxidant 
defence mechanisms that counteract the damage caused but if these are not sufficient, 
cells will die by either apoptosis or necrosis. In chronically exposed cells, the 
antioxidant defence mechanism is altered as exposure of cells to low doses of 
oxidants usually provokes the development of a distinct adaptive response that differs 
quite sharply from that following acute exposure. Because of such adaptive responses, 
cells may withstand high toxic doses of the oxidising agent that would otherwise be 
lethal. The study of the mechanisms underlying the adaptive responses of cells to 
oxidising agents provides clues to understand the promotion and progression of the 
chronic inflammatory process in diseases such as Rheumatoid Arthritis (RA). A 
potentially major factor influencing this process is that the rheumatoid synovium is 
relatively hypoxic, and is exposed to chronic cycles of hypoxia and reperfusion. This 
promotes oxidative stress, which has marked effects on many cell types, including 
enhanced production of pro-inflammatory cytokines by mononuclear cells.  
 
The Jurkat T cell lines composed of ‘parental J16’ and ‘H2O2 resistant HJ16’ provide 
a good model to study the differential response of cells to both acute and chronic 
exposure. Furthermore the HJ16 cell line that was established following adaptation of 
J16 cell line to increasing concentrations of oxidising agent H2O2, provides us with a 
useful model to mimic the chronic exposure of T cells in synovium to ROS that are 
almost certainly involved in the pathology of RA. 
 
The potentially harmful free ‘labile’ iron is recognised as an important promoter of 
oxidative stress through aiding the production of ROS and thus a potential mediator 
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of the inflammatory process in RA. Previous studies carried out by A. Yiakouvaki in 
this laboratory (PhD Thesis, 2003 – University of Bath)  have provided us with a link 
between the amount of H2O2-induced labile iron release and the extent of oxidative 
damage and cell death in Jurkat T cells. Furthermore the study has shown that 
adaptation of Jurkat T cells to H2O2 can influence the basal level of antioxidant 
enzymes that is likely to contribute to resistance of HJ16 cells to H2O2 insult.  
 
This thesis has continued the study of Yiakouvaki (PhD Thesis, 2003 – University of 
Bath) by further characterising the differential response of parental J16 and H2O2-
adapted/resistant HJ16 Jurkat T cells to H2O2. 
 
 
3.1    Determination of the sensitivity of J16 and HJ16 cell lines to H2O2 
The accumulation of the damage caused by ROS, including H2O2, plays an 
important role in the aetiology and/or progression of a number of diseases (Moskovitz 
et al, 2002).  In order to evaluate the cytotoxicity of H2O2 on J16 (parental) and HJ16 
(H2O2-resistant) cell lines, both cell lines were treated with various concentrations of 
H2O2 (i.e. 0.1, 0.5, 1, and 3 mM) and two cytotoxicity assays were performed; MTT 
(see section 2.4) and flow cytometry (see section 2.5).  These assays were performed 
24 h following H2O2 treatment, since previous studies have revealed that the 
cytotoxicity of H2O2 towards these cell lines is only apparent from 18 h post-treatment 
time point (A.Yiakouvaki - PhD thesis, 2003).  Epsztejn et al, (1999) have also 
reported that cell damage and death was only present 24 h-post H2O2 treatment. 
 
3.1.1    MTT assay 
According to MTT analysis that assesses cell viability, treatment of both cell 
lines with H2O2 resulted in a concentration-dependent decrease in cell viability (see 
figure 3.1).  However J16 cells were more sensitive to H2O2 treatment than HJ16 
cells.  Indeed even a concentration of H2O2 as low as 0.1 mM was able to cause 
damage to the J16 cells as the intracellular dehydrogenase activity of H2O2-treated 
cells decreased to 57.4 ± 0.8 % of the control.   On the other hand, the HJ16 cells 
were clearly resistant to H2O2 treatment up to 3 mM final concentration. 
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Figure 3.1 :  
 
Effect of different concentrations of H2O2 treatment on the viable cells in J16 
(parental) and HJ16 (H2O2-resistant) cell lines. 
  
MTT analysis (see section 2.4) was performed 24 h following H2O2 treatment.  These 
results are expressed as mean ± standard deviation (n=3) 
 
* : p < 0.05 significantly different when compared with corresponding control of the 
same cell line. 
+ : significantly different when compared with J16 cell line of the same treatment. 
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3.1.2    Flow cytometric analysis 
Since two mechanisms of cell death occur within the cells, flow cytometric 
analysis was performed to distinguish between the two mechanisms.  Cells either die 
by necrosis (accidental form of cell death) or alternatively by apoptosis (programmed 
form of cell death).  The dual staining of the cells with Annexin-V / Propidium iodide 
(PI) will allow to gate the cells to determine the percentage of live, apoptotic, and 
necrotic cells. 
 An example of such analysis is illustrated in figure 3.2.  In this example J16 
and HJ16 cell lines were either untreated or treated with H2O2 concentrations of 0.5 
and 3 mM.  As displayed in figure 3.2, there are 4 compartments.  The lower left 
quadrant indicates the total of live cells (i.e. Annexin-V negative - PI negative), 
whereas the lower right quadrant indicates apoptosis (i.e. Annexin-V positive - PI 
negative).  The upper right (i.e. Annexin-V positive - PI positive) and upper left (i.e. 
Annexin-V negative - PI positive) quadrants indicate primary and secondary necrosis, 
respectively.  
Flow cytometric analysis (see figure 3.3) carried out following dual Annexin-
V / PI staining of both J16 and HJ16 cell lines 24 h after H2O2 treatment confirms our 
previous results determined with MTT analysis.  Overall, the flow cytometric analysis 
revealed that neither J16 nor HJ16 cell lines undergo H2O2–mediated apoptotic cell 
death.  Furthermore in both cell lines, H2O2 induced a concentration–dependent 
necrotic cell death.  However the comparison of the percentage of necrotic cell death 
in both cell lines following H2O2 treatment clearly demonstrated that the HJ16 cell 
line has significantly higher resistance to the oxidising agent (i.e. up to 3 mM H2O2) 
than the J16 cell line.  Indeed in the J16 cell line, the cytotoxicity of H2O2 was already 
apparent at a concentration as low as 0.5 mM, since the population of live cells was 
decreased from 90% to 50%.  At a higher concentration of 3 mM H2O2, almost no live 
J16 cells were present in the flow cytometric chart.  The dose-dependent decrease in 
live J16 cells following H2O2 treatment also coincided with a reciprocal increase in 
the percentage of necrotic cells, strongly suggesting that necrosis is the primary mode 
of cell death induced by H2O2 in this cell line.     
In summary, the flow cytometric analysis was in agreement with the MTT 
analysis, as both assays confirmed that the HJ16 cell line possessed higher resistance 
to H2O2 than the parental J16 cell line. 
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                                   J16 cell line                             HJ16 cell line 
       
 
 
 
 
 
 
 
Figure 3.2 : 
 
An example of the evaluation of flow cytometry analysis following H2O2 treatment     
(i.e. 0.5, and 3 mM) of J16 and HJ16 cell lines.  
 
The analysis (see section 2.5) was performed 24 h after H2O2  treatment following 
dual Annexin-V/PI staining.  Live cells are situated in the lower left quadrant (LL), 
whereas apoptotic cells are situated in the lower right quadrant (LR), and primary and 
secondary necrotic cells are situated in the upper right (UR) and upper left (UL) 
quadrant, respectively. 
 
 H2O2 concentration 
 
 
0 
 
 
 
 
 
 
0.5 mM 
 
 
 
 
 
 
3.0 mM 
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Figure 3.3 : 
 
The effect of H2O2 on the percentage of live, necrosis, and apoptosis in J16 and HJ16 
cell lines.  Flow cytometric analysis (see section 2.5) was performed 24 h after H2O2  
treatment following dual Annexin-V/PI staining.  The results are expressed as mean ± 
standard deviation (n=3) 
 
+ : p < 0.05 significantly different between treated and corresponding controls.   
*  : p < 0.05 significantly different from HJ16 cell line (Live cells). 
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3.2 The role of total intracellular glutathione  
The total intracellular glutathione (GSH/GSSG) system acts as a homeostatic 
redox buffer (see section 1.4.1.1) providing a major constitutive defence against 
oxidants (Applegate et al, 1992).  Yiakouvaki (2003) showed that while the basal 
level activity of GPx enzyme in the HJ16 cell line is 2-fold higher than in J16 cell 
line, catalase activity is only 1.2-fold higher in HJ16 cells (non-significant). The 
higher GPx activity is likely to contribute to higher resistance of the HJ16 to H2O2-
mediated toxicity.  To determine whether the total intracellular levels of glutathione 
play a role in increased resistance of HJ16 cell line to H2O2, the basal GSH/GSSG 
level was monitored in both parental (J16) and H2O2 – resistant (HJ16) cell lines.  
Furthermore an attempt was made to deplete GSH/GSSG in both cell lines (i.e. by 
BSO, see next section) to demonstrate the possible link between GSH/GSSG and 
susceptibility of both cell lines to H2O2–mediated cytotoxicity. 
 
3.2.1   The effect of Buthionine-[S,R]sulfoximine (BSO) treatment on J16 and HJ16 
cells 
Buthionine-[S,R]sulfoximine (BSO) is known to be a relatively non-toxic 
compound whose effect is apparently restricted to the inhibition of γ-glutamylcysteine 
synthetase.  In vivo studies have shown that the administration of BSO to mice for 
several weeks has no undesirable effects other than glutathione depletion (Dethmers 
and Meister, 1981). 
To evaluate the toxicity of BSO in our cell lines, MTT analysis (see section 
2.4) was performed.  J16 and HJ16 cell lines were treated for 18 h with a range of 
BSO (see section 2.3.2) concentrations (i.e. 2, 5, 15, 25, 50, and 250 µM).  The results 
(see figure 3.4) clearly showed that in both cell lines the compound has no toxicity 
towards the cells at concentrations up to 250 µM.   
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Figure 3.4 :   
Effect of BSO on the viable cells in both J16 and HJ16 cell lines. 
 
MTT analysis (see section 2.4) was performed 18 h following treatment of both cell 
lines with BSO at concentrations of 2, 5, 15, 25, 50, and 250 µM for 18 h.  The results 
were expressed as mean ± standard deviation (n=3). 
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3.2.2 The effect of BSO on the total intracellular levels of glutathione in J16 
and HJ16 cells       
To study the modulation of GSH/GSSG by increasing concentrations of BSO, 
the GSH/GSSG was determined using Tietze’s method (see section 2.7).  Furthermore 
it was important to check the differences in basal intracellular glutathione levels that 
might contribute to the higher resistance of HJ16 cell line to H2O2 when compared to 
J16 cell lines.  For this purpose both cell lines were treated with a range of 
concentrations of BSO (i.e. 2, 5, 15, 25, 50, and 250 µM) and then assayed by 
Tietze’s method to evaluate the intracellular glutathione levels.  The GSH/GSSG level 
was then normalised by two methods: cell count [per 106 cells] and protein 
concentration [per total protein (mg)].  The normalisation with both methods (see 
figure 3.5 and figure 3.6) showed that a dose of 25 µM of BSO was sufficient to 
deplete the GSH/GSSG level in both J16 and HJ16 cell lines.   
 
 
3.2.3    Basal levels of the total intracellular glutathione in J16 and HJ16 cell lines 
The basal level of the GSH/GSSG was assessed in both cell lines by using 
Tietze’s method.  The normalisation with cell count and with protein concentrations 
(see figure 3.5 and figure 3.6) revealed that HJ16 cells possess significantly higher 
levels of intracellular glutathione than J16 cells.  Indeed, the measurement of the 
intracellular glutathione in the HJ16 cell line was found to be 3.4-fold higher than in 
the J16 cell line (see table 3.1).  Since in an independent study from our laboratory 
(i.e. Yiakouvaki, 2003), it was found that these two cell lines had considerable 
difference in their cell volume (i.e. J16 cells: 0.47 ± 0.08 pl and HJ16: 1.6 ± 0.19 pl), 
it was therefore concluded that the normalisation with cell count is an inaccurate 
method for estimating the basal level of the GSH/GSSG in these cell lines, and that 
the data normalised with protein concentration should be used instead. 
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Figure 3.5 : 
 
The normalisation of intracellular glutathione in J16 and HJ16 cell lines to cell count. 
 
Both cell lines were treated with BSO for 18 h at concentration of  2, 5, 15, 25, 50, 
and 250 µM prior to intracellular glutathione measurements (see section 2.7). The 
results were expressed as mean ± standard deviation (n=3). 
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Figure 3.6 : 
 
The normalisation of intracellular glutathione for J16 and HJ16 cell lines to total 
intracellular protein levels. 
 
Both cell lines were treated with BSO for 18 h at concentration of  2, 5, 15, 25,  
50, and 250 µM prior to intracellular glutathione measurements (see section 2.7).  The 
results were expressed as mean ± standard deviation (n=3). 
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Table 3.1 :  
 
Effect of BSO on the total intracellular glutathione content of J16 and HJ16 cell line. 
 
 
 
 
 
 
Treatment 
 
J16 Cell Line 
(µM glutathione  / mg protein) 
 
HJ16 Cell Line 
(µM glutathione / mg protein)  
 
Control 
 
0.47 ± 0.07 
 
1.61 ± 0.67 * 
 
25 µM BSO for 18 h 
 
0 
 
0 
 
 
 
 
Cells were pre-treated with 25 µM BSO for 18 h as described in section 2.7.  The total 
glutathione levels were assayed by Tietze’s Method (see section 2.7) and normalised 
to total cellular protein . The results were expressed as mean ± standard deviation 
(n=4). 
 
 
 
* : p < 0.05 significantly different when compared with J16 cell line. 
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3.2.4 The susceptibility of both cell lines to H2O2 following glutathione 
depletion by BSO 
To investigate the susceptibility of both cell lines to H2O2 treatment following 
the depletion of the GSH/GSSG, J16 and HJ16 cell lines were first incubated for 18 h 
with 25 µM BSO and then treated with H2O2 at concentrations of  0.1, 0.5, 1.0, and 3 
mM.  The MTT analysis was then performed to determine the levels of cytotoxicity 
following these various treatments.  The MTT results (see figure 3.7) showed that the 
susceptibility of the J16 cell line to a range of concentrations of H2O2 increases 
following the depletion of the GSH/GSSG by BSO.  In HJ16 cells (see figure 3.7) the 
depletion of the GSH/GSSG also lead to enhanced cytotoxicity of the H2O2 treatment.   
The MTT results were also confirmed by flow cytometric analysis using H2O2 
doses up to 1 mM only, since the H2O2 dose of 3 mM was lethal to the J16 cell line.  
We have introduced to the treatments the H2O2 dose of 0.05 mM; therefore the 
concentrations of H2O2 used for flow cytometric analysis became 0.05, 0.1, 0.5, and 
1.0 mM.   The results obtained from flow cytometric analysis (see figure 3.8) 
confirmed the results shown by MTT analysis.  Indeed in both cell lines, the 
susceptibility of cells to necrotic cell death increased after various doses of H2O2 
following the depletion of the GSH/GSSG by 25 µM BSO.  The cytotoxicity was 
significantly different in both the J16 and the HJ16 cell lines at all concentrations of 
H2O2 used. 
 
3.2.5    Levels of total intracellular glutathione in J16 and HJ16 cell lines after the 
treatment of H2O2 
 The levels of total intracellular glutathione were determined following H2O2 
treatment in J16 and HJ16 cell lines following the observation that the susceptibility 
of both cell lines to a range of concentrations of H2O2 increases following the 
depletion of the GSH/GSSG by BSO (see section 3.2.2).  Our results (see figure 3.9) 
showed that H2O2 doses of higher than 0.1 mM depletes significantly the amount of 
total intracellular glutathione in the J16 cell line.  However in HJ16 cells, H2O2 
treatment only decreased to half the GSH/GSSG.   
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Figure 3.7 : 
The evaluation of the susceptibility of J16 and HJ16 cell lines to H2O2 after the 
depletion of intracellular glutathione (Analysis : MTT). 
 
Cells were treated overnight with BSO (25 µM) and then treated with various 
concentrations of H2O2 (0.1, 0.5, 1.0, and 3 mM).  MTT analysis (see section 2.4) was 
performed 24 h following H2O2 treatment.  The results are expressed as mean ± 
standard deviation (n=3). 
 
* : p < 0.05 significantly different when compared with corresponding control of the 
same treatment. 
+ : p < 0.05 significantly different when compared with cells treated with BSO prior 
to H2O2 treatment.  
NS : non-significant different when compared with cells treated with BSO prior to 
H2O2 treatment  
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Figure 3.8 : 
The determination of the susceptibility of J16 and HJ16 cell lines to H2O2 after the 
depletion of total intracellular glutathione (Flow cytometric analysis). 
 
Cells were treated overnight with BSO (25 µM) and then treated with various 
concentrations of H2O2 (0.05, 0.1, 0.5, and 1.0 mM).  Flow cytometry analysis (see 
section 2.5) was performed 24 h following H2O2 treatment.  The results are expressed 
as mean ± standard deviation (n=3). 
 
* : p < 0.05 significantly different when compared with corresponding control of the 
same treatment. 
+ : p < 0.05 significantly different when compared with cells treated with BSO prior 
to H2O2 treatment.  
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Figure 3.9 : 
 
The determination of the levels of glutathione after the treatment with H2O2.  
 
Cells were treated with H2O2 (0, 0.05, 0.1, 0.5, 1.0mM) as described in Materials and 
Methods and the total glutathione levels were assayed by Tietze’s Method (see 
section 2.7) after the H2O2 treatment by 24 h. The results were expressed as mean ± 
standard deviation (n=3). 
 
* : p  < 0.05 significantly different between treated and the corresponding control.  
NS :  non-significant difference from the corresponding control. 
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The results suggest that chronic exposure of HJ16 cells to H2O2 provokes an adaptive 
mechanism preventing the total depletion of total intracellular glutathione in these 
cells.  This will almost certainly contribute to the resistance of HJ16 cells to doses as 
high as 1mM H2O2. 
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3.3 Characterisation of the response of NF-κB to H2O2  
As mentioned earlier (see section 1.6.5), the inducibility of the NF-κB complex 
in response to H2O2 is cell-specific.  Furthermore it is not clear whether this response 
will be lost if cells are chronically adapted to H2O2 treatment, in the case of the HJ16 
cell line.  Therefore the inducibility of NF-κB complex, measured by Electrophoretic 
Mobility Shift Assay (EMSA) and immunocytochemistry was investigated in both 
J16 and HJ16 cell lines following H2O2 treatment.   
 
3.3.1 The induction of NF-κB complex in the J16 and HJ16 cell lines 
After the performance of supershift analysis it was found that the first 
complex (CI) is the classical NF-κB complex (RelA / p50), and the second complex 
(CII) appears to be p50 / p50 homodimer (A.Al-Qenaei MPhil Thesis, 2004 – 
University of Bath).  This result was compatible with other studies that have been 
previously performed with other cell lines including Jurkat cells (Ginn-Pease and 
Whisler, 1996; Schoonbroodt et al, 2000; Gilston et al, 2001; Shin et al, 2004).   
After 1 hour of various treatments of H2O2 (i.e. 0.5, and 1.0 mM), the 
induction of NF-κB complex binding was observed in J16 cell line (see figure 3.10). 
The induction of NF-κB in J16 cells appeared to be weak compared to HJ16 cell line.  
Nevertheless the NF-κB complex binding by H2O2 was dose-dependent in J16 cells, 
as shown by the quantification of the bands (see table 3.2).  The HJ16 cell line was 
treated with the same concentrations of H2O2 (0.5, and 1.0 mM).  The basal NF-κB 
complex binding was strongly induced in both concentration used (see figure 3.10 and 
table 3.2).  These results confirm that NF-κB complex is present and induced by H2O2 
in both J16 and HJ16 cells, although the induction was higher in HJ16 cells.       
 
3.3.2 Characterisation of the response of NF-κB and Oct-1 to H2O2 treatment 
by immunocytochemistry 
To confirm the previous results with EMSA, both J16 and HJ16 cells were 
treated with an intermediate dose, i.e. 0.5 mM H2O2, and subsequently the cells were 
incubated with 1, 6, and 24 h in condition medium and then immunocytochemistry of 
RelA (p65)  and Oct-1 was performed (see section 2.10). The results shown in figure 
3.11 and 3.12 reveal that p65 was situated in the cytoplasm, as expected.  
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                           J16 cell line                                          HJ16 cell line                           
               ______________________                   ______________________ 
     
                   0           0.5           1.0                              0             0.5            1.0     
                 
             
 
Lane :         1             2             3                                 5               6              7 
                                                                                                    
 
 
 
 
 
 
 
 
Figure 3.10 : 
 
The induction of NF-κB activation in J16 and HJ16 cell lines 1 hour after H2O2 
treatment.  
 
[Analysed by electrophoretic mobility shift assay (EMSA) (see section 2.8)] 
 
Lane 1 is the untreated J16 cell line (control), lanes 2 and 3 indicate the treatment of 
H2O2 (0.5 and 1.0 mM) respectively. Lane 5 is the untreated HJ16 cell line (control), 
lanes 6 and 7 indicate the treatment of H2O2 (0.5 and 1.0 mM) respectively.  
 
The arrow indicates the position of the classical NF-κB complex (RelA / p50).   
 
 
 
 
NF-κB
H2O2 (mM)
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Table 3.2:  
 
Numerical values of the quantification of the bands observed in Figure 3.11 (HJ16 
and J16 cell line). 
 
 
 
 
 
 
 
H2O2 Concentration 
(mM) 
 
J16 cell line 
 
HJ16 cell line 
 
0 
 
100 % 
 
100 % 
 
0.5 
 
109 % 
 
143 % 
 
1.0 
 
128 % 
 
158 % 
 
 
 
 
The bands were scanned and the quantification was assessed (see section 2.12.4) 
using LabImage software - Version 2.7.2 (Kapelan Bio-Imaging Solutions, Germany). 
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                                        p65                                                      Oct-1                       
 
Control 
                                                  
 
1 hour       
                                                              
 
6 h 
                                                  
 
24 h 
                                                  
   
Figure 3.11 : 
Localisation of RelA (p65) and Oct-1 following H2O2 treatment in J16 cell line. 
 
J16 cells were treated with 0.5 mM of H2O2 and processed for immunochemistry (see 
section 2.13) at 1, 6, and 24 h post-treatment as described in section 2.13. The 
photographs are representative of three experiments. 
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                                        p65                                                      Oct-1                       
 
Control 
                                                 
                                                  
1 hour   
                                                     
                                                               
6 h 
                                                   
                                                  
24 h 
                                                 
                                                  
Figure 3.12 : 
 
Localisation of RelA (p65) and Oct-1 following H2O2 treatment in HJ16 cell line. 
 
HJ16 cells were treated with 0.5 mM of H2O2 and processed for immunochemistry 
(see section 2.13) at 1, 6, and 24 h post-treatment as described in section 2.13. The 
photographs are representative of three experiments. 
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Following H2O2 treatment, p65 translocated to the nucleus as early as 1 hour post-
treatment and remained in the nucleus for at least 24 h after treatment.  Studies with 
NF-κB and UVA in our laboratory have shown that UVA damages the nuclear 
membrane leading to the leakage of freshly translocated NF-κB to the cytosol. This 
was monitored by parallel leakage of nuclear Oct-1 to the cytosol (Reelfs et al, 2004).   
We therefore used Oct-1 in this study, to monitor possible damage to the nuclear 
membranes by H2O2.  Our results demonstrated that Oct-1, the ubiquitous nuclear 
protein in mammalian cells, remained nuclear before and after H2O2 treatment in both 
cell lines in agreement with the notion that H2O2 does not damage the nuclear 
membrane.  Taken together, the results showed that H2O2 activates the NF-κB 
translocation in both cell lines and confirmed the activation observed in EMSA.  
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3.4    The role of labile iron 
 Iron is a known catalyst of biological oxidation. Studies from this laboratory 
and others have demonstrated that both ‘basal’ and ‘oxidant-induced’ level of labile 
iron pool (LIP) could influence the susceptibility of cells to oxidative damage and cell 
death (e.g. Bissett et al, 1991; Zhong et al, 2004; Morliere et al, 1997).   
For example in the case of acute exposure of skin to UVA, Zhong et al, (2004) 
from this laboratory, demonstrated that epidermal keratinocytes have higher 
resistance to UVA-induced oxidative damage and cell death than dermal fibroblasts 
presumably because both the ‘basal’ and ‘UVA-induced’ level of labile iron is 
dramatically lower in keratinocytes than fibroblasts. Furthermore the modulation of 
‘basal’ and ‘UVA-induced’ level of LIP by either DFO (iron chelating) and/or hemin 
(iron loading) treatment significantly affected the extent of UVA-induced necrotic 
cell death in both cell lines and it was concluded that cellular susceptibility to UVA-
induced necrotic cell death reflects the intracellular level of LIP.    
The study carried out by Yiakouvaki (2003) using a Jurkat T cell model and 
H2O2, indicated that although cellular resistance to H2O2 is tightly associated with 
intracellular level of LIP, it is the ‘H2O2-induced’ rather than ‘basal’ level of LIP that 
is responsible for the increased susceptibility of cells to oxidative stress, although the 
underlying mechanism remained unclear.  We therefore decided to further investigate 
this phenomenon in our cell lines. 
 
3.4.1 The role of LIP in differential sensitivity of the J16 and HJ16 cells to 
H2O2 treatment  
Figures 3.13 to 3.15 summarize the main finding of A. Yiakouvaki (PhD 
Thesis, 2003) that was repeated and confirmed and then complemented in the present 
study.  The results demonstrated that the ‘basal’ level of LIP in both J16 and HJ16 
cells are quite similar i.e. 3.08 µM ± 0.59 and 3.34 µM ± 0.87 respectively, but 
following H2O2 treatment (e.g. at a final concentration 0.5 mM), the ‘H2O2-induced’ 
level of LIP increases in both cell lines but to a lesser extent in HJ16 cells. The lower 
induction of H2O2-mediated LIP release in HJ16 cell line correlated with lower 
necrotic cell death (see table 3.3). 
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Table 3.3 : 
 
 
The effect of H2O2-induced LIP on necrotic cell death in J16 and HJ16 cells. 
 
 
 
 
 
 
Condition /  Cell line 
 
 
J16  cells 
 
HJ16 cells 
 
 
Basal LIP 
 
 
3.08 µM ± 0.59 
 
3.34 µM ± 0.87 
 
H2O2-induced  LIP 
 
 
9.86 µM ± 0.15 * 
 
5.27 µM ± 1.12 *+ 
 
Fold increase 
in H2O2-induced LIP 
 
 
3.2-fold increase 
 
 
1.6-fold increase 
 
Percentage necrotic 
cell death post-H2O2 
 
 
 
47 %  ± 11 
 
 
30 %  ± 2 + 
 
 
 
Note : Measurements of LIP were performed by CA-assay immediately after 0.5 mM 
of H2O2 treatment.  The results are expressed as mean ± standard deviation (n=3-8). 
Flow cytometric analysis (see section 2.5) was performed 24 h after H2O2  treatment 
following dual Annexin-V/PI staining.  The results are expressed as mean ± standard 
deviation (n=3) 
 
* : p < 0.05 significantly different between treated and the corresponding control 
+ : p < 0.05 significantly different from the corresponding J16 cell line. 
 
 
 
 
 
 
Chapter three – Results 
 
 
Page | 85 
 
To ascertain the importance of H2O2-induced labile iron release in modulating the 
susceptibility of cells to H2O2-induced necrotic cell death, both J16 and HJ16 were 
treated with DFO, a strong iron chelator or hemin (i.e. ferric haem) as a source of iron 
for 18 h prior to H2O2 treatment and then the level of LIP was measured following 
H2O2 treatment using the CA assay. The results demonstrated that DFO treatment 
abolishes both the ‘basal’ and ‘H2O2-induced’ LIP levels and necrotic cell death (see 
table 3.4a-b, figures 3.13 and 3.14) in both cell lines, consistent with the notion that 
iron chelation by DFO protects the cells against H2O2-induced necrotic cell death.  In 
the case of hemin treatment, hemin alone (i.e. when not followed by H2O2 treatment) 
does not modulate the level of LIP in J16 cells but upon H2O2 treatment it causes a 
low increase in LIP that correlates with low necrosis (see table 3.4-a, figures 3.13 and 
3.15). This is in agreement with previews studies by Balla and co-workers showing 
that the endothelium’s susceptibility to H2O2-mediated insults decreases following 
exposure to hemin or haemoglobin (Balla et al, 1992 and 1993).  On the other hand, 
hemin treatment modulated both the basal and H2O2-induced LIP levels in HJ16 cells. 
The accumulation of high levels of LIP in HJ16 cells following hemin treatment 
increased their susceptibility to H2O2-induced damage since the level of necrosis 
significantly increased upon hemin- H2O2 treatment (see table 3.4b, figures 3.13 and 
3.15).   
Further investigation with time course analysis revealed that in J16 cells, 
hemin treatment (20 µM) transiently increases the LIP levels within the first 4 h up to 
2.2-fold, after which it returns to normal levels (see table 3.5a).  In the HJ16 cells, 
hemin treatment provokes higher accumulation of LIP that is sustained at least for 18 
h. The hemin-mediated increase in LIP appeared also to be concentration-dependent 
in the HJ16 cells (see figure 3.16).  Since the high accumulation of LIP in HJ16 cells 
following hemin treatment increases the percentage of necrotic cell death, it was 
concluded that the intracellular level of LIP may play a key role in determining the 
level of sensitivity of these cells to H2O2-mediated necrotic cell death.   
To further demonstrate the strict–dependence of H2O2-induced necrotic cell 
death to LIP level present in the cells, hemin treatment (20 µM) for 18 h was followed 
by an additional treatment with 1 mM DFO for 2h.  The latter treatment was expected 
to lower the hemin-mediated increase in LIP, leading to decreased necrosis by H2O2. 
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Table 3.4 a: LIP measurements and the % of necrosis in J16 cell line. 
 
Condition 
(J16 cell line) 
LIP (µM) 
 
Percentage necrotic 
cell death 
Control (Basal) 
 
3.08 µM ± 0.59 11 %  ± 5 
H2O2-0.5mM 
 
9.86 µM ± 0.15 * 47 %  ± 11 * 
DFO-100µM – 18 h 
 
0 * 0.53 %  ± 0.12 * 
DFO-100µM + H2O2-0.5mM 
 
0 * 0.53 %  ± 0.11 * 
Hemin-20µM – 18 h 
 
2.93 µM ± 0.73  NS 1.4 %  ± 0.47 * 
Hemin-20 µM + H2O2-0.5mM 
 
4.02 µM ± 0.95 NS 27.2 %  ± 0.8 * 
 
 
Table 3.4 b:  LIP measurements and the % of necrosis in HJ16 cell line. 
 
Condition 
(HJ16 cell line) 
LIP (µM) 
 
Percentage necrotic 
cell death 
Control (Basal) 
 
3.34 µM ± 0.87 3 %  ± 0.6 
H2O2-0.5mM 
 
5.27 µM ± 1.12 *+ 30 %  ± 1.9 *+ 
DFO-100µM -18 h 
 
0 * 4.3 %  ± 1.6 NS 
DFO-100µM + H2O2-0.5mM 
 
0 * 4.2 %  ± 0.95 NS 
Hemin-20µM – 18 h 
 
7.2 µM ± 0.56 *+ 3 %  ± 0.76 NS+ 
Hemin-20 µM + H2O2-0.5mM 
 
12.2 µM ± 0.34 *+ 43.2 %  ± 3.1 *+ 
 
Note: Measurements of LIP were performed by CA-assay immediately after the 
specified treatments (above).  The results are expressed as mean ± standard deviation 
(n=3-8).  Flow cytometric analysis (see section 2.5) was performed 24 h after H2O2 
treatment following dual Annexin-V/PI staining.  The results are expressed as mean ± 
standard deviation (n=3). 
 
 
* : p < 0.05 significantly different between treated and the corresponding control 
NS :  non-significantly different from the corresponding control. 
+ : p < 0.05 significantly different from the corresponding J16 cell line. 
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Figure 3.13 : 
 
The evaluation of the susceptibility of J16 and HJ16 cell lines to iron chelation and 
loading prior to H2O2 treatment (Flow cytometric analysis). 
 
Cells were pretreated with either 100 µM DFO or 20 µM hemin for 18 h before H2O2 
treatment.  Flow cytometric analysis (see section 2.5) was performed 24 h after H2O2 
treatment following dual Annexin-V/PI staining.  These results are expressed as mean 
± standard deviation (n=3). 
 
* : p < 0.05 significantly different from the cells treated with H2O2 treatment alone. 
NS :  non-significant different from the cells treated with H2O2 treatment alone. 
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Figure 3.14: 
 
Schematic representation of the effect of DFO ± H2O2 treatment on labile iron pool 
(LIP) and the viability of  J16 and HJ16 cells. 
 
Both cell lines were either treated overnight with 100 µM DFO alone or 100 µM DFO 
for 18 h prior an intermediate dose of H2O2 (i.e. 0.5mM).  The levels of LIP was 
determined (Yiakovaki, 2003) by a modification of the method developed by Epsztejn 
et al (1997).  The level of necrosis was determined by flow cytometric analysis (see 
section 2.5). 
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Figure 3.15: 
 
Schematic representation of the effect of hemin ± H2O2 treatment on labile iron pool 
(LIP) and the viability of J16 and HJ16 cells. 
 
Both cell lines were either treated overnight with 20 µM hemin alone or 20 µM hemin 
for 18 h prior an intermediate dose of H2O2 (i.e. 0.5mM).  The levels of LIP was 
determined by a modification of the method developed by Epsztejn et al (1997).  The 
level of necrosis was determined by flow cytometric analysis (see section 2.5). 
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Table 3.5a: Time course of LIP measurements and the fold increase of LIP after 20 
µM hemin treatment of J16 cells. 
 
Condition LIP (µM) Fold increase 
Basal - 0 h  3.3 µM ± 0.87 1 
 
2 h 6.8 µM ± 1.6 * 2-fold increase 
 
4 h 7.4 µM ± 1.8 * 2.2-fold increase 
 
6 h 3.1 µM ± 0.53 Non-significant 
 
8 h 3.5 µM ± 0.38 Non-significant 
 
18 h 2.6 µM ± 0.42 
 
Non-significant 
 
 
 
 
Table 3.5b: Time course of LIP measurements and the fold increase of LIP after 20 
µM hemin treatment of HJ16 cells. 
 
Condition LIP (µM) Fold increase 
Basal - 0 h  3.34 µM ± 0.87 1 
 
2 h 11.8 µM ± 1.8 *+ 3.5-fold increase 
 
4 h 11.2 µM ± 1.7 *+ 3.4-fold increase 
 
6 h 14.1 µM ± 0.93 *+ 4.2-fold increase 
 
8 h 10.3 µM ± 0.41 *+ 3.1-fold increase 
 
18 h 7.2 µM ± 0.56 *+ 
 
2.2-fold increase 
 
 
Note : The LIP was monitored by Calcein assay following the treatment of J16 and 
HJ16 cells with 20 µM hemin for various times (i.e. 2, 4, 6, 8 and 18 h). The results 
are expressed as mean ± standard deviation (n=6-8). 
 
 
* : p < 0.05 significantly different between treated and the corresponding control 
+ : p < 0.05 significantly different from the corresponding J16 cell line. 
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Figure 3.16: 
 
Fold increase in LIP measurements after various concentrations of hemin. 
 
LIP measurements were taken after J16 cell line and HJ16 cell line were treated with 
different concentration of hemin (i.e. 5, 10, 15, and 20 µM) for 18 h.  These results 
are expressed as mean ± standard deviation (n=3). 
 
* : p < 0.05 significant difference between untreated and treated cells. 
NS : Non-significant difference between untreated and treated cells. 
+ : p < 0.05 significant difference from the corresponding J16 cell line. 
 
  
 
 
 
+ + 
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The results (see figure 3.17) showed that, in agreement with our hypothesis, in both 
cell lines, DFO treatment of cells pre-treated with hemin significantly decreased the 
levels of H2O2-induced necrotic cell death when compared to cells treated with hemin 
alone. 
 
 
The source of iron in HJ16 cells following hemin treatment  
The source of iron after overnight hemin treatment of the HJ16 cell line was an 
interesting point to investigate in this study. Hemin (ferric haem) is a known substrate 
of HO proteins (i.e. HO-1 and HO-2). Both the inducible form HO-1 and the 
constitutive HO-2 enzymes break down haem to release its iron (see section 1.4.2.4). 
This iron is then stored within the iron storage protein ferritin (Ft).  
 
We hypothesised that the high accumulation of labile iron in HJ16 cells following 
hemin treatment could either be due to higher HO protein levels or lower intracellular 
Ft levels in HJ16 cells when compared to parental J16 cells.  We therefore 
investigated the level of these proteins in both J16 and HJ16 cells following various 
treatments as detailed below. 
 
3.4.2    The expression of HO-1 and HO-2 in Jurkat T cell lines 
The higher expression of HO-1 and/or HO-2 in HJ16 cell line might contribute 
to accumulation of labile iron following hemin treatment.  Previous analysis of the 
level of ho-1 mRNA accumulation in J16 and HJ16 cells using the real-time PCR 
technique (Yiakouvaki, 2003) revealed that the basal level of ho-1 cDNA is 2-fold 
higher in the H2O2-resistant HJ16 cells than in the parental J16 cells. Yiakouvaki 
(2003) also performed a series of Western blot analyses using a polyclonal HO-1 
antibody.  These Western blot analyses were not conclusive since the polyclonal 
antibody cross-reacted with a number of proteins in cell extracts resulting in high 
background and multiple bands that made the interpretation of results difficult.  The 
study therefore moved on to use flow cytometry as a more trustworthy technique to 
study the expression of HO-1 in the Jurkat cells using a monoclonal antibody. The 
results revealed that in agreement with real-time PCR data, the basal level of HO-1 
protein in H2O2 resistant cells was up to 2-fold higher than in parental cells.  
Chapter three – Results 
 
 
Page | 93 
 
 
 
 
 
Figure 3.17: 
 
The evaluation of the susceptibility of J16 and HJ16 cell lines after DFO treatment 
following iron loading prior to H2O2 treatment. 
 
Cells were pretreated with either 20 µM Hemin for 18 h or 20 µM Hemin for 18 h and 
then 1mM DFO for 2 h before H2O2 treatment.  Flow cytometric analysis (see section 
2.5) was performed 24 h after H2O2 treatment following dual Annexin-V/PI staining.  
These results are expressed as mean ± standard deviation (n=3). 
 
* : p < 0.05 significantly different between the hemin (+H2O2)  treated cells. 
NS: non-significantly different when compared with the hemin (+H2O2) treated cells. 
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So it was concluded, with the previous observations, that HO-1 expression should 
play a role in hemin-induced iron accumulation in HJ16 cells. Furthermore when both 
cell lines were treated with 20 µM hemin at various time points, a significant increase 
in HO-1 was only observed in the parental J16 cell line. Yiakouvaki (2003) concluded 
that HO-1 protein is not inducible in HJ16 cells presumably because gradual 
adaptation of cells to H2O2 has provoked a refractory response of HO-1 to hemin. 
Since hemin is also a known substrate of HO-2 protein, it was important to 
check the level of its expression in Jurkat T cells. We therefore decided to carry out 
an in depth study of the expression of HO-1 and HO-2 at protein levels using Western 
blot analysis. For HO-2 analysis, we used the polyclonal antibody raised in R.M. 
Tyrrell’s laboratory (Pourzand et al, 1999 and Kvam et al, 2000) as this antibody, 
unlike commercially available HO-2 antibodies, is known to be very specific. For 
HO-1, the Western blotting was carried out with a monoclonal antibody to avoid high 
background and cross-hybridisations. This antibody induced less background but still 
some cross hybridization was observed in the study. As a result one important 
positive control was added in each blot to identify the true HO-1 band in blots. That 
control was FEK4 cells (human fibroblast cell line) treated with a UVA dose of 250 
kJ/m2 and incubated in condition media (CM) for 8 h before it was collected.  
 Figures 3.18 to 3.21 compare the level of HO-1 and HO-2 in both J16 and 
HJ16 cells collected immediately (0 h) or left in CM for 24 h (24 h) following hemin, 
DFO and/or H2O2 treatment. As can be seen, the basal level of HO-1 was very low in 
these cells and the difference in expression observed by Flow cytometry could not be 
visualized here. Furthermore neither overnight treatments with 20 µM hemin, 100 µM 
DFO, nor exposure to 0.5 mM H2O2 alone or combined with hemin or DFO treatment 
increased the level of HO-1 in these cell lines. The basal HO-2 level on the other hand 
was higher than HO-1 in both cell lines but it was not modulated by any of the above 
treatments. 
To ascertain that HO protein levels were not modulated following hemin 
and/or H2O2, the HO-1 and HO-2 levels were followed in time course analysis from 0 
to 18 and/or 24 h following hemin and/or H2O2 treatments.  The results (see figures 
3.22-3.27) revealed that neither HO-1 nor HO-2 levels are modulated by these 
treatments.  
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A. 
 
B. 
           
Figure 3.18: 
 
The induction of HO-1 and HO-2 in J16 and HJ16 cell lines (0 h). 
 
J16 and HJ16 (C) are the untreated cells (controls), J16 and HJ16 (0.5) are cells 
treated with 0.5mM H2O2, J16 and HJ16 (H) are cells treated with 20 µM hemin for 
18 h, and J16 and HJ16 (H/0.5) are cells treated overnight with 20µM hemin and then 
with 0.5mM H2O2.  Cells were collected immediately following the specified 
treatments and used to prepare whole cellular extracts for Western blot analysis (see 
section 2.9). The positive control (+ve) was FEK4 cells (human fibroblast cell line) 
treated with a UVA dose of 250 kJ/m2 and collected after 8 h.  (B) The relative 
expression levels of HO-2 were normalised with respect to the intensity of the actin 
signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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A. 
 
B.          
 
Figure 3.19: 
 
The induction of HO-1 and HO-2 in J16 and HJ16 cell lines (24 h). 
 
J16 and HJ16 (C) are the untreated cells (controls), J16 and HJ16 (0.5) are cells 
treated with 0.5mM H2O2, J16 and HJ16 (H) are cells treated with 20 µM hemin for 
18 h, and J16 and HJ16 (H/0.5) are cells treated overnight with 20µM hemin and then 
with 0.5mM H2O2.  Cells were collected 24 h following the specified treatments and 
used to prepare whole cellular extracts for Western blot analysis (see section 2.9). The 
positive control (+ve) was FEK4 cells (human fibroblast cell line) treated with a UVA 
dose of 250 kJ/m2 and collected after 8 h.  (B) The relative expression levels of HO-2 
were normalised with respect to the intensity of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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A. 
 
B. 
 
Figure 3.20: 
The induction of HO-1 and HO-2 in J16 and HJ16 cell lines (0 h). 
 
J16 and HJ16 (C) are the untreated cells (controls), J16 and HJ16 (0.5) are cells 
treated with 0.5mM H2O2, J16 and HJ16 (D) are cells treated with 100 µM DFO for 
18 h, and J16 and HJ16 (D/0.5) are cells treated overnight with 100 µM DFO and 
then with 0.5mM H2O2.  Cells were collected immediately following the specified 
treatments and used to prepare whole cellular extracts for Western blot analysis (see 
section 2.9). The positive control (+ve) was FEK4 cells (human fibroblast cell line) 
treated with a UVA dose of 250 kJ/m2 and collected after 8 h.  (B) The relative 
expression levels of HO-2 were normalised with respect to the intensity of the actin 
signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
Chapter three – Results 
 
 
Page | 98 
 
A. 
 
B. 
 
Figure 3.21: 
 
The induction of HO-1 and HO-2 in J16 and HJ16 cell lines (24 h). 
 
J16 and HJ16 (C) are the untreated cells (controls), J16 and HJ16 (0.5) are cells 
treated with 0.5mM H2O2, J16 and HJ16 (D) are cells treated with 100 µM DFO for 
18 h, and J16 and HJ16 (D/0.5) are cells treated overnight with 100 µM DFO and 
then with 0.5mM H2O2.  Cells were collected 24 h following the specified treatments 
and used to prepare whole cellular extracts for Western blot analysis (see section 2.9). 
The positive control (+ve) was FEK4 cells (human fibroblast cell line) treated with a 
UVA dose of 250 kJ/m2 and collected after 8 h.  (B) The relative expression levels of 
HO-2 were normalised with respect to the intensity of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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A.     
 
 
B.     
 
Figure 3.22 : 
Time course induction of HO-1 and HO-2 in J16 cell line after 20 µM hemin. 
 
(A)  J16 cell line was treated with 20 µM hemin.  Cells were collected at various 
times (i.e. 2, 4, 6, 8, 14, 16, and 18 h) and used to prepare whole cellular extracts for 
Western blot analysis (see section 2.9). The positive control (+ve) was FEK4 cells 
(human fibroblast cell line) treated with a UVA dose of 250 kJ/m2 and collected after 
8 h.  (B)  The relative expression levels of HO-2 were normalised with respect to the 
intensity of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
Chapter three – Results 
 
 
Page | 100 
 
A.  
 
 
B. 
      
Figure 3.23 : 
 
Time course induction of HO-1 and HO-2 in HJ16 cell line after 20 µM hemin. 
 
(A)  HJ16 cell line was treated with 20 µM hemin.  Cells were collected at various 
times (i.e. 2, 4, 6, 8, 14, 16, and 18 h) and used to prepare whole cellular extracts for 
Western blot analysis (see section 2.9). The positive control (+ve) was FEK4 cells 
(human fibroblast cell line) treated with a UVA dose of 250 kJ/m2 and collected after 
8 h.  (B) The relative expression levels of HO-2 were normalised with respect to the 
intensity of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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A. 
 
B. 
 
Figure 3.24 : 
 
Time course induction of HO-1 and HO-2 in J16 cell line after 0.5 mM H2O2. 
 
(A)  J16 cell line was treated with an intermediate dose of H2O2 (i.e. 0.5 mM).  Cells 
were collected at various times (i.e. 0, 2, 4, 6, 8, 18, and 24 h) and used to prepare 
whole cellular extracts for Western blot analysis (see section 2.9). The positive 
control (+ve) was FEK4 cells (human fibroblast cell line) treated with a UVA dose of 
250 kJ/m2 and collected after 8 h.  (B) The relative expression levels of HO-2 were 
normalised with respect to the intensity of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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A. 
 
B. 
 
Figure 3.25 : 
 
Time course induction of HO-1 and HO-2 in HJ16 cell line. 
 
(A)  HJ16 cell line was treated with an intermediate dose of H2O2 (i.e. 0.5 mM).  Cells 
were collected at various times (i.e. 0, 2, 4, 6, 8, 18, and 24 h) and used to prepare 
whole cellular extracts for Western blot analysis (see section 2.9). The positive 
control (+ve) was FEK4 cells (human fibroblast cell line) treated with a UVA dose of 
250 kJ/m2 and collected after 8 h.  (B)  The relative expression levels of HO-2 were 
normalised with respect to the intensity of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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A. 
 
B. 
 
Figure 3.26 : 
Time course induction of HO-1 and HO-2 in J16 cell line following overnight 
treatment of 20µM hemin followed by an intermediate dose of H2O2 (i.e. 0.5 mM) 
 
(A)  J16 cell line was treated overnight with 20µM hemin and then with an 
intermediate dose of H2O2 (i.e. 0.5 mM).  Cells were collected at various times (i.e. 0, 
2, 4, 6, 8, 18, and 24 h) and used to prepare whole cellular extracts for Western blot 
analysis (see section 2.9). The positive control (+ve) was FEK4 cells (human 
fibroblast cell line) treated with a UVA dose of 250 kJ/m2 and collected after 8 h.  (B) 
 The relative expression levels of HO-2 were normalised with respect to the intensity 
of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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A. 
 
B. 
      
Figure 3.27: 
Time course induction of HO-1 and HO-2 in HJ16 cell line following overnight 
treatment of 20µM hemin followed by an intermediate dose of H2O2 (i.e. 0.5 mM) 
 
(A)  HJ16 cell line was treated overnight with 20µM hemin and then with an 
intermediate dose of H2O2 (i.e. 0.5 mM).  Cells were collected at various times (i.e. 0, 
2, 4, 6, 8, 18, and 24 h) and used to prepare whole cellular extracts for Western blot 
analysis (see section 2.9). The positive control (+ve) was FEK4 cells (human 
fibroblast cell line) treated with a UVA dose of 250 kJ/m2 and collected after 8 h.  (B) 
 The relative expression levels of HO-2 were normalised with respect to the intensity 
of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
(Kapelan Bio-Imaging Solutions, Germany). 
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To complete the analysis, the level of HO-1 and HO-2 proteins were also 
checked after combined hemin (20 mM, 18 h) + DFO (1 mM, 2 h) and/or H2O2 (0.5 
mM) treatment. Again here, no modulation in protein levels of HO-1 and HO-2 was 
observed (see figure 3.28).  In summary, HO-1 expression was found to be very low 
and it was not induced with any of the above treatments (in both cell lines).  On the 
other hand, HO-2 protein was present at higher levels than HO-1 in both cell lines but 
was not induced by any treatment used.  Taken together these results showed that 
high iron accumulation after hemin treatment in HJ16 cells might not be related to 
differential expression of HO proteins in these cells. 
  
3.4.3 The level of ferritin in Jurkat T cell lines 
Ferritin sequesters the potentially harmful labile iron within its shells by H-
Ft’s ferroxidase activity so that iron can be stored in an inactive form. Several cellular 
studies have shown that in oxidative stress conditions Ft may have a protective effect 
against oxidative damage as it removes iron that acts as a catalyst in biological 
oxidation (reviewed in Arosio and Levi, 2002 and Torti and Torti, 2002).  
In the case of UVA irradiation however, Ft when degraded has been identified 
as a potential source of harmful labile iron that triggers necrotic cell death in skin 
fibroblasts (Pourzand et al, 1999). Indeed UVA has been shown to promote the 
proteolytic degradation of Ft and the consequent release of potentially harmful labile 
iron in skin cells. The release of Ft’s iron exacerbates the extent of UVA-induced 
peroxidative damage in the cell membrane as well as membranes of vital organelles, 
notably those of mitochondria and lysosomes, leading to necrotic cell death (Zhong et 
al, 2004).  The proteolytic degradation of Ft occurs as a result of damage to lysosomal 
membranes leading to leakage of potentially harmful lysosomal proteases into the 
cytosol which in turn act to degrade cytosolic proteins, notably Ft.  
Studies by Brunk and co-workers (Brunk et al, 1995b) have demonstrated that 
acute exposure of macrophage–like J-774 cells to H2O2 also triggers lysosomal 
damage.  The irradiation of human fibroblasts with a moderate dose of blue light also 
resulted in oxidative apoptotic cell death as a result of damage to lysosomal 
organelles (Brunk et al, 1997).  
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A. 
 
B. 
 
Figure 3.28 : 
 
The induction of HO-1 and HO-2 in J16 and HJ16 cell lines (0,24 h) 
 
(A) J16 and HJ16 (0) are cells treated with 20 µM hemin for 18 h and then with 1 mM 
DFO for 2 h, and J16 and HJ16 (0.5) are cells with 20 µM hemin for 18 h and then 
with 1 mM DFO for 2 h and finally with 0.5mM H2O2.  Cells were collected at 0 and 
24 h following the specified treatments mentioned above, and used to prepare whole 
cellular extracts for Western blot analysis (see section 2.9). The positive control (+ve) 
was FEK4 cells (human fibroblast cell line) treated with a UVA dose of 250 kJ/m2 
and collected after 8 h.  (B) The relative expression levels of HO-2 were normalised 
with respect to the intensity of the actin signal.  
The intensities of the bands were assessed using LabImage software - Version 2.7.2 
Kapelan Bio-Imaging Solutions, Germany). 
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Damage to lysosomes was accompanied by leakage of lysosomal contents including 
hydrolytic enzymes, such as cathepsin D (CATH D) (Roberg and Öllinger, 1998) that 
should almost certainly lead to proteolytic degradation of Ft as well.  
Interestingly epidermal skin keratinocytes that have low basal levels of Ft and 
LIP are naturally resistant to UVA-induced necrotic cell death but overnight hemin 
treatment renders these cells vulnerable to UVA-induced peroxidative damage and 
necrotic cell death (Zhong et al, 2004). This is because iron loading of cells with 
hemin increases strongly the level of intracellular Ft which in turn increases the level 
of UVA-induced LIP upon radiation-mediated proteolysis of Ft molecules.   
Since HJ16 cells’ resistance to H2O2 was abolished after hemin treatment 
presumably because of high accumulation of labile iron in these cells, it was 
important to investigate the role of Ft in this phenomenon.  Ferritin level was first 
investigated by Western blot analysis (Yiakouvaki, 2003) but because the H- and L-Ft 
levels were not detectable, it was decided to do the analysis by ELISA that is a more 
sensitive assay to detect low protein levels in cellular studies. Tables 3.6 and 3.7 (a, b, 
c, and d), and figures 3.29-3.33 summarises the ELISA results in J16 and HJ16 cells 
following various treatments. 
 
3.4.3.1     Basal levels of Ft in J16 and HJ16 cell line 
As it can be seen in table 3.6-a, the ‘basal’ levels of H-Ft in J16 cell line 
(381.3 ± 53.6 ng/mg) were found to be more that 7 fold higher than in HJ16 cell line 
(51.6 ± 2 ng/mg).  The lower H-Ft levels in HJ16 might be part of the adaptive 
response developed during gradual adaptation of these cells to H2O2.  As for L-Ft they 
had the same ‘basal’ level; 10.2 ± 3 ng/mg in J16 cells and 9.2 ± 0.95 ng/mg in HJ16 
cells.  
 
3.4.3.2   Effect of H2O2 on the Ft levels 
When cells were treated with 0.5 mM H2O2 and the Ft levels were measured 
immediately (see table 3.6-b) the H-Ft level decreased to 70 % of the control value in 
J16 cells but did not affect significantly the L-Ft.  The H-Ft levels in HJ16 were not 
significantly affected by H2O2 treatment, L-Ft on the other hand increased up to 3-
fold of the control value (see table 3.6-b).   
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Table 3.6 a:  Basal H- & L-Ft measurements in J16 and HJ16 cell lines 
 
Cell line H-Ft (ng/mg) % L-Ft (ng/mg) % 
 
J16 381 ± 54 100 10  ± 3 100 
 
HJ16 52 ± 2 100 9  ± 1 100 
 
 
 
 
Table 3.6 b:  H- & L-Ft measurements immediately following H2O2-0.5mM  
 
Cell line H-Ft (ng/mg) % L-Ft (ng/mg) % 
 
J16 263 ± 36 69  15 ± 6 Non-significant  
 
HJ16 58 ± 8 Non-significant 
 
26 ± 7 288  
 
 
 
 
Table 3.6 c: H- & L-Ft measurements immediately following 100 µM DFO for 18 h 
 
Cell line H-Ft (ng/mg) % L-Ft (ng/mg) % 
 
J16 32 ± 8 8  3 ± 1 30 
 
HJ16 20 ± 2 38  18 ± 4 200 
 
 
 
 
Table 3.6 d: H- & L-Ft measurements immediately following 20 µM hemin for 18 h 
 
Cell line H-Ft (ng/mg) % L-Ft (ng/mg) % 
 
J16 965 ± 30  253  52 ± 8 520 
 
HJ16 380 ± 11 730  20 ± 10 222 
 
 
 
 
Note : H- and L-Ft measurements performed by ELISA (see section 2.10)  
immediately following the condition/treatments specified above. The percentage 
represents the significant difference of the corresponding basal levels. These results 
are expressed as mean ± standard deviation (n=3). 
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But when the cells were incubated for 24 h in CM following H2O2 treatment 
(see table 3.7-b), the H-Ft decreased more in J16 cells (i.e. to 32 % of the control 
value) but there not a significant change in HJ16 cells. The L-Ft on the other hand, 
was not significantly affected in J16 cells, but was increased in HJ16 cells by 2.4-fold 
of the control value (see table 3.7-b). 
The time course experiment (see figure 3.29) further revealed that following 
H2O2 treatment the levels of H-Ft decreased gradually in J16 cells at 6 h post 
treatment time point and then remained low up to 24 h following treatment. Hydrogen 
peroxide treatment of cultured fibroblasts and macrophages significantly inhibited the 
synthesis of Ft (Pantopoulos and Hentze, 1995 and Mehlhase et al, 2005, 
respectively). This is also shown when rat liver lysates were subjected to 
postischemic reperfusion (Tacchini et al, 1997). The L-Ft time course study following 
H2O2 treatment revealed that the L-Ft levels remain unchanged in J16 cells but 
slightly increase up to 2-fold control value in HJ16 cells at 6 h time point and then 
return to around control value at 24 h (see figure 3.29).   
 
3.4.3.3   Effect of DFO ± H2O2 on the Ft levels 
The treatment of cells with 100 µM DFO strongly reduced the level of H-Ft in 
J16 cells to 8 % of the control value (see table 3.6-c and figure 3.30-A1). In HJ16 
cells, DFO treatment also decreased the level of H-Ft although to a lesser extent than 
in J16 cells (i.e. to 38 % of the control value).  The decrease in H-Ft levels by DFO is 
consistent with previous observations showing that DFO diminishes Ft biosynthesis in 
B6 fibroblasts (Pantopoulos and Hentze, 1995) and reduces Ft levels in macrophages 
(Mehlhase et al, 2005).  The L-Ft levels on the other hand decreased significantly in 
J16 but were strongly induced in HJ16 cells (see table 3.6-b and figure 3.30-A2). 
Following 24 h incubation in CM after the DFO treatment (see table 3.7-c and figure 
3.30-B1), H-Ft decreased significantly in J16 and HJ16 cells (i.e. to 6 % and 15 % of 
the control values, respectively).  DFO treatment of HeLa cells demonstrated nearly a 
total repression of Ft (Cairo et al, 1985), as it also significantly decreased both 
subunits in K562 cells (Konijn et al, 1999).  On the other hand, the L-Ft levels (see 
table 3.7-c and figure 3.30-B2) decreased significantly in J16 cells but there was a 
non-significant increase in HJ16 cells. 
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Table 3.7 a:  Basal H- & L-Ft measurements in J16 and HJ16 cell lines 
 
Cell line H-Ft (ng/mg) % L-Ft (ng/mg) % 
 
J16 381 ± 54 100 10  ± 3 100 
 
HJ16 52 ± 2 100 9  ± 1 100 
 
 
 
 
Table 3.7 b:  H- & L-Ft measurements 24 h following H2O2-0.5mM  
 
Cell line H-Ft (ng/mg) % L-Ft (ng/mg) % 
 
J16 122 ± 51 32 14 ± 6 Non-significant  
 
HJ16 42 ± 15 Non-significant 
 
22 ± 8 244 
 
 
 
 
Table 3.7 c: H- & L-Ft measurements 24 h following 100 µM DFO for 18 h 
 
Cell line H-Ft (ng/mg) Fold difference L-Ft (ng/mg) % 
 
J16 23 ± 14 6 2 ± 1 20 
 
HJ16 8 ± 3 15 12 ± 3 Non-significant  
 
 
 
 
Table 3.7 d: H- & L-Ft measurements 24 h following 20 µM hemin for 18 h 
 
Cell line H-Ft (ng/mg) % L-Ft (ng/mg) % 
 
J16 1443 ± 150 379 30 ± 10 300 
 
HJ16 474 ± 49 912 69 ± 19 767 
 
 
  
Note : H- and L-Ft measurements performed by ELISA (see section 2.10)  
immediately following the condition/treatments specified above. The percentage 
represents the significant difference of the corresponding basal levels. These results 
are expressed as mean ± standard deviation (n=3). 
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A. 
 
 
B. 
 
 
Figure 3.29: 
 
Effect of 0.5 mM H2O2 on H and L-Ft in J16 and HJ16 cell lines. 
 
J16 and HJ16 cell lines were treated with an intermediate dose of H2O2 (i.e. 0.5 mM) 
and were then collected at various times (i.e. 2, 4, 6, 8, 18, and 24 h).  Whole cellular 
extracts were prepared for Ferritin ELISA (see section 2.10) to investigate the roles of 
H and L-Ft (A. and B., respectively). These results are expressed as mean ± standard 
deviation (n=3). 
 
* : p < 0.05 significant difference between corresponding control.  
NS : Non-significant difference between corresponding control. 
+ : p < 0.05 significantly different when compared with the other cell line. 
 
Chapter three – Results 
 
 
Page | 112 
 
 
 
 
Figure 3.30:  
 
Effect of hemin or/and DFO on H and L-Ft in J16 and HJ16 cell lines (0,24 h). 
 
J16 and HJ16 cell lines were either treated overnight with 20µM hemin (H), 100 µM 
DFO (D), 1mM DFO for 2 h (D-2h), or with 20 µM hemin for 18 h and then with 1 
mM DFO for 2 h (H+D).  Cells were either collected immediately after the specified 
treatment (i.e. 0h, A1 and A2) or after incubating them in CM for 24 h following the 
specified treatments (i.e. 24 h, B1 and B2) and used to prepare whole cellular extracts 
for Ferritin ELISA (see section 2.10) to investigate the roles of H and L-Ft (A1 – B1 
and A2 – B2, respectively). These results are expressed as mean ± standard deviation 
(n=3). 
 
* :  p < 0.05 significant difference between corresponding control.  
NS : Non-significant difference between corresponding control. 
+ : p < 0.05 significantly different when compared with the corresponding J16 cells. 
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DFO treatment of cells (100 µM, 18 h) followed by H2O2 treatment, decreased 
significantly the H-Ft in both J16 cells and HJ16 cells (i.e. to 11 % and 38 % of the 
control values, respectively) (see figure 3.31-A1).  On the other hand, not a 
significant change in the L-Ft expression in both cell lines (see figure 3.31-A2).  The 
same relationship between H- and L-Ft was also observed when cells were incubated 
for another 24 h in CM following DFO + H2O2 treatment; H-Ft was strongly 
decreased in both J16 cells and HJ16 cells (i.e. to 7 % and 13 % of the control values, 
respectively) (see figure 3.31-B1).  On the other hand, there was a non-significant 
change in the L-Ft expression was observed in both cell lines (see figure 3.31-B2).   
 
3.4.3.4   Effect of hemin ± H2O2 on the Ft levels 
The time course experiment following hemin treatment revealed that the 
increase in H- or L-Ft in the J16 and HJ16 cells was not highly induced in the early 
hours after treatment (see figure 3.32), presumably because Ft molecules takes time to 
get synthesized. The latter data are expected as hemin should first be broken down by 
HO and release its iron which in turn will stimulate de novo Ft synthesis. The iron 
accumulation in HJ16 cells after hemin treatment is only apparent after 2 h post 
treatment (see table 3.5) with a peak at 6h after which it is reduced, presumably 
because of sequestration of a portion of it in the newly synthesized Ft molecules. This 
timing coincides with detection of higher Ft levels presumably as a result of its de 
novo synthesis. The H-Ft in J16 cells decreased up to 4 h and then was strongly 
induced after 8 h till 24 h after hemin treatment. The L-Ft, on the other hand, did not 
significantly increase during the time course in J16 cells, except at 18 and 24 h (see 
figure 3.32). 
When J16 cells were treated with 20 µM hemin for 18 h and the Ft levels were 
measured immediately, both the H-Ft and L-Ft were significantly induced (i.e. up to 
2.5-fold and 5-fold of the control values, respectively) (see table 3.6-d and figure 
3.30-A1,A2). In HJ16 cells, the same treatment strongly increased the levels of H-Ft 
(i.e. up to 7.3-fold of the control value). On the other hand, there was a non-
significant change in the L-Ft expression (see table 3.6-d and figure 3.30-A1,A2).  
Ferritin biosynthesis also strongly increased in B6 fibroblasts pre-treated with haem 
arginate (Pantopoulos and Hentze, 1995).   
Chapter three – Results 
 
 
Page | 114 
 
 
Figure 3.31:     
      
Effect of hemin and/or DFO prior to H2O2 treatment on H and L-Ft in J16 and HJ16 
cell lines (0, 24h). 
 
J16 and HJ16 cell lines were either treated with 0.5mM H2O2 alone (0.5), treated 
overnight with 20µM hemin and then with 0.5mM H2O2 (H+0.5), treated overnight 
with 100 µM DFO and then with 0.5mM H2O2 (D+0.5), or treated with 20 µM hemin 
for 18 h and then with 1 mM DFO for 2 h and finally with 0.5mM H2O2 (H/D+0.5). 
Cells were either collected immediately after the specified treatment (i.e. 0h, A1 and 
A2) or after incubating them in CM for 24 h following the specified treatments (i.e. 
24 h, B1 and B2) and used to prepare whole cellular extracts for Ferritin ELISA (see 
section 2.10) to investigate the roles of H and L-Ft (A1 – B1 and A2 – B2, 
respectively). These results are expressed as mean ± standard deviation (n=3). 
 
* :  p < 0.05 significant difference between corresponding control.  
NS : Non-significant difference between corresponding control. 
+ : p < 0.05 significantly different when compared with the corresponding J16 cells. 
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A. 
 
B. 
 
 
Figure 3.32: 
 
Effect of hemin on H and L-Ft in J16 and HJ16 cell lines. 
 
J16 and HJ16 cell lines were treated with 20 µM hemin and were then collected at 
various times (i.e. 2, 4, 6, 8, 18, and 24 h). Whole cellular extracts were prepared for 
Ferritin ELISA (see section 2.10) to investigate the roles of H and L-Ft (A. and B., 
respectively). These results are expressed as mean ± standard deviation (n=3). 
 
* :  p < 0.05 significant difference between corresponding control.  
NS : Non-significant difference between corresponding control. 
+ : p < 0.05 significantly different when compared with the other cell line. 
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Ferritin expression was also increased 6-fold following overnight treatment with 
hemin in macrophages (Mehlhase et al, 2005). A strong up-regulation of both H- and 
L-Ft chains was reported in HeLa cells after iron administration (Cairo et al, 1985).  
On the contrary, only H-Ft was induced after hemin treatment in bovine artery 
endothelial cells (Lin et al, 1998), L-Ft on the other hand was unaffected.  Incubation 
of cells for 24 h in CM following 18 h hemin treatment, increased significantly the 
levels H- and L-Ft in both cell lines (see table 3.7-d figure 3.30-B1,B2).   
The time course experiment revealed that iron loading prior to H2O2 treatment 
decreased the H-Ft levels in J16 cells only at early hours following treatment (i.e. 2, 
6, and 8 h post- H2O2).  While in HJ16, significant decrease in H-Ft was only 
apparent at 4 and 24 h post-H2O2 treatment.  The L-Ft time course study revealed that 
the L-Ft levels remain unchanged in HJ16 cells but it was slightly decreased in J16 
cells at 4, 8, 18 and 24 h time points (see figure 3.33).  
ELISA performed immediately after the exposure of hemin-treated cells 
(20μM, 18 h) to 0.5 mM H2O2 revealed an already significant increase in the H-Ft and 
L-Ft levels  in J16 cell line (i.e. up to 5-fold of the control value) (see figure 3.32-
A1,A2).  Both H-Ft and L-Ft were also induced in HJ16 cells (i.e. up to 18-fold and 
5-fold of the control values, respectively) (see figure 3.32 A1,A2).  Following 24 h 
incubation in CM, H-Ft and L-Ft were also strongly induced in J16 cells (i.e. 6-fold 
and 4-fold of the control values, respectively).  In HJ16 cells, H-Ft and L-Ft were also 
strongly induced (i.e. up to 12-fold and of the control values) (see figure 3.32 B1,B2). 
 
3.4.3.5   Effect of combined DFO/hemin ± H2O2 on the Ft levels 
 Finally the effect of hemin and DFO treatment with and without H2O2 
treatment was also investigated.  When the ELISA was performed immediately in J16 
cells, 20 µM hemin (18 h) + 1mM DFO (2 h) significantly increased the H-Ft  and L-
Ft (i.e. up to 2-fold and 4-fold of the control value, respectively) (see figure 3.32 
A1,A2).  The levels of H-Ft and L-Ft were also significantly induced in HJ16 cells 
(i.e. up to 10-fold and 7-fold of the control value, respectively) (see figure 3.30 
A1,A2).  Following 24 h incubation in CM, the levels of H-Ft and L-Ft were 
significantly induced in J16 cells (i.e. up to 2-fold and 3-fold of the control value, 
respectively) (see figure 3.30-B1,B2).  
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A.
 
B. 
 
 
Figure 3.33: 
 
Effect of 20 µM hemin + 0.5 mM H2O2 on H and L-Ft in J16 and HJ16 cell lines. 
 
J16 and HJ16 cell lines were treated overnight with 20µM hemin and then with an 
intermediate dose of H2O2 (i.e. 0.5 mM). Cells were collected at various times (i.e. 2, 
4, 6, 8, 18, and 24 h) and used to prepare whole cellular extracts for Ferritin ELISA 
(see section 2.10) to investigate the roles of H and L-Ft (A. and B., respectively).  
These results are expressed as mean ± standard deviation (n=3). 
 
* :  p < 0.05 significant difference between corresponding control.  
NS : Non-significant difference between corresponding control. 
+ : p < 0.05 significantly different when compared with the other cell line. 
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This was also seen in HJ16 cells, levels of H-Ft and L-Ft were also significantly 
induced in HJ16 cells (i.e. up to 8-fold and 6-fold of the control value, respectively) 
(see figure 3.30-B1,B2).   
ELISA performed immediately following H2O2 treatment of combined hemin-
DFO cells, revealed a significant increase in the levels of H-Ft and L-Ft in J16 cells 
(i.e. up to 3-fold and 2-fold of the control value, respectively) (see figure 3.32 
A1,A2).  The levels of both H-Ft and L-Ft were also significantly induced in HJ16 
cells (i.e. up to 14-fold and 8-fold of the control values, respectively) (see figure 3.32 
A1,A2). Following 24 h incubation in CM, the levels of H-Ft and L-Ft were also 
significantly induced in J16 cells (i.e. up to 2-fold and 4-fold of the control values, 
respectively) (see figure 3.32 B1,B2). This was also seen in HJ16 cells, as levels of 
H-Ft and L-Ft were also significantly induced following hemin-DFO- H2O2 treatment 
(i.e. up to 8-fold of the control value)  (see figure 3.32 B1,B2). 
 
3.4.3.6   Mitochondrial ferritin in the J16 and HJ16 cell line 
Mitochondrial ferritin (Mt-Ft) was also measured in both cell lines.  In the J16 
cell line Mt-Ft basal level was 0.53 ng/mg and 1.52 ng/mg in HJ16 cells.  In J16 cell 
line, Mt-Ft levels following either hemin or DFO treatment prior H2O2 treatment or 
H2O2 treatment alone, were negligible.  On the other hand, in the HJ16 cell line, Mt-Ft 
was increased up to 4-fold after 0.5 mM H2O2 treatment (measured 24 h following the 
treatment), overnight treatment with 20 µM hemin (measured 24 h following the 
treatment), and H2O2 treatment (0.5 mM) following overnight treatment with 20 µM 
hemin (measured immediately following the treatment).  It was also increased up to 5-
fold after overnight treatment with 100 µM DFO (measured 24 h following the 
treatment).  Mitochondrial ferritin (Mt-Ft) is currently under investigation in our cell 
model. 
 
3.4.4 The role of iron-mediated lysosomal damage in J16 and HJ16 cells 
Since lysosomal iron release and necrosis have been related (see section 1.5.1) 
we wanted to a great extent understand this relationship in our cell model. To 
investigate the role of iron-mediated lysosomal damage in both acute and chronic 
oxidative stress conditions, the lysosomal damage was monitored by three 
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independent assays: (1) Neutral red uptake assay (2) Lysosensor 
immunofluorescence, and (3) Cathepsin B immunocytochemistry. 
 
3.4.4.1   Neutral red uptake assay 
Primarily, the effect of H2O2 treatment on lysosomal damage in both J16 and 
HJ16 cell lines was investigated via Neutral red (NR) uptake assay.  Figure 3.34 
clearly demonstrates that the lysosomal membranes in the parental J16 cells are very 
sensitive to H2O2 treatment.  However, in the HJ16, cells the lysosomal membrane 
were very resistant to the same treatment.   
Using the same approach, in J16 cells, we found that both DFO and hemin 
protected the cells from lysosomal damage (see figure 3.35).  This is in agreement 
with our previous results showing that these two compounds protected J16 cells from 
H2O2–induced necrosis.  In HJ16 cells (see figure 3.36), the scenario was quite 
different: Interestingly DFO pre-treatment (unlike the necrosis data, see figure 3.15) 
had no significant protective effect when compared with cells treated with H2O2 
alone.  Hemin, on the other hand, promoted more lysosomal damage in HJ16.   
The lysosomal damage was also investigated in both cell lines after combined 
hemin (i.e. 20 µM for 18 h) - DFO (i.e. 1mM for 2 h) treatment.  It was shown that 
DFO treatment following iron loading for 18 h (see figure 3.37) protected both cell 
lines from lysosomal damage.  These results are in agreement with necrosis data using 
Flow cytometry (see section 3.4.2). 
 
3.4.4.2    Lysosensor immunofluorescence 
The LysoSensorTM Green DND-153 was used to monitor the integrity of 
lysosomal membranes after relevant treatments. As can be seen in figure 3.38, H2O2 
damages the lysosomes in J16 cells in a dose-dependent manner (i.e. 0.1, 0.5, and 
1mM) as observed by the loss of fluorescence due to the leakage of the dye to the 
cytosol. However, overnight treatment of J16 cells with either DFO or hemin 
protected the lysosomes against H2O2-induced damage. This is in agreement with the 
NR assay and the necrosis data using Flow cytometry.   In contrast to J16 cells, the 
lysosomes in HJ16 cells were quite resistant to H2O2 treatment (see figure 3.39). 
Indeed, intact lysosomes could be detected even when cells were exposed to a high 
dose of H2O2 (i.e. 1mM).  
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Figure 3.34 :  
 
Effect of different concentrations of H2O2 treatment on J16 (parental) and HJ16 
(H2O2-resistant) cell lines (Analysis : NR assay). 
  
Neutral red assay was performed 24 h following H2O2 treatment (see section 2.11).  
These results are expressed as mean ± standard deviation (n=3) 
 
 
* :  p < 0.05 significant difference between corresponding control.  
NS : Non-significant difference between corresponding control. 
+ :  p < 0.05 significantly different when compared with the corresponding J16 cells. 
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A. 
 
 
B. 
 
Figure 3.35 : 
 
The assessment of iron chelation and loading on lysosomal damage in J16 cell line 
(parental cells) - (Analysis : NR assay).  
  
J16 cells were pretreated with either 100 µM DFO (A) or 20 µM hemin (B) for 18 h 
before H2O2 treatment.  Neutral red (NR) assay was performed 24 h following H2O2 
treatment (see section 2.11).  These results are expressed as mean ± standard 
deviation (n=3). 
 
+ : p < 0.05 significant difference between DFO (A) or hemin (B) pre-treated cells 
and cells treated with H2O2 alone. 
NS : Non-significant difference between DFO (A) or hemin (B) pre-treated cells and 
cells treated with H2O2 alone. 
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A. 
 
 
B. 
 
Figure 3.36 : 
 
The assessment of iron chelation and loading on lysosomal damage in HJ16 cell line 
(H2O2-resistant cells) - (Analysis : NR assay).  
  
HJ16 cells were pretreated with either 100 µM DFO (A) or 20 µM hemin (B) for 18 h 
before H2O2 treatment.  Neutral red assay was performed 24 h following H2O2 
treatment (see section 2.11).  These results are expressed as mean ± standard 
deviation (n=3). 
 
+ : p < 0.05 significant difference between DFO (A) or hemin (B) pre-treated cells 
and cells treated with H2O2 alone. 
NS : Non-significant difference between DFO (A) or hemin (B) pre-treated cells and 
cells treated with H2O2 alone. 
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A. 
 
 
B. 
 
Figure 3.37 : 
 
The assessment of DFO treatment following iron loading prior to H2O2 treatment on 
lysosomal damage in J16 (A) and HJ16 (B) cell lines (Analysis : NR assay).  
  
Both cell lines were pretreated with either 20 µM Hemin for 18 h or 20 µM Hemin 
for 18 h and then 1mM DFO for 2 h, before H2O2 treatment.  Neutral red assay was 
performed 24 h following H2O2 treatment (see section 2.11). These results are 
expressed as mean ± standard deviation (n=3). 
 
+ : p < 0.05 significant difference when compared with cells pre-treated with hemin 
and H2O2 alone. 
NS : Non-significant difference when compared with cells pre-treated with hemin and 
H2O2 alone. 
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Figure 3.38 : 
 
The effect of iron chelation and loading on the H2O2-mediated lysosomal damage in 
J16 cell line (parental cells).  
  
J16 cells were pre-treated with either 100 µM DFO (second row) or 20 µM hemin 
(third row) for 18 h before H2O2 treatment (i.e. 0.1, 0.5, and 1mM).  The Lysosensor 
assay (see section 2.12) was performed 24 h following H2O2 treatment.  The 
photographs are representative of three experiments. 
 
 
 
J16  0 mM J16  0.1 mM J16  0.5 mM J16  1.0 mM 
J16 DFO -  0 mM J16 DFO -  0.5 mM J16 DFO -  1.0 mM
J16 Hemin - 0 mM J16 Hemin – 0.1 mM J16 Hemin – 0.5 mM J16 Hemin – 1.0 mM
J16 DFO -  0.1 mM
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Figure 3.39 : 
 
The effect of iron chelation and loading on the H2O2-mediated lysosomal damage in 
HJ16 cell line (H2O2-resistant cells).  
  
HJ16 cells were pre-treated with either 100 µM DFO (second row) or 20 µM hemin 
(third row) for 18 h before H2O2 treatment (i.e. 0.1, 0.5, and 1mM).  The Lysosensor 
assay (see section 2.12) was performed 24 h following H2O2 treatment.  The 
photographs are representative of three experiments. 
 
 
 
HJ16  0 mM HJ16  0.1 mM HJ16  0.5 mM HJ16  1.0 mM 
HJ16 DFO -  0 mM HJ16 DFO -  0.1 mM HJ16 DFO -  0.5 mM HJ16 DFO -  1.0 mM
HJ16 Hemin - 0 mM HJ16 Hemin – 0.1 mM HJ16 Hemin – 0.5 mM HJ16 Hemin – 1.0 mM
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Overnight treatment of HJ16 cells with DFO had no significant effect on the 
lysosomal integrity.   Hemin pre-treatment on the other hand caused dose-dependent 
damage to the lysosomes following H2O2 insult. The latter data are found to be in 
agreement with the NR assay and the necrosis data by Flow cytometry. 
 
3.4.4.3 Cathepsin B immunocytochemistry 
Cathepsin B is a cysteine protease found within the lysosomes. It has been 
implicated in diseases such as arthritis and cancer.  When secreted, it has been shown 
to degrade the extracellular matrix proteins (Roshy et al, 2003).  The results obtained 
from Cathepsin B immunocytochemistry confirmed the results shown with either NR 
or Lysosensor assays.  In J16 cells (see figure 3.40), both DFO and hemin pre-
treatments protected the cells against lysosomal membrane damage induced by H2O2,  
whereas in HJ16 cells (see figure 3.41), only hemin pre-treatment was shown to 
damage the lysosomes following H2O2 exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter three – Results 
 
 
Page | 127 
 
 
 
 
 
 
 
Figure 3.40: 
 
The effect of iron chelation and loading on the H2O2-mediated lysosomal damage in 
J16 cell line (parental cells).  
  
J16 cells were pre-treated with either 100 µM DFO (second row) or 20 µM hemin 
(third row) for 18 h before H2O2 treatment (i.e. 0.1, 0.5, and 1mM).   Cathepsin B 
immunocytochemistry (see section 2.13) was performed 24 h following H2O2 
treatment.  The photographs are representative of three experiments. 
 
 
 
J16  0 mM J16  0.1 mM J16  0.5 mM J16  1.0 mM 
J16 DFO -  0 mM 
J16 DFO -  0.1 mM
J16 DFO -  0.5 mM J16 DFO -  1.0 mM
J16 Hemin - 0 mM J16 Hemin – 0.1 mM J16 Hemin – 0.5 mM J16 Hemin – 1.0 mM
J16 DFO -  0.1 mM
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Figure 3.41 : 
 
The effect of iron chelation and loading on the H2O2-mediated lysosomal damage in 
HJ16 cell line (H2O2-resistant cells).  
  
HJ16 cells were pre-treated with either 100 µM DFO (second row) or 20 µM hemin 
(third row) for 18 h before H2O2 treatment (i.e. 0.1, 0.5, and 1mM).  Cathepsin B 
immunocytochemistry (see section 2.13) was performed 24 h following H2O2 
treatment.  The photographs are representative of three experiments. 
 
 
 
HJ16  0 mM HJ16  0.1 mM HJ16  0.5 mM HJ16  1.0 mM 
HJ16 DFO -  0 mM HJ16 DFO -  0.1 mM HJ16 DFO -  0.5 mM HJ16 DFO -  1.0 mM
HJ16 Hemin - 0 mM HJ16 Hemin – 0.1 mM HJ16 Hemin – 0.5 mM HJ16 Hemin – 1.0 mM
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3.5 Preliminary clinical data 
A preliminary study on human and rat fibroblasts was conducted in parallel 
with the current study (see section 2.16).  In addition to this, LPI measurements of 
normal, RA and OA synovial fluid (SF) were performed. 
 
3.5.1    MTT assay 
 Normal (HN-1) and osteoarthritic (HOA-1) human fibroblasts cells were 
treated with 1, 3, 5, and 7 mM H2O2.  Unfortunately, MTT studies on the rheumatoid 
arthritic (HRA-1) cells were not possible due to the difficulty in growing and 
maintaining these cells. The results (see figure 3.42) revealed that both HN-1 and 
HOA-1 cells were resistant even to high non-physiological doses of H2O2.  FEK4 
(human fibroblasts cell line, derived from a newborn foreskin explants) and J16 cells 
were added as controls.  The results show that the HN-1 was the most resistant cells.  
HOA-1 was less resistant than HN-1 and at high doses of H2O2, it was even less 
resistant than human primary fibroblast cell line; FEK4. 
Normal (VW-1) and AA (AAVW-1) rat fibroblasts were also treated with the 
same concentrations of H2O2 (i.e. 1, 3, 5, and 7 mM) and it was quite interesting to 
note (see figure 3.43) that AAVW-1 were very resistant to all the doses used while 
VW-1 was very sensitive to the same treatment.  R6 (the immortalised rat embryo 
fibroblast cell line) and J16 cells were added as controls.   
 
3.5.2   LIP measurements 
 The LIP was measured in normal (HN-1), rheumatoid arthritic (HRA-1), and 
osteoarthritic (HOA-1) human fibroblasts cells.  The basal and H2O2-induced level of 
LIP was investigated (see table 3.8).  The basal LIP levels of HN-1, HRA-1, and 
HOA-1 were so low that with this assay were undetectable (i.e. below the threshold).  
Because of the higher susceptibility of HOA-1 to H2O2-mediated damage it was 
hypothesised that H2O2-induced levels of LIP in HOA-1 may be higher than HN-1 
following treatment with an intermediate dose of H2O2 (i.e. 1mM).  
MTT assay with 1mM of H2O2 showed a decrease in the percentage of 
intracellular dehydrogenase activity of HN-1 to 91.5 % of the control value (i.e. 
100%) and to 60.8% in HOA-1 cells.   
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Figure 3.42 :  
 
Effect of different concentrations of H2O2 on viable human cells (Analysis : MTT 
assay). 
 
Normal (HN-1),  osteoarthritic (HOA-1) human fibroblasts, FEK4 and J16 cells were 
treated with 1, 3, 5, and 7 mM H2O2.  MTT analysis (see section 2.4) was performed 
24 h following H2O2 treatment (n=1). 
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Figure 3.43 : 
 
Effect of different concentrations of H2O2 on viable rat cells (Analysis : MTT assay). 
 
Normal (VW-1) and AA (AAVW-1) rat fibroblasts, R6 (rat cell line) and J16 cells 
were treated with 1, 3, 5, and 7 mM H2O2.  MTT analysis (see section 2.4) was 
performed 24 h following H2O2 treatment (n=1). 
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Table 3.8: 
Labile iron pool (LIP) basal and H2O2-induced (i.e. 1mM) levels of normal (HN-1) 
and osteoarthritic (HOA-1) human fibroblasts. 
 
 
 
 
Cells 
 
 
Basal levels (µM/µg) 
 
Post 1mM-H2O2 (µM/µg) 
 
HN-1 
 
 
Undetectable 
 
Undetectable 
 
HRA-1 
 
 
Undetectable 
 
Undetectable 
 
HOA-1 
 
 
Undetectable 
 
0.18 ± 0.06 
 
 
 
 
As described in section 2.15, the LIP basal levels and H2O2-induced (i.e. 1mM) of 
both normal (HN-1) and osteoarthritic (HOA-1) human fibroblasts was measured.  
These results are expressed as mean ± standard deviation (n=3). 
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These results were in agreement with our hypothesis, since following treatment of 
cells with an intermediate dose of 1mM H2O2, the LIP levels in HOA-1 increased to a 
detectable level (i.e. 0.18 ± 0.06 µM/µg) while it remained at undectable levels in 
HN-1.  However, more samples are needed to validate our hypothesis.  The LIP was 
also undetectable in HRA-1 cells.   
The basal and the H2O2-induced (i.e. 1mM) levels of LIP were also 
investigated in normal (VW-1) and AA (AAVW-1) rat fibroblasts (see table 3.9).  
The basal levels of the LIP were undetectable in VW-1 but in AAVW-1 cells it was 
found to be within detectable range of 0.003 ± 1.25 x 10-5 µM/µg.   Similarly with our 
rat cell model, it was hypothesised that an increase in LIP will be only seen in the 
normal (VW-1) cells when compared to AA (AAVW-1) rat fibroblasts after H2O2 
treatment. The rationale for this hypothesis was that at 1mM of H2O2, the intracellular 
dehydrogenase activity of VW-1 decreased to 4.2 % of the control value (i.e. 100%), 
and it was not modified in AAVW-1 cells.  Following an intermediate dose of 1mM 
of H2O2, the LIP levels of VW-1 increased to the detectable levels and in AAVW-1 
cells, the increase was interestingly more than 13-fold.   
 
3.5.3 LPI measurements 
Labile plasma iron (LPI) was also measured, as described in section 2.16 in 
the synovial fluid (SF) of normal, rheumatoid arthritic (RA), and oesteoarthric (OA) 
patients.  Synovial fluid from a normal, two RA, and six OA patients was analysed.  
The results (see table 3.10) show that there was no consistent pattern in these samples.  
The LPI of the normal patient was 0.45 ± 0.3 µM, it seems to be slightly higher in RA 
but it was non-significant (p value > 0.05).  In OA samples, some had higher value 
than the normal sample and others had lower values, but they were all non-significant. 
Clearly, more samples are needed to complement these observations. 
 
 
 
 
 
 
 
Chapter three – Results 
 
 
Page | 134 
 
 
 
 
 
Table 3.9: 
 Labile iron pool (LIP) basal and H2O2-induced (i.e. 1mM) of the normal (VW-1) and 
AA (AAVW-1) rat fibroblasts. 
 
 
 
 
 
Cells 
 
 
Basal levels (µM/µg) 
 
Post 1mM-H2O2 (µM/µg) 
 
VW-1 
 
 
Undetectable 
 
0.02 ± 0.008 
 
AAVW-1 
 
 
0.003 ± 1.25 x 10-5 
 
0.04 ± 0.007 *+ 
 
 
 
As described in section 2.15, the LIP basal levels and H2O2-induced (i.e. 1mM) of 
both of the normal (VW-1) and AA (AAVW-1) rat fibroblasts was measured.  These 
results are expressed as mean ± standard deviation (n=3). 
 
 
 
* :  p < 0.05 significantly different when compared with the basal levels.  
+ :  p < 0.05 significantly different when compared with the corresponding VW-1. 
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Table 3.10 : 
 
Labile plasma iron (LPI) measurements of synovial fluid from normal, rheumatoid 
arthritic (RA), and osteoarthritic (OA) patients. 
 
 
 
 
Condition 
 
LPI   (µM) 
 
 
Normal knee 
 
 
0.45 ± 0.3 
 
RA knee 
 
0.47 ± 0.09  NS 
 
 
RA knee 
 
0.54  ± 0.71 NS 
 
 
OA knee 
 
1.4  ±  1.06  NS 
 
 
OA knee 
 
0.29 ± 0.19  NS 
 
 
OA knee 
 
0.76 ± 0.36  NS 
 
 
OA knee 
 
0.44 ± 0.2  NS 
 
 
OA knee 
 
0.47 ± 0.29  NS 
 
 
OA knee 
 
0.04 ± 0.01  NS   
 
 
 
 
LPI was measured as described in section 2.16. These results are expressed as mean ± 
standard deviation (n=3). 
 
NS : non significantly different from the normal sample. 
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CHAPTER FOUR 
 
DISCUSSION 
 
Inflammation is a term used to illustrate the body's complex physiological response, 
whether acute or chronic, to tissue injury (Underwood, 1996). The role of the acute 
response is to clear dead cells from the site of the injury, to protect the site against any 
pathogens, and to permit the immune system to gain access to the site of 
inflammation (Junqueira et al, 1986).  It is crucial that inflammatory reactions are 
self-limited upon e.g. elimination of the triggering factors, if not, they do perpetuate 
to chronic inflammation (Schett, 2008).  The transition between the acute phase and 
the chronic phase is largely dependent on the persistence of the inflammatory cause.  
When the cause persists, chronic inflammation follows, which may last for a 
prolonged duration of time - weeks, months, or even indefinitely, and subsequently 
the cell population changes (Feghali and Wright, 1997).  Lymphocytes and 
macrophages are the predominant cells in chronic inflammation (Junqueira et al, 
1986; Underwood, 1996; Stevens and Lowe, 1999).  In the inflamed area, these cells 
engulf the remains of cells and fibres and participate in the production of antibodies 
against invading microorganisms (Junqueira et al, 1986).  Lymphocytes are also the 
key components in the onset and exacerbation of autoimmune diseases and the 
cytokines produced by them have a great impact on disease progression (Horwood, 
2008).  Cytokines are the key mediators of inflammation and can be found in 
abundance in the joints and the blood of patients suffering from rheumatoid arthritis 
(Christodoulou and Choy, 2006). 
 
Rheumatoid arthritis (RA) is an example of a chronic auto-immune inflammation 
disease. It primarily affects the joints and ultimately leads to their destruction (Huber 
et al, 2006).  Several studies indicate that during an inflammatory response, 
considerable amounts of ROS are generated that participate in the aetiology and/or the 
progression of the condition.  For example in an inflammatory environment, 
lymphocytes are exposed to extensive quantities of H2O2 produced by macrophages 
and neutrophils as a result of the inflammatory response.  Therefore, oxidative stress 
has been implicated in several physiological and pathological conditions (Vendemiale 
Chapter four – Discussion 
 
Page |   
 
137
et al, 1999), notably RA.  Superoxide anion and H2O2 per se are not injurious but may 
become so in the presence of redox active iron or other transition metals.  The 
potentially harmful free ‘labile’ iron is recognised as an important promoter of 
oxidative stress through aiding the production of ROS and thus a potential mediator 
of the inflammatory process in RA. 
 
In addition to UVA (Morliere et al, 1997 and Pourzand et al, 1999) and visible light 
irradiation (Ohishi et al, 2005), it has already been shown that the exposure of cells to 
H2O2 (see section 1.3.6) provokes an increase in the LIP that correlates with cell 
damage and necrotic cell death, although the mechanisms involved had not been fully 
understood.  The lysosomal compartment seems to contain the major important 
cellular pool of labile iron (Petrat et al, 2001; Kakhlon and Cabantchik, 2002; Persson 
et al, 2003) since the degradation of many macromolecules that are rich in iron (e.g. 
ferritin and mitochondrial electron-transport complexes) occurs in the lysosomes 
(Radisky and Kaplan, 1998 and Kurz et al, 2007) making these organelles vulnerable 
to oxidative stress (Persson et al, 2005). Therefore, understanding the link between 
lysosomal membrane damage and the iron may define pathological mechanisms 
associated with oxidative stress and lysosomal activity.  
 
 In this present study, we have used H2O2 as an oxidising agent, since treatment with 
this agent is commonly used to study the effect of ROS in biochemical pathways and 
it diffuses easily across cellular compartments (Auntes and Cadenas, 2000).  It is 
known that H2O2 is generated during normal metabolism and produced in large 
quantities by phagocytic cells at inflammatory sites (Hylop et al, 1995).  Several 
studies have shown the crucial role iron in inflammatory diseases such as RA; but 
none, to our knowledge, had differentiated between the role of iron in both acute and 
chronic phases in the disease and the origin of this 'free' iron.  Therefore our primary 
aim was to investigate the role of iron in both acute and chronic oxidative conditions.   
 
To achieve our aim we have extensively studied two cell lines which were Jurkat 
cells, human T-cell leukaemia cell line. Our model consisted of two human Jurkat T 
cell lines of “parental (J16)” and “H2O2 adapted/resistant/stressed (HJ16)” types.  J16 
cells were used to mimic the acute phase of oxidative stress.  The HJ16 cell line was 
used to mimic the chronic phase since unpublished data from N.D Hall’s laboratory 
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(Department of Pharmacy and Pharmacology, University of Bath) have shown that 
HJ16 cells have characteristics similar to that of rheumatoid synovial T cells. 
 
A. Yiakouvaki from this laboratory (PhD Thesis, 2003 – University of Bath) has 
already characterised these Jurkat T cell lines in terms of antioxidant defence and 
modulation of intracellular LIP following H2O2.  Overall her results provided a link 
between the amount of H2O2-induced labile iron release and the extent of oxidative 
damage and cell death in Jurkat T cells. Furthermore the study showed that adaptation 
of Jurkat T cells to H2O2 can influence the basal level of antioxidant enzymes that is 
likely to contribute to resistance of HJ16 cells to H2O2 insult.  
 
This thesis has continued the study of Yiakouvaki (2003) by further characterising the 
differential response of parental J16 and H2O2-resistant HJ16 Jurkat T cells to H2O2.   
 
The level of resistance of Jurkat T cell lines to H2O2-mediated toxicity 
Tissues, in different pathological conditions, are confronted with elevated 
H2O2 concentrations derived either extra- or intra-cellularly.  Overall the treatment of 
both cell lines with various concentrations of H2O2 revealed that exposure of parental 
J16 cells to moderate concentrations of H2O2 was capable of damaging half of the J16 
cell line population since the percentage of live cells was found to be decreased to 
around 50 % of the control values.  On the other hand, the HJ16 cell line showed 
higher resistance to H2O2-mediated oxidative insult, even at doses as high as 3 mM.  
Flow cytometry analysis further revealed that both cell lines are highly resistant to 
H2O2-mediated apoptotic cell death and that necrosis rather than apoptosis is 
responsible for H2O2-induced cell death. 
 The ultimate response of cells to oxidative stress is cell death in the form of 
apoptosis or necrosis. While apoptosis is recognised as a physiological programmed 
process to eliminate aged, superfluous or superficially damaged cells, necrosis is 
usually the ultimate response of cells to severe physical- or chemical-induced acute 
injury. Our results show that J16 parental cells are very sensitive to acute H2O2 insult 
since they die preferentially via necrosis. The gradual adaptation of HJ16 cells to 
H2O2 on the other hand appears to have increased their tolerance to H2O2-induced 
oxidative damage since the percentage of HJ16 cells dying by necrosis is dramatically 
lower than in parental J16 cells.  The higher resistance of HJ16 cells to H2O2-induced 
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necrotic cell death is likely to be related to higher detoxification of H2O2 by 
intracellular antioxidant molecules/enzymes such as catalase, GPx and glutathione. 
The comparative study carried out by A. Yiakouvaki has already indicated that HJ16 
cells have higher intracellular glutathione content and GPx activity when compared to 
J16 cells. However catalase activity was quite similar between the two cell lines. The 
study concluded that catalase should have a minor role in detoxifying H2O2 as it is 
located in peroxisomes and its access to cytosolic H2O2 is limited. However both GPx 
and glutathione that is required to complete the catalytic cycle of H2O2 are reside in 
the cytosol.    
Interestingly, studies with synovial fluid have shown that RA patients have 
significantly higher GPx and catalase than normal controls (Biemond et al, 1984).   
GPx was also increased in the serum of patients with RA compared with the healthy 
control groups (Butkiene et al, 2007).  It was therefore suggested that oxidative stress 
occurs in RA because of disturbance of enzymatic and non-enzymatic antioxidants 
systems. 
In the present study it was decided to further characterise the Jurkat T cell 
lines cells in terms of their antioxidant defence mechanism by comparing the level of 
glutathione, Ft, HO-1 and HO-2 in presence or absence of H2O2 between parental and 
H2O2-resistant cells.     
 
The role of intracellular glutathione 
 The intracellular glutathione system within the cells acts as a homeostatic 
redox buffer providing a major constitutive defence against oxidants (Applegate et al, 
1992).   To determine whether the total intracellular levels of glutathione play a role 
in increased resistance of HJ16 cell line to H2O2, the basal glutathione level was 
monitored in both parental (J16) and H2O2–resistant (HJ16) cell lines.  Furthermore 
an attempt was made to deplete the intracellular level of glutathione in both cell lines 
(i.e. by BSO) to demonstrate the possible link between the intracellular level of 
glutathione and susceptibility of both cell lines to H2O2–mediated cytotoxicity.   
The results revealed that in agreement with Yiakouvaki’s data, HJ16 cells 
possess significantly higher (i.e. 3.4-fold) ‘basal’ levels of intracellular glutathione 
than J16 cells. However it was important to investigate the fate of glutathione 
following H2O2 treatment in our Jurkat cell models and to check whether the possible 
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modulation of glutathione levels by H2O2 insult could influence the susceptibility of 
Jurkat cells to necrotic cell death. 
  Glutathione is believed to be a very important cellular antioxidant compound, 
as its depletion is used to induce oxidative stress (Recalcati et al, 2003 and Tacchini 
et al, 2006). In fact, several studies have shown that the depletion of intracellular 
glutathione sensitises cell populations to several circumstances e.g. aerobic ionising 
radiation and cytotoxic drugs.  For example glutathione depletion (by BSO) sensitises 
cultured human lymphoid cells to γ radiation (Dethmers and Meister, 1981), therefore 
it is regarded as a major protective agent against such radiation.  Glutathione not only 
protects cells from the cytotoxic UVA damage, but also against the damage cause by 
UVB radiation (Tyrrell and Pidoux, 1988).  It was also shown that yeast cells 
developed an increased sensitivity against H2O2 and ionising radiation following the 
depletion of glutathione (Sipos et al, 2002).  In the present study we also 
demonstrated that the susceptibility of both cell lines to H2O2-mediated cytotoxicity 
was substantially increased following the depletion of the intracellular glutathione 
level.  These results are in agreement with the previous observations made by others 
indicating that intracellular glutathione provides a constitutive mechanism of defence 
against ROS during oxidative stress conditions.  
Oxidative stress in the form of UVA radiation (320 - 380 nm) and H2O2 have 
been shown to deplete intracellular glutathione (Lautier et al, 1992; Brunk et al, 
1995a; Hempel et al, 1996).  Therefore, the levels of total intracellular glutathione 
were measured following H2O2 treatment in J16 and HJ16 cell lines.  Our results 
showed that H2O2 doses higher than 0.1 mM depleted significantly the total 
intracellular glutathione content in J16 cell line.  However in HJ16 cells, H2O2 
treatment only decreased to half the total intracellular level of glutathione.  These 
results strongly suggest that chronic exposure of HJ16 cells to H2O2 provokes an 
adaptive mechanism preventing the total depletion of total intracellular glutathione in 
these cells. The latter should almost certainly contribute to the resistance of HJ16 
cells to the high doses of H2O2. 
 
Characterisation of the response of NF-κB to H2O2 treatment  
The NF-κB complex has been shown to be activated in response to multiple 
stimuli many of which are possibly mediated by the generation of ROS (Piette et al, 
1997 and Gilston et al, 2001).  In response to these stimuli, NF-κB complex 
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activation has been examined in neutrophils, macrophages, and lymphocytes 
(reviewed in Makarov, 2001).  The inducibility of the NF-κB complex in response to 
H2O2 is cell-specific.  Furthermore it is not clear whether this response will be lost if 
cells are chronically adapted to H2O2 treatment, in the case of HJ16 cell line.  
Therefore the inducibility of NF-κB complex, by Electrophoretic Mobility Shift 
Assay (EMSA) and immunocytochemistry was investigated in both J16 and HJ16 cell 
lines following H2O2 treatment.  Our results demonstrated that NF-κB complex is 
present and induced by H2O2 in both J16 and HJ16 cells, although the induction was 
higher in HJ16 cells.  These findings are in conflict with other studies that have 
shown that the induction of NF-κB is strongly suppressed in cells pre-exposed to 
sources of oxidative stress such as H2O2 (Lahdenpohja et al, 1998).      
The NF-κB complex has been shown to be activated in cancer cells and also 
after chemotherapy or radiotherapy, and therefore it has been associated with the 
resistance of these cells to apoptosis (reviewed in Piva et al, 2006 and Sethi et al, 
2008).  The NF-κB complex therefore plays an important role in cell survival (Habens 
et al, 2005).  The higher activation of NF-κB by H2O2 in HJ16 cells could be seen as 
another adaptive mechanism in these cells increasing their survival against H2O2-
induced oxidative damage and necrotic cell death. To this regard, several recent 
studies have provided evidence about the existence of a prosurvival pathway initiated 
by NF-κB that appeared to be responsible for the radioadaptive response (i.e. 
radioresistance) in all cells (reviewed in Ahmed and Li, 2008).  Furthermore it has 
been speculated that the inducibility of the NF-κB complex in synovial T cells of 
rheumatoid arthritic patients should be low as these cells are chronically exposed to 
ROS.   In vitro studies have proven that this speculation is incorrect (see section 
1.6.6).   
Studies by Marok et al (1996) and Gilston et al (1997) have demonstrated 
that NF-κB complex is highly activated in patients with chronic inflammatory 
conditions such as rheumatoid arthritis.  Our data appears to be in agreement with 
such studies.  As mentioned in section 1.6.3, activation of NF-κB can be divided into 
two pathways, the ‘classical’ and the ‘alternative’ pathway.  The classical pathway 
has been proposed to be responsible for the NF-κB activation in the RA synovium 
(reviewed Simmonds and Foxwell, 2008). Clearly further studies are necessary to 
unravel the role of NF-κB in both oxidative stress and inflammatory conditions. 
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Similarly, in our cell models, further investigations are necessary to understand the 
mechanism underlying the higher NF-κB activation in HJ16 cells.   
 
The role of LIP in differential sensitivity of the J16 and HJ16 cells to H2O2 
treatment  
 Hydrogen peroxide-sensitive (and ionising radiation-resistant) mouse 
lymphoma cell line has 3-fold higher ‘basal’ LIP levels than H2O2-resistant (and 
ionising radiation-sensitive) cells (Lipinski et al, 2000). However what these authors 
called ‘LIP’ levels in their measurements with CA-assay reflects only the CA-bound 
iron that is usually referred to as chelatable iron pool. The LIP according to 
Cabantchik and co-workers who developed the CA-assay is operationally defined as 
the sum of the intracellular level of CA-bound iron (i.e. [CA-Fe]) and free iron (i.e. 
[Fe] unbound to CA) and requires the determination of the cell-dependent 
dissociation constant (Kd) for CA-Fe by taking into account the cell volume. These 
determinations were lacking in the study by Lipinski et al, (2000).  In our cell volume 
study we have observed that the HJ16 cells are significantly larger cells than the 
parental cells (i.e. 3.4-fold bigger than J16), therefore in all our iron studies, it was 
necessary to first determine the cell-dependent Kd of CA-bound iron in order to 
calculate the absolute level of LIP. The results demonstrated that the ‘basal’ LIP 
levels of both cell lines were quite similar; J16 cells (3.08 µM ± 0.59) and HJ16 cells 
(3.34 µM ± 0.87).  However following H2O2 treatment, the LIP was increased by 
more than 3.2-fold in J16 cells (9.86 µM ± 0.35) and this was correlated with high 
necrosis.  In HJ16 cells, H2O2 produced only a moderate increase in the basal LIP 
level (5.27 µM ± 1.12) when compared with J16 cells and this correlated to lower 
necrosis than in J16 cells. The lower increase of LIP in HJ16 cells after H2O2 
treatment is likely to be part of the adaptive mechanism developed in these cells 
making these cells less susceptible to H2O2-induced oxidative iron-damage and 
necrotic cell death. Interestingly human epidermal keratinocytes that are naturally 
resistant to UVA-induced damage also show lower LIP levels than the UVA-sensitive 
dermal fibroblasts following UVA irradiation. The lower UVA-induced LIP levels in 
keratinocytes has been correlated with their low propensity to UVA-induced necrotic 
cell death (Zhong et al, 2004). It appears that in our cell model, the modulation of the 
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LIP levels following H2O2 treatment also correlates with the extent of cell damage 
and necrotic cell death.   
To ascertain the importance of H2O2-induced labile iron release in modulating 
the susceptibility of cells to H2O2-induced necrotic cell death, both J16 and HJ16 
were treated with DFO, a strong iron chelator or hemin (i.e. ferric haem) as a source 
of iron for 18 h prior to H2O2 treatment and then the level of LIP was measured 
following H2O2 treatment using the CA assay. The results demonstrated that DFO 
treatment abolishes both the ‘basal’ and ‘H2O2-induced’ LIP levels and necrotic cell 
death in both cell lines, consistent with the notion that iron chelation by DFO protects 
the cells against H2O2-induced necrotic cell death.  In the case of hemin treatment, 
hemin alone (i.e. when not followed by H2O2 treatment) did not modulate the level of 
LIP in J16 cells but upon H2O2 treatment it caused a low increase in LIP that 
correlated with low necrosis. This is in agreement with previews studies by Balla and 
co-workers showing that the endothelium’s susceptibility to H2O2-mediated insults 
decreases following exposure to hemin or haemoglobin (Balla et al, 1992 and 1993).  
It was also demonstrated that extracellular Fe2+ and H2O2 preserved intracellular 
glutathione, prostaglandin H synthase, mitochondrial electron transport, and cell 
calcium entry, and therefore protected endothelial cells from cellular damage 
(Hempel et al, 1996).  On the other hand, in HJ16 cell line, hemin treatment 
modulated both the ‘basal’ and ‘H2O2-induced’ LIP levels in HJ16 cells. The higher 
levels of LIP accumulation after overnight hemin treatment of HJ16 cells abolished 
their resistance to H2O2-induced damage since the level of necrosis was significantly 
increased upon hemin-H2O2 treatment.  These results strongly suggested that the 
presence of higher LIP in HJ16 cells following hemin treatment should be responsible 
for abolishing the resistance of HJ16 cells to H2O2–mediated oxidative insult.  
Hydrogen peroxide can react with Fe3+ to form O2·- and if H2O2 is in excess, the Fe2+ 
which is formed can subsequently generate ROS via the Fenton reaction (Henle and 
Linn, 1997).  The iron-mediated damage is very powerful and should almost certainly 
contribute to severe oxidative damage in HJ16 cells leading to necrotic cell death. 
Further investigation with time course analysis revealed that in J16 cells, hemin only 
caused a transient and moderate increase in the LIP levels within the first 2-4 h after 
treatment, but in HJ16 hemin provoked a higher accumulation of LIP levels that was 
sustained at least for 18 h. In HJ16 cells, the hemin-mediated increase in LIP was also 
concentration-dependent.  The high accumulation of LIP in HJ16 cells following 
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hemin treatment increased dramatically the percentage of necrotic cell death, 
consistent with the notion that the intracellular level of LIP plays an important role in 
determining the level of sensitivity of these cells to H2O2-mediated necrotic cell 
death.   
To further demonstrate the strict dependence of H2O2-induced necrotic cell 
death on LIP level present in the cells, hemin treatment for 18 h was followed by an 
additional treatment with 1 mM DFO for 2h.  The latter treatment was expected to 
lower the hemin-mediated increase in LIP, leading to decreased necrosis by H2O2. 
The results showed that, in agreement with our hypothesis, in both cell lines DFO 
treatment of cells pre-treated with hemin, significantly decreases the levels of H2O2-
induced necrotic cell death when compared to cells treated with hemin alone. 
Taken together, from the above results; a picture emerged suggesting that LIP 
levels must be a key component in determining the extent of the sensitivity of these 
cells to H2O2-induced necrotic cell death.  However it was surprising to see how the 
same treatment provoked two entirely different responses in the cell lines. The hemin 
treatment increased the resistance of J16 to H2O2-induced necrotic cell death but 
abolished the resistance of HJ16 cells. The hemin overnight treatment increased the 
levels of LIP in HJ16 cells but not in J16 cells. We hypothesised that the high 
accumulation of labile iron in HJ16 cells following hemin treatment could either be 
due to higher HO protein levels or lower intracellular Ft levels in HJ16 cells when 
compared to parental J16 cells.  We therefore investigated the level of these proteins 
in both J16 and HJ16 cells following various treatments as detailed below. 
 
The role of HO-1 and HO-2 in Jurkat cell lines 
The higher expression of HO-1 and/or HO-2 in HJ16 cell line might contribute 
to accumulation of LIP levels following hemin treatment, since hemin is a known 
substrate for these enzymes.  Previous analysis of the level of ho-1 mRNA 
accumulation in J16 and HJ16 cells using the real-time PCR technique (Yiakouvaki, 
2003) revealed that the basal level of ho-1 cDNA is 2-fold higher in the H2O2-
resistant cells than in the parental cells. Furthermore the basal level of HO-1 protein 
in H2O2 resistant cells was found to be 2-fold higher than in parental cells. So it was 
concluded that HO-1 expression should play a role in hemin-induced iron 
accumulation in HJ16 cells. Furthermore when both cell lines were treated with 20 
µM hemin at various time points, a significant increase in HO-1 was only observed in 
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parental cell line. Yiakouvaki (2003) concluded that HO-1 protein is not inducible in 
HJ16 cells presumably because gradual adaptation of cells to H2O2 provokes a 
refractory response of HO-1 to hemin.  
Since hemin is also a known substrate of HO-2 protein, it was important to 
check in our study the level of its expression in Jurkat T cells. We therefore decided 
to carry out an in depth study of the expression of HO-1 and HO-2 at protein levels 
following various treatments using Western blot analysis. Overall, these treatments 
were (1) Hemin/DFO alone or Hemin/DFO pre-treatment prior to H2O2 treatment, (2) 
Time-course of hemin treatment, (3) Time-course of H2O2 treatment, (4), Time-
course of hemin pre-treatment prior to H2O2 treatment and (5) Hemin pre-treatment 
followed by with 1 mM DFO for 2 hours and finally H2O2 treatment.   
The basal level of HO-1 was found to very low in both cell lines and the 
difference in expression observed by Flow cytometry could not be visualized by 
Western blot analysis. Furthermore the analysis showed no increase in HO-1 level in 
these cell lines. Studies with Jurkat T cells performed by others have also shown that 
HO-1 protein expression is not detectable at basal levels by Western analysis (Pae et 
al, 2004a; Choi et al, 2004; Pae et al, 2004b).  The basal HO-2 level on the other hand 
was higher than HO-1 in both cell lines but it was not modulated by any of the above 
treatments. 
To ascertain that HO protein levels were not modulated at early hours 
following hemin and/or H2O2, the HO-1 and HO-2 levels were followed in time 
course analysis from 0 to 18 and/or 24 h following hemin and/or H2O2 treatments.  
The results revealed that neither HO-1 nor HO-2 levels are modulated by these 
treatments. To complete the analysis, the levels of HO-1 and HO-2 proteins were also 
checked after combined hemin+DFO and/or H2O2 treatment. Again here, no 
modulation in protein levels of HO-1 and HO-2 was observed.  Taken together these 
results showed that high iron accumulation after hemin treatment in HJ16 cells might 
not be related to differential expression of HO proteins in these cells. 
Following oxidative stress (UVA and H2O2), HO-1 mRNA levels were 
strongly inducible in dermal fibroblasts and were barely inducible in human 
epidermal keratinocytes that are known to be naturally resistant to oxidative insults 
(Applegate et al, 1995).  HO-2 mRNA levels on the other hand were found to be high 
in epidermal keratinocytes but low in dermal fibroblasts.  The higher resistance of 
epidermal keratinocytes to UVA-induced necrotic cell death has also been linked to 
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the LIP, since both ‘basal’ and ‘UVA-induced’ levels in keratinocytes were several 
fold lower than in their matched dermal fibroblasts (Zhong et al, 2004).   
In eight of the human cancer cells examined (Ding et al, 2006); HO-1 
expression was not detectable in three, including Jurkat cells.  Interestingly, HO-2 
was highly expressed in these three cells whereas HO-1 was not present.  Si-RNA-
mediated knocking down of HO-1 has also been shown to increase HO-2 expression 
in human skin fibroblasts (Julia Zhong Li and Rex M. Tyrrell, unpublished data). 
These studies suggested that HO-2 may down regulate the expression of HO-1, 
thereby directing the co-ordinated expression of HO-1 and HO-2.   
Seta et al, (2006) were the first to demonstrate that HO-2 is crucial in the 
regulation of inflammation; in the absence of HO-2, resolution of inflammation was 
impaired resulting in a continuous influx of inflammatory cells and subsequently, an 
exacerbation of cellular injury. They have also demonstrated that HO-1 function 
depends on the activity of HO-2, since the study indicates that in the absence of HO-
2, functional HO-1 induction is impaired and HO activity is abrogated. 
Both HO-1 and HO-2 break down hemin as their substrate to release its iron. 
The excess iron is usually sensed by IRP-1 that activates the synthesis of Ft molecules 
to sequester the iron that would otherwise be potentially harmful to cells especially 
during an oxidative stress condition. In the present study the high expression of HO-2 
appeared to be sufficient to break down hemin to release its iron. But the fate of the 
released iron appeared to be different in these two cell lines and we speculated that 
this difference could be related to differential expression of Ft protein in these cell 
lines.   
 
The role of ferritin in Jurkat cell lines 
Ferritin sequesters the potentially harmful labile iron within its shells by H-
Ft’s ferroxidase activity so that iron could be stored in an inactive form.  H-Ft has 
ferroxidase activity and is required for incorporation of iron in vivo.  L-Ft (which 
lacks the ferroxidase centre) on the other hand, promotes nucleation of the metal 
inside the cavity and stabilizes the ferritin shell; it does not incorporate iron in vivo. 
Several cellular studies have shown that in oxidative stress conditions Ft could have a 
protective effect against oxidative damage as it removes iron that acts as a catalyst in 
biological oxidation (reviewed in Arosio and Levi, 2002 and Torti and Torti, 2002).  
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As mentioned in section 1.4.1.3, in the early stages of oxidative challenge, Ft 
degradation could be a potential source of iron.  Cairo et al (1995) have suggested 
that liver Ft can act as a pro- or an antioxidant in a time dependant manner.  An early 
decrease in Ft has been shown after treatment of Wistar rats with phorone, a 
glutathione depleting drug that amplifies the effects of ROS. Interestingly, 6-fold 
induction in Ft synthesis was observed as a late response. In the case of UVA and 
skin cells, Ft also acts as a pro- and antioxidant in a time dependent manner. 
Treatment of skin fibroblasts with UVA leads to an immediate degradation of 
intracellular Ft (Pourzand et al, 1999).  The consequent iron release played a key role 
in exacerbating UVA-induced oxidative damage and led to necrotic cell death (Zhong 
et al, 2004 and Yiakouvaki et al, 2006). However 6 h after UVA treatment, Ft levels 
returned to normal and then increased thereafter up to 3-fold 24-48 hours following 
UVA treatment. The long term increase in Ft levels was associated with increased 
resistance of skin fibroblasts to subsequent UVA-induced membrane damage (Vile 
and Tyrell 1993).   
The proteolytic degradation of Ft upon UVA irradiation of skin cells occurs as 
a result of damage to lysosomal membranes leading to leakage of potentially harmful 
lysosomal proteases to cytosol which in turn act to degrade cytosolic proteins; notably 
Ft (Pourzand et al, 1999). Studies by Brunk and co-workers (Brunk et al, 1995b) have 
demonstrated that acute exposure of macrophage–like J-774 cells to H2O2 also 
triggers lysosomal damage.  The irradiation of human fibroblasts with a moderate 
dose of blue light also resulted in oxidative apoptotic cell death as a result of damage 
to lysosomal organelles (Brunk et al, 1997). Damage to lysosomes was accompanied 
by leakage of lysosomal contents including hydrolytic enzymes, such as cathepsin D 
(CATH D) (Roberg and Öllinger, 1998) that should almost certainly lead to 
proteolytic degradation of Ft as well.  
Interestingly epidermal skin keratinocytes that have low basal level of Ft and 
LIP are naturally resistant to UVA-induced necrotic cell death but overnight hemin 
treatments renders these cells vulnerable to UVA-induced peroxidative damage and 
necrotic cell death (Zhong et al, 2004). This is because iron loading of cells with 
hemin increases strongly the level of intracellular Ft which in turn increases the level 
of UVA-induced LIP upon radiation-mediated proteolysis of Ft molecules.   
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Since HJ16 cells’ resistance to H2O2 was abolished after hemin treatment 
presumably because of high accumulation of labile iron in these cells, it was 
important to investigate the role of Ft in this phenomenon.   
As in HO, in general the conditions for H- and L-Ft levels measurements 
were: (1) Time-course of H2O2 treatment, (2) Time-course of hemin treatment, (3) 
Time-course of hemin pre-treatment prior to H2O2 treatment, (4) Hemin/DFO alone or 
Hemin/DFO pre-treatment prior to H2O2 treatment, and (5) Hemin pre-treatment 
followed by with 1 mM DFO for 2 hours and finally H2O2 treatment.   
Our results demonstrated that the ‘basal’ levels of H-Ft in J16 cell line are 7- 
fold higher than in HJ16 cell line. The lower H-Ft levels in HJ16 might be part of the 
adaptive response developed during gradual adaptation of these cells to H2O2.  As for 
L-Ft they had the same ‘basal’ level in both cell lines. However in the study carried 
out by Lipinski et al (2000), both the H- and L-Ft levels were found to be higher in 
the H2O2-resistant cells than in the H2O2-sensitive mouse lymphoma cells. The latter 
results differ from our study, presumably due to difference in cell type or due to 
difference in the regulation of iron homeostasis or the adaptive mechanism developed 
following chronic H2O2 treatment.   
The time course experiment further revealed that following H2O2 treatment the 
levels of H-Ft decreased gradually in J16 cells at 6 h post treatment time point and 
this level remained lower than control value up to 24 h following treatment. Hydrogen 
peroxide treatment of cultured fibroblasts and macrophages has also been shown to 
significantly inhibit the synthesis of Ft (Pantopoulos and Hentze, 1995 and Mehlhase 
et al, 2005, respectively). The decrease in Ft levels has also been shown in rat liver 
lysates subjected to postischemic reperfusion (Tacchini et al, 1997). The L-Ft time 
course study following H2O2 treatment revealed that the L-Ft levels remain 
unchanged in J16 cells but slightly increase up to 2-fold control value in HJ16 cells at 
6 h time point and then return to around control value at 24 h.    
When cells were treated with 0.5 mM H2O2 and the Ft levels were measured 
immediately, the H-Ft level slightly decreased in J16 cells but did not affect 
significantly the L-Ft.  The H-Ft levels in HJ16 were not significantly affected by 
H2O2 treatment, L-Ft on the other hand increased up to 3-fold of the control value.  
But when the cells were incubated for an additional 24 h in CM, the H-Ft decreased 
more in J16 cells but in HJ16 cells, the H-Ft levels remained unchanged. The H2O2-
mediated decrease in H-Ft levels in J16 is likely to contribute to their increased 
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susceptibility to H2O2-induced oxidative damage, since the lower Ft levels will not be 
able to sequester all the iron that is released by H2O2. Furthermore since lysosomes 
are severely damaged after H2O2 treatment in J16 cells, it is possible that the decrease 
in Ft levels is due to its proteolytic degradation by lysosomal proteases leaked in the 
cytosol. Lysosomes themselves are a known source of iron so their damage should 
almost certainly increase the pool of potentially harmful iron in the cytosol. It is 
assumed that a proportion of LIP levels detected in J16 cells following H2O2 
treatment originates from lysosomal compartments. Similarly, Yiakouvaki (2003) has 
demonstrated that H2O2 also damages the mitochondrial membranes in J16 but not 
HJ16 cells, leading to intracellular depletion of ATP that contributes to H2O2-induced 
necrotic cell death observed in J16 cells. Damage to mitochondria will release the iron 
content of these organelles. Indeed in addition to lysosomes, mitochondria are known 
to contain considerable amount of iron (Petrat et al, 2002). 
In HJ16 cells, the H-Ft levels remained unchanged following H2O2 treatment. 
Since lysosomal organelles are not significantly damaged by H2O2 in this cell line, it 
is reasonable to assume that Ft molecules remain intact in HJ16 cells and are not 
subject to proteolytic degradation by lysosomal proteases that leak in the cytosol in 
the case of J16 cells. Mitochondrial membrane was also more resistant to H2O2-
induced oxidative damage in HJ16 cells (Yiakouvaki, 2003). The resistance of 
lysosomal and mitochondrial membranes in HJ16 cells will almost certainly 
contribute to the observed low LIP levels after H2O2 treatment as their compartmental 
LIP would not release to cytosol as a result of damage. Therefore it is reasonable to 
suggest that lower Ft levels in HJ16 cells is due to adaptive mechanism developed in 
these cells, because these cells would only show low LIP levels after H2O2 so the 
presence of high basal levels of H-Ft were redundant for the response of these cells to 
H2O2.   
Unlike in our cell model, overexpression of the H-Ft increased the resistance 
of murine erythroid leukaemia (MEL) cells and HeLa cells to H2O2 treatment 
(Epsztejn et al, 1999 and Cozzi et al, 2000). Ferritin seems to act as a pro-oxidant 
molecule in J16 cells and an antioxidant in HJ16 cells following H2O2 treatment. The 
L-Ft on the other hand, was not significantly affected in J16 cells but it was slightly 
increased in HJ16 cells.   
The treatment of cells with 100 µM DFO strongly reduced the level of H-Ft in 
J16 cells. In HJ16 cells, DFO treatment also decreased the level of H-Ft although to a 
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lesser extent than in J16 cells.  The decrease in H-Ft levels by DFO is consistent with 
previous observations showing that DFO diminishes Ft biosynthesis in B6 fibroblasts 
(Pantopoulos and Hentze, 1995) and reduces Ft levels in macrophages (Mehlhase et 
al, 2005).  The DFO treatment decreased significantly the L-Ft levels in J16 cells but 
strongly induced their levels in HJ16 cells. The reason for this increase is not clear. 
One explanation would be that L-Ft compensates for the strong decrease of H-Ft in 
HJ16 cells. Indeed Kakhlon et al, (2001) have reported that there is an active role of 
both H- and L-Ft in modulating LIP and that they both balance each other when one 
of them was repressed.  Following the 24 h incubation in CM after the DFO 
treatment, H-Ft decreased further in J16 and HJ16 cells.  DFO treatment of HeLa cells 
demonstrated nearly a total repression of Ft (Cairo et al, 1985), as it also significantly 
decreased both subunits in K562 cells (Konijn et al, 1999).  On the other hand, the L-
Ft levels decreased significantly in J16 cells but not in HJ16 cells. 
The H2O2 treatment of DFO-treated cells, decreased even more the H-Ft levels 
in J16 cells and HJ16 cells.  On the other hand, there was a non-significant change in 
the L-Ft expression in both cell lines.  This was also true following the 24 h 
incubation in CM following DFO + H2O2 treatment; H-Ft was strongly decreased in 
J16 cells and HJ16 cells.  On the other hand, the L-Ft levels remained unchanged in 
both cell lines.  DFO is known to suppress the Ft synthesis via activation of IRP-1 
binding. This has been seen for example with treatment of skin fibroblast cells with 
DFO (Pourzand et al, 1999) and in B6 fibroblasts. In the latter case the IRP/IRE 
binding activity was increased in B6 cells when pre-treated with DFO alone or prior 
to H2O2 treatment (Pantopoulos and Hentze, 1995). 
The time course experiment following hemin treatment revealed that the 
increase in H-Ft levels in both the J16 and HJ16 cells was not highly induced in the 
early hours after treatment, presumably because Ft molecules takes time to get 
synthesized. However this level was increased dramatically from 8 h time point. The 
latter data is expected as hemin should first be broken down by HO and release its 
iron which in turn will stimulate de novo Ft synthesis. The rate of Ft synthesis in Hela 
cells increased only 4 h after hemin treatment (Kvam et al, 2000). The de novo 
synthesis of Ft in skin fibroblasts following its proteolytic degradation by UVA was 
also apparent from 4 h post-irradiation time point (Pourzand et al, 1999). The iron 
accumulation in HJ16 cells after hemin treatment was only apparent after 2 h post 
treatment with a peak at 6 h after which was then reduced, presumably because of 
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sequestration of a portion of it in the newly synthesized Ft molecules since this timing 
coincided with detection of higher Ft levels.  
Overall the comparison of H-Ft levels between J16 and HJ16 after 18 h hemin 
treatment shows that J16 has much higher H-Ft levels than HJ16. Ferritin biosynthesis 
also strongly increased in B6 fibroblasts pre-treated with haem arginate (Pantopoulos 
and Hentze, 1995).  Ferritin expression was highly induced when skin keratinocytes 
and fibroblasts were treated overnight with hemin (Zhong et al, 2004 and Reelfs et al, 
2004). Ferritin expression was also increased 6-fold following overnight treatment 
with hemin in macrophages (Mehlhase et al, 2005). A strong up-regulation of both H- 
and L-Ft chains was reported in HeLa cells after iron administration (Cairo et al, 
1985). On the contrary, only H-Ft was induced after hemin treatment in bovine artery 
endothelial cells (Lin et al, 1998), L-Ft on the other hand was unaffected.  
The lower H-Ft level in HJ16 cells after hemin treatment appears to be not 
sufficient to sequester the excess iron load by hemin, since the level of LIP remains 
high even after 18 h post-treatment time point. Under conditions of severe 
macrophage lysosomal iron overload, induction of Ft synthesis is also not enough to 
completely prevent the H2O2-mediated cytotoxicity effects (Garner et al, 1997). On 
the other hand, the higher level of H-Ft in J16 cells appears to be sufficient to 
incorporate the excess iron from hemin breakdown, since the LIP level were returned 
to control value 18 h after hemin treatment. Additional incubation of J16 and HJ16 
cells for 24 h in CM following 18 h hemin treatment increased further the H-Ft levels 
in both cell lines although still to much lower extent in HJ16 cells.     
Exposure of hemin treated cells to 0.5 mM H2O2 significantly increased the H-
Ft and L-Ft levels in both cell lines although to a lesser extent in HJ16 cells. The 
presence of excess iron in HJ16 cells promoted severe oxidative damage in this cell 
line that led to high percentage of necrotic cell death. These results indicated that 
loading of HJ16 cells with iron in the form of hemin abolishes their resistance to 
H2O2. In J16 cells, induction of high H-Ft levels after hemin treatment appeared to 
protect the cells against H2O2-induced oxidative damage and necrotic cell death. So Ft 
molecules in J16 cells acted as an antioxidant as has been reported in some studies. 
For example, in endothelial cells, iron loading for 1 h significantly increased the 
cytotoxicity of H2O2 or oxidants from activated inflammatory cells (Balla et al, 1992).  
Interestingly, at 16 hrs the cells became highly resistant to oxidative-mediated injury.  
This was correlated with 50-fold and 10-fold increase in HO and Ft, respectively.  
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This has also been demonstrated in murine L1210 lymphocytic leukaemia cells using 
various types of oxidative insults (Lin and Girotti, 1997).  Only after long-term 
exposure (20-24 hrs) to hemin, cells became significantly resistant to both H2O2 and 
1O2 toxicity. This observation was correlated with 12 to 15-fold increase in H-Ft. L-
Ft, on the other hand, was not modified.  This seems to be the case in J16 cells where 
Ft is acting as an antioxidant, as hemin pre-treatment prior H2O2 treatment promoted 
less necrosis. This could explain the protection that hemin has offered in J16 cells 
prior to H2O2 treatment. In HJ16 cells, the H- and L-Ft induction was highly induced 
to incorporate the LIP release after hemin pre-treatment, but the absolute level of H-Ft 
was dramatically lower than that of J16. That is why HJ16 could not cope by excess 
iron from hemin treatment since Ft induction was not sufficient to sequester extra iron 
and protect the cells from oxidative damage exerted by H2O2 treatment.  In the latter 
case Ft failed to act as an antioxidant. 
Finally the effect of hemin and DFO treatment with and without H2O2 
treatment was investigated.  The DFO treatment increased the level of H- and L-Ft 
induction after hemin treatment in both cell lines. Accordingly the level of necrotic 
cell death decreased in HJ16 cells after H2O2 treatment. The latter data confirmed that 
the increased susceptibility of HJ16 cells to H2O2 was due to high iron accumulation 
by hemin breakdown that could not be entirely sequestered within low amount of Ft 
molecules available. But additional DFO treatment cleared excess iron from the cells 
and therefore decreased the high level of necrotic cell death observed with hemin 
treatment alone.  In at least six different cell lines, DFO exposure to iron pre-loaded 
cells accelerated Ft protein turnover in the lysosomes and consequently iron release 
from Ft (Truty et al, 2001; Kindane et al, 2006; De Domenico et al, 2006). 
Mitochondrial ferritin (Mt-Ft) was also measured in both cell lines.  In J16 cell 
line Mt-Ft basal level was 0.53 ng/mg and 1.52 ng/mg in HJ16 cells.  In J16 cell line, 
following either hemin or DFO treatment prior H2O2 treatment or H2O2 treatment 
alone, Mt-Ft was negligible.  On the other hand, in HJ16 cell line, Mt-Ft was increased 
up to 4-fold after 0.5 mM H2O2 treatment (measured 24 h following the treatment), 
overnight treatment with 20 µM hemin (measured 24 h following the treatment), 
H2O2 treatment (0.5 mM) following overnight treatment with 20 µM hemin 
(measured immediately following the treatment).  It was also increased up to 5-fold 
after overnight treatment with 100 µM DFO (measured 24 h following the treatment).  
Mitochondrial ferritin (Mt-Ft) is currently under investigation in our cell model. 
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The role of iron-mediated lysosomal damage in J16 and HJ16 cells 
 Lysosomes have been implicated in the turnover of Ft (and consequently, iron 
release) in K562 cells (human leukaemia cell line) and human fibroblasts (Roberts 
and Bomford, 1988 and Radisky and Kaplan, 1998).  Treatment of human skin 
fibroblasts with UVA radiation (320 – 380 nm) lead to an immediate release of iron 
via the proteolysis of Ft (Pourzand et al, 1999).  This study provided the first 
evidence that UVA-mediated Ft degradation originates from the destabilization of 
lysosomal membranes and the subsequent leakage of proteolytic enzymes.  
Chymotrypsin, a lysosomal protease that is responsible for the degradation of Ft 
molecules in lysosomes, was around 3-fold higher in UVA-treated cells when 
compared with unirradiated controls.  The degradation of Ft was prevented when cells 
were pretreated with Chymotrypsin-specific lysosomal protease inhibitors (i.e. 
Chymostatin and Leupeptin). Delocalisation of CATH B from the lysosomal 
compartment to the cytosol was observed after UVA radiation in human skin 
fibroblasts (Basu-Modak et al, 2006).   When human skin fibroblasts were pre-treated 
with catechins, flavonoid constituents with protective properties predominantly 
against oxidative stress, prior to UVA-radiation; iron release was prevented (Basu-
Modak et al, 2006).   De Domenico et al, (2006) have suggested that the Ft can be 
degraded by two mechanisms:  lysosomal degradation of Ft and a cytosolic route in 
which iron is extracted from Ft prior to the degradation by proteasome.  It has been 
also demonstrated that in three different cell types [Rat hepatoma cells, human Caco2 
(colonic tumour), and K562 cells] cytosolic Ft is largely degraded in the lysosomes.  
And that the release of iron from Ft is dependent on the degradation of Ft protein shell 
by lysosomal proteases (Kidane et al, 2006).  Therefore it is well known that 
lysosomes contain high amounts of redox-active iron.  Such iron can catalyse Fenton 
reactions in the presence of H2O2, resulting in lysosomal membrane damage and the 
subsequent efflux of redox-active iron and cathepsins (and other hydrolytic enzymes) 
into the cytoplasm (Yu et al, 2003 and Kurz et al, 2004).  This efflux can lead to cell 
damage and ultimately cell death (either apoptotic or necrotic, depending on the 
magnitude of the insult).  Therefore, it was decided to monitor lysosomal membrane 
damage in the cell model by three independent assays: (1) Neutral red uptake assay 
(2) Lysosensor immunofluorescence, and (3) Cathepsin B immunocytochemistry.  
Overall the results clearly demonstrated that the lysosomal membranes in the 
parental J16 cells are very sensitive to H2O2 treatment, whereas in the HJ16 cells, the 
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lysosomal membranes were very resistant to the same treatment.  In the absence of 
catalytically active iron neither superoxide radicals nor H2O2 induced any lysosomal 
damage by themselves, in lysosome-enriched mitochondrial fraction of a rat liver 
homogenate (Zdolsek and Svensson, 1993).  Lysosomal rupture may occur within 
minutes following an oxidative stress insult, however the ultimate leakage of iron 
may be delayed by hours (reviewed in Kurz et al, 2008).  In J16 cells, both DFO and 
hemin protected the cells from lysosomal damage (as discussed previously).  This is 
in agreement with our previous results showing that these two compounds protected 
J16 cells from H2O2-induced necrosis.  Since DFO is a hydrophilic molecule, it 
cannot penetrate cellular membranes very easily.  It was therefore proposed that DFO 
is taken up predominantly via endocytosis and localises almost exclusively within the 
lysosomal compartment where it seems to remain and makes the iron redox-inactive 
(Graf et al, 1984 and Lloyd et al, 1991).  Several studies have shown the DFO can 
protect the cells against H2O2-mediated oxidative damage (Doulias et al, 2003; Yu et 
al, 2003; Kurz et al, 2004).  This therefore revealed (1) the importance of redox-
active iron in the stability of lysosomes in oxidative stress and (2) H2O2 per se is not 
detrimental (reviewed in Kurz et al, 2008). In HJ16 cells, the scenario was quite 
different, interestingly DFO pre-treatment (unlike the necrosis data) had no 
significant protective effect when compared with cells treated with H2O2 alone.  
Hemin, on the other hand, promoted more lysosomal damage in HJ16.  Ferric iron has 
been shown to be essential for the cell death of hepatocytes by H2O2 and the 
lysosomal pool seems to be the source of this iron (Starke et al, 1985).  The lysosomal 
damage was also investigated in both cell lines after combined hemin-DFO treatment.  
It was shown that DFO treatment following iron loading for 18 h protected both cell 
lines from lysosomal damage.  These results were in agreement with necrosis data 
using Flow cytometry, since combined hemin-DFO pre-treatment increased 
significantly the number of live cells. 
Cathepsin B is one of the most abundant and widely expressed lysosomal 
cysteine proteases and is considered necessary for protein turnover in cells (Chapman 
et al, 1997).  In the synovial fluid of RA, CATH B may participate in the joint 
destruction by the degradation of bone collagen (Hashimoto et al, 2001).  It has been 
also reported that CATH B contributes to TNF-α-mediated hepatocyte apoptosis by 
promoting mitochondrial release of cytochrome c.  Inhibition of CATH B is a 
mechanism by which NF-κB protects the cells from lysosomal-mediated apoptosis 
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and necrosis (Liu et al, 2003). The results obtained from Cathepsin B 
immunocytochemistry confirmed the results shown with either NR or Lysosensor 
assays.  In J16 cells, both DFO and hemin pre-treatments protected the cells against 
lysosomal membrane damage induced by H2O2.  In contrast, hemin pre-treatment in 
HJ16 cells significantly damaged the lysosomes following H2O2 exposure where DFO 
pre-treatment had no significant effect. 
 
 Preliminary Clinical data 
 A preliminary study on human and rat fibroblasts were conducted in parallel 
of the current study.  In addition to this, LPI measurements of normal, RA and OA 
synovial fluid (SF) were measured.  
The results revealed that both HN-1 and HOA-1 cells were resistant even to 
high non-physiological doses of H2O2. The basal LIP levels of HN-1, HRA-1, and 
HOA-1 were very low. Because of the higher susceptibility of HOA-1 to H2O2-
mediated damage it was hypothesised that H2O2-induced levels of LIP in HOA-1 
would be higher than HN-1 following treatment with an intermediate dose of H2O2 
(i.e. 1mM).  The results were in agreement with our hypothesis, since following 
treatment of cells with an intermediate dose of 1mM H2O2, the LIP levels in HOA-1 
increased to a detectable level (i.e. 0.18 ± 0.06 µM/µg) while it remained at 
undetectable levels in HN-1.  The LIP was also undetectable in HRA-1 cells.   
Normal (VW-1) and AA (AAVW-1) rat fibroblasts were also treated with the 
same concentrations of H2O2 and it was quite interesting to note that AAVW-1 cells 
were very resistant to all the doses used while VW-1 was very sensitive to the same 
treatment.  The basal levels of the LIP were also undetectable in VW-1 but in 
AAVW-1 cells it was found to be within detectable range of 0.003 ± 1.25 x 10-5 
µM/µg.   Similarly with our rat cell model, it was hypothesised that an increase in LIP 
will be only seen in the normal (VW-1) cells when compared to AA (AAVW-1) rat 
fibroblasts after H2O2 treatment. Following an intermediate dose of 1mM of H2O2, the 
LIP levels of VW-1 increased to the detectable levels and in AAVW-1 cells, the 
increase was interestingly more than 13-fold.    From the above results, it seems that 
the increase in LIP is correlated with H2O2-induced cell damage. However, 
statistically, more clinical samples are needed to draw a proper conclusion. The 
culture of these synovial fibroblasts was time consuming and difficult and despite 
receiving appropriate number of biopsies for this thesis, we failed to keep most of 
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these biopsies in culture. It is therefore necessary to set up in the future new improved 
culture conditions to be able to provide satisfactory answers to the questions asked in 
this thesis.     
Spectrographic studies showed that synovial fluid (SF) from patients with RA 
contained elevated concentrations of iron when compared with normal subjects 
(Niedermeier et al, 1962). By emission spectrometric analysis, the mean 
concentration of iron was higher in the SF of RA patients than normal subjects 
(Niedermeier and Griggs, 1971). Using a colorimetric method, plasma iron in RA and 
OA patients were non-significantly lower (p value > 0.05) than healthy subjects 
(Yazar et al, 2005).  On the other hand, iron in the SF was significantly higher in OA 
patients than RA and healthy subjects.  Ferritin levels were significantly higher in the 
SF of RA patients when compared with OA patients (Ahmadzadeh et al, 1990).  
Labile iron (LI) was measured in the synovial fluid (SF) of normal, 
rheumatoid arthritic (RA), and osteoarthritic (OA) patients.  Synovial fluid from a 
normal, two RA, and six OA patients was analysed.  The results showed that there 
was no consistent pattern in these fluids.  The LPI of the normal patient was 0.45 ± 
0.3 µM, it seems to be slightly higher in RA but it was non-significant (p value > 
0.05).  In OA samples, some had higher value than the normal sample and others had 
lower values, but they were all non-significant. Clearly, more samples are needed to 
complement these observations and to draw a proper conclusion. 
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Concluding Remarks and Limitations of this study 
 A model of the major findings in this thesis is demonstrated in figures 4.1 and 
4.2.  Figure 4.1 provides a summary of the effect of H2O2 treatment alone or 
following iron chelation in J16 and HJ16 cells in regard to the LIP levels, lysosomal 
damage, the influence on Ft synthesis/decrease, and the ensuing necrotic cell death. 
Figure 4.2 provides a summary of the effect of H2O2 treatment alone or following iron 
loading in J16 and HJ16 cells in regard to the LIP levels, lysosomal damage, the 
influence on Ft synthesis/decrease, and the ensuing necrotic cell death.  Since the Ft 
levels were not modulated in HJ16 cells following H2O2 treatment, the source of 
labile iron could generally be from the lysosomal damage shown in HJ16 cells.    
Overall the findings of this thesis revealed that the resistance of HJ16 cells to 
H2O2 was mainly related to higher total intracellular glutathione content, higher GPx 
activity and lower Ft levels than J16 cells. These results strongly suggest that both 
antioxidants and H2O2-induced labile iron are modulated when cells are chronically 
exposed to H2O2. The modulation of intracellular LIP and glutathione content appears 
to directly influence the susceptibility of cells to H2O2-induced oxidative damage and 
necrotic cell death.  These results are consistent with the conclusion that both 
antioxidant defence mechanisms and labile iron status are important factors to 
consider in oxidative injuries and in related pathological conditions such as RA.  
Indeed, during the progression of RA in joints, the synovial cell components notably 
T-cells and fibroblasts are constantly exposed to high levels of ROS that are 
generated during ischemia-reperfusion in response to inflammation.  The chronic 
exposure of synovial cells to ROS should almost certainly modulate the intracellular 
antioxidant defence mechanism of cells; however to our knowledge, no study has 
investigated this phenomenon in detail.   Furthermore, studies carried out by our 
laboratory and others (e.g. Breuer et al, 1997) have clearly demonstrated that acute 
exposure of cells to oxidising agents such as UVA or H2O2, promotes an increase in 
potentially harmful labile iron in the cells that acts to exacerbate the ongoing 
peroxidative cell damage, leading to necrotic cell death.  However no study has 
explored this important phenomenon in chronic oxidative conditions such as RA.  In 
order to gain insight into the adaptation of synovial cell components to chronic 
oxidative exposure in RA, it is necessary to study the behaviour of synovial 
fibroblast, macrophages and T-cells to both acute and chronic exposure to oxidising 
agents such as H2O2. 
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A. J16 cell line 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. HJ16 cell line 
 
 
 
 
 
                                                                                                                                   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 : Effect H2O2 alone or following iron chelation in J16 and HJ16 cells. 
 
Protection/increase is represented by a solid line - Degradation/decrease is 
represented by a dashed line, and the upper arrow represents the fold increase of LIP 
compared with the basal levels). Lysosomes may have been implicated in the 
degradation of ferritin. The green colour indicates the effect of DFO pre-treatment.                           
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In J16 cells, H2O2 decreases 
the ferritin levels and causes 
damage to the lysosomal 
membrane.  This has been 
correlated with an increase in 
LIP levels and the ensuing 
necrotic cell death.  DFO pre-
treatment prior to H2O2 
protects the lysosomal 
membrane and decreases the 
ferritin levels. This has been 
correlated with a decrease in 
the LIP levels and the ensuing 
cell death. 
In HJ16 cells, H2O2 does not 
significantly modulate the 
ferritin levels but causes 
damage to the lysosomal 
membrane to a lesser extent 
than in the J16 cells.  This has 
been correlated with an 
increase in LIP levels and the 
ensuing necrotic cell death.  
DFO pre-treatment prior to 
H2O2 has no significant effect 
on lysosomal membrane but 
decreases the ferritin levels. 
This has been correlated with a 
decrease in the LIP levels and 
the ensuing cell death. 
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A.   J16 cell line 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.   HJ16 cell line 
 
 
 
 
 
                                                                                                                                   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 : Effect H2O2 alone or following iron loading in J16 and HJ16 cells. 
 
(Protection/increase is represented by a solid line - Degradation/decrease is 
represented by a dashed line, and the upper arrow represents the fold increase of LIP 
compared with the basal levels). Lysosomes may have been implicated in the 
degradation of ferritin. The red colour indicates the effect of hemin pre-treatment.                              
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In J16 cells, H2O2 decreases 
the ferritin levels and causes 
damage to the lysosomal 
membrane.  This has been 
correlated with an increase in 
LIP levels and the ensuing 
necrotic cell death.  Hemin 
pre-treatment prior to H2O2 
protects the lysosomal 
membrane and increases the 
ferritin levels. This has been 
correlated with a decrease in 
the LIP levels and the ensuing 
cell death. 
In HJ16 cells, H2O2 does not 
significantly modulate the 
ferritin levels but causes 
damage to the lysosomal 
membrane to a lesser extent 
than in the J16 cells.  This has 
been correlated with an 
increase in LIP levels and the 
ensuing necrotic cell death.  
Hemin pre-treatment prior to 
H2O2 increased the lysosomal 
membrane damage and the 
ferritin levels. This has been 
correlated with an increase in 
the LIP levels and the ensuing 
cell death. 
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Lymphocytes and macrophages are the predominant cells in chronic 
inflammation (Junqueira et al, 1986; Underwood, 1996; Stevens and Lowe, 1999).  
Lymphocytes are also the key components in the onset and exacerbation of 
autoimmune diseases and the cytokines produced by them have a great impact on 
disease progression (Horwood, 2008). Infiltration of numerous T-cells has been 
noticed in the RA synovium; T-cells represent 40% of the synovial cellular infiltrate 
(Ling and Miossec, 2007). Chronic inflammation occurs in an autoimmune disease 
(e.g. RA) in which self-antigens continually activate T-cells (Goldsby et al, 2003).  
Macrophages, fibroblasts, and T lymphocytes are three cell populations which are 
found abundantly in the rheumatoid arthritic synovium (Tran et al, 2005).  T-cells can 
stimulate both macrophages and fibroblasts to produce more pro-inflammatory 
cytokines.  T-cells can exert potentially pathogenic effects through their ability to 
modulate the functions of the surrounding cells by cell to cell contact (e.g. 
macrophages) or through the release of soluble factors (e.g. IL-17 on fibroblasts). 
Indeed, activated synovial T cells are key initiators and orchestrators of inflammation 
in RA, and therefore they represent key cellular targets for therapy (Cope et al, 2007).   
Several studies have attempted to isolate synovial T-cells and macrophages to 
study e.g. the role of NFκB in rheumatoid arthritis conditions, but these cells have a 
short half-life in laboratory-based cell culture conditions and as a result can not be 
used for in-depth long term studies.  Furthermore the isolation of these cells in RA is 
subject to patient to patient differences and most importantly in such studies the lack 
of a ‘proper control’ should severely hamper the interpretation of the data obtained.  
The use of Jurkat parental T-cells (i.e. J16 cell line) in the present study provided us 
with such ‘proper control’ for the effects seen in its H2O2-adapted counterpart (i.e. 
HJ16 cell line). Jurkat cells are widely used in the study of T-cell activation processes 
(Schreck et al, 1991) as these cells are considered as critical determinants of the 
extent and chronicity of an inflammatory response.  Furthermore Jurkat T-cells are 
particularly vulnerable to oxidative stress and therefore could illustrate clearly the 
nature of oxidative damage in cells upon acute exposure to oxidative stress.  On the 
other hand, the H2O2-adapted cell line provides a precious tool to undertake an in-
depth long term comparative study in terms of adaptation of T-cells to chronic 
exposure.  Unpublished data from N.D Hall’s laboratory (Department of Pharmacy 
and Pharmacology, University of Bath) have shown that HJ16 cells have 
characteristics similar to those of rheumatoid synovial T cells.  These characteristics 
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include low CD3 levels, elevated CD69 expression, increased intracellular glutathione 
levels, and enhanced resistance to apoptosis.  They have also noticed that HJ16 cells 
can stimulate monocytes to secrete pro-inflammatory cytokines (i.e. IL-1β). Although 
Jurkat cells are not the same as T-cells (otherwise they would not be immortal) in 
regard to the biochemistry, they are compromised in the study of T-cell function.  
HJ16 cells were derived by treating the J16 cell line with increasing concentration of 
H2O2 (i.e. from 0.1 mM to 3 mM) at weekly to fortnightly intervals.  After each 
treatment the surviving cells were allowed to recover normal growth characteristics 
before further exposure to a higher concentration of H2O2.  Although they were 
resistant up to a dose of 3mM H2O2, at 0.1 mM around 30 % of the cells were dead. 
The reason may be that the HJ16 cell line is a polyclonal cell line and therefore within 
its population, it will still contain some fraction of cells with higher susceptibility to 
H2O2 doses used.  
 The outcome of this study was intended to be checked in synovial fibroblasts 
obtained from OA and RA patients, so that the study could verify a series of 
parameters such as the level of antioxidant systems and the labile iron status as well 
as their level of resistance to H2O2 doses applied.  As it can be seen in section 3.5, we 
encountered serious problems in maintaining the synovial fibroblast biopsies in 
culture and therefore the study lacked a proper end-point for a direct link between the 
effects observed in the Jurkat cell model and RA/OA cell components.  Nevertheless, 
although our clinical samples were not studied extensively, it appears that synovial 
fibroblasts were very resistant to H2O2 and that iron is implicated in their resistance. 
Since synovial fibroblasts are the major source of proteases involved in tissue damage 
in RA, it is expected that an alteration in iron homeostasis would occur and that the 
potential relevance of iron chelation would be beneficial.  The present thesis brings a 
new dimension to the role of iron in rheumatoid arthritis.    
 Our results raise the hypothesis that cells chronically exposed to oxidative 
stress as anticipated in the RA environment can withstand high and continuous levels 
of free radicals due to the modulation of both the antioxidants and the oxidative 
stress-induced iron release.  It could be predicted that the high iron concentration 
shown in RA in the cells or in the synovial fluid arises found from the lysosomal 
membrane damage, and/or degradation of Ft, and/or mitochondrial damage, and/or 
nuclear damage occurring subsequent to the oxidative stress. However, more 
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investigations are needed to complement the observations revealed in the Jurkat T cell 
lines (i.e. J16 and HJ16 cell lines) and to draw a proper conclusion. 
 
 
Further Directions 
 The present study provided a potential link between iron, lysosomal-
membrane damage and the ensuing necrotic cell death that will almost certainly help 
to understand their role in progression of iron- related chronic inflammatory disorders 
such as RA. However it is clear that more in depth investigations are required to 
unravel the role of Ft in chronic oxidative stress/ inflammatory conditions. Metabolic 
labelling of Ft and immunoprecipitation with a pulse chase experiment would be very 
useful in knowing if there was a difference in the half-life of Ft and if there was any 
difference in its processing in both cell lines. Mitochondrial iron and ferritin would be 
an important area to look into as Mt-Ft has the potential of being an iron regulator in 
the cell and to protect the mitochondria from iron-induced damage.  Preliminary 
findings indicate the cells overexpressing Mt-Ft (i.e. HJ16 cells) are more resistant to 
oxidative damage induced by H2O2, but obviously additional studies are required. It 
would be useful to measure the lysosomal proteases and to use their inhibitors and the 
lysosomal-membrane stabilisation compounds.  Although this study has been useful 
to unravel some of the mechanisms and factors that might have lead to the resistance 
of HJ16 cells, more investigations are required:  for example, to examine the TfR 
levels by Western blotting, ferroportin levels, human poly (rC)-binding protein 
(PCBP1), and the IRP/IRE system in our cell model. It will be important to look at the 
activity of the ferroxidase site in the H-Ft. This will hopefully lead to a better 
understanding of the high LIP levels measured after iron loading in HJ16 especially 
after the study of the radiolabel incorporation of iron. In addition to this, the effect of 
acute (i.e. 1-2 h) iron loading prior to oxidative stress would be an important area to 
explore. In the process of this study, iron loading was achieved by using haem iron 
since it is the most physiological source of iron, however it would be interesting to 
examine the effects of other sources of iron such as ferric chloride to increase 
lysosomal iron or ferric ammonium citrate to increase extracellular iron. The use of 
HO-1 and HO-2 siRNA could also provide more clues as to the role of HO in these 
cell lines. Moreover, the role of iron in NFκB activation should be interesting to 
investigate.  The role of thioredoxin is ill-defined in our system and it is important in 
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the future to investigate the role of this key molecule in redox regulation of genes and 
its role in iron metabolism.    
To mimic an inflammatory environment it is necessary i.e. to combine the 
H2O2 treatment with cytokines (e.g. IL-1β and TNF-α) in our cell model so that the 
effects mimic closely the in vivo condition.  Measurements of cytokines in these cell 
lines after relevant treatments would be an interesting area to explore.  A completion 
of the in vitro studies is also essential with the human and rat samples to further 
characterise them in respect to the current findings in our cell lines. It would be also 
beneficial to harvest and study lymphocytes from RA patients and compare the results 
obtained from this study.  The culture of these synovial fibroblasts from patients were 
time consuming and difficult and despite receiving appropriate number of biopsies for 
this thesis, we failed to keep most of these biopsies in culture. It is therefore necessary 
to set up in the future new improved culture conditions to be able to prevent the 
contamination of the biopsies and cells. This will hopefully increase our 
understanding of what is occurring in RA cells. 
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